• Principal Investigator
  • Male

Prof. dr. H.R. Büller

Position: Professor
Main activities: Research
Specialisation: Vascular Medicine
foto H.R. Büller is one of the AMC Principal Investigators
Focus of research:

Etiology, diagnosis and treatment of:

  • Pulmonary embolism
  • Thrombosis
  • Athero thrombosis
  • Anticoagulants and cancer
AMC themes: Cardiovascular Diseases
Departments: Internal Medicine: Vascular Medicine
Bleker SM. Clinical aspects of venous thromboembolism in special patient populations. S.l.: s.n.; 2017. 297p. ISBN 978-94-6299-663-2 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Middeldorp S; copromotor(s): Büller HR, Di Nisio M)
Bleker SM, Brekelmans MPA, Eerenberg ES, Cohen AT, Middeldorp S, Raskob G, Büller HR, Clinical impact of major bleeding in patients with venous thrombo-embolism treated with factor Xa inhibitors or vitamin K antagonists. THROMB HAEMOSTASIS 2017;117 (10):1944-1951 [PubMed]
Brekelmans MPA, Kappelhof M, Nieuwkerk PT, Nierman M, Buller HR, Coppens M, Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism. NETH J MED 2017;75 (2):50-55 [PubMed]
Brekelmans MPA, Scheres LJJ, Bleker SM, Hutten BA, Timmermans A, Büller HR, Middeldorp S, Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin. THROMB HAEMOSTASIS 2017;117 (4):809-815 [PubMed]
Di Minno MND, Ageno W, Lupoli R, Conte G, van Es N, Buller HR, Dentali F, Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials. EUR RESPIR J 2017;50 (3):1701097 [PubMed]
Di Nisio M, Raskob G, Büller HR, Grosso MA, Zhang G, Winters SM, Cohen A, Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists. THROMB HAEMOSTASIS 2017;117 (4):784-793 [PubMed]
Khan F, Rahman A, Carrier M, Kearon C, Schulman S, Couturaud F, Prandoni P, Eichinger S, Becattini C, Agnelli G, Büller HR, Brighton TA, Palareti G, Pinede L, Sabri E, Hutton B, Wells GA, Rodger MA, Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis. BMJ OPEN 2017;7 (9):e016950 [PubMed]
Kraaijpoel N, van Es N, Porreca E, Büller HR, Di Nisio M, The diagnostic management of upper extremity deep vein thrombosis: A review of the literature. THROMB RES 2017;156:54-59 [PubMed]
Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, Brekelmans MPA, Büller HR, Elias A, Farge D, Konstantinides S, Palareti G, Prandoni P, Righini M, Torbicki A, Vlachopoulos C, Brodmann M, Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function. EUR HEART J 2017;-:- [PubMed]
Robert-Ebadi H, Mostaguir K, Hovens MM, Kare M, Verschuren F, Girard P, Huisman MV, Moustafa F, Kamphuisen PW, Buller HR, Righini M, Le Gal G, Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score. J THROMB HAEMOST 2017;15 (9):1764-1769 [PubMed]
Scheres LJJ, Brekelmans MPA, Beenen LFM, Büller HR, Cannegieter SC, Middeldorp S, Sex-specific differences in the presenting location of a first venous thromboembolism. J THROMB HAEMOST 2017;15 (7):1344-1350 [PubMed]
van der Hulle T, van Es N, den Exter PL, van Es J, Mos ICM, Douma RA, Kruip MJHA, Hovens MMC, ten Wolde M, Nijkeuter M, ten Cate H, Kamphuisen PW, Büller HR, Huisman MV, Klok FA, Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability?. THROMB HAEMOSTASIS 2017;117 (8):1622-1629 [PubMed]
van Es N. Cancer and thrombosis: Improvements in strategies for prediction, diagnosis, and treatment. S.l.: s.n.; 2017. 297p. ISBN 978‐94‐6299‐749‐3 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Middeldorp S, Bossuyt PMM; copromotor(s): Büller HR, Di Nisio M)
van Es N, Bleker SM, Di Nisio M, Kleinjan A, Beyer-Westendorf J, Camporese G, Aggarwal A, Verhamme P, Righini M, Büller HR, Bossuyt PM, Improving the diagnostic management of upper extremity deep vein thrombosis. J THROMB HAEMOST 2017;15 (1):66-73 [PubMed]
van Es N, Di Nisio M, Cesarman G, Kleinjan A, Otten HM, Mahé I, Wilts IT, Twint DC, Porreca E, Arrieta O, Stépanian A, Smit K, de Tursi M, Bleker SM, Bossuyt PM, Nieuwland R, Kamphuisen PW, Büller HR, Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study. HAEMATOLOGICA 2017;102 (9):1494-1501 [PubMed]
van Es N, Franke VF, Middeldorp S, Wilmink JW, Büller HR, The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer. THROMB RES 2017;150:30-32 [PubMed]
van Es N, Kraaijpoel N, Klok FA, Huisman MV, den Exter PL, Mos ICM, Galipienzo J, Büller HR, Bossuyt PM, The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis. J THROMB HAEMOST 2017;15 (4):678-684 [PubMed]
van Es N, Le Gal G2g, Otten HM, Robin P, Piccioli A, Lécumberri R, Palomares LJ, Religa P, Rieu V, Rondina MT, Beckers MM, Prandoni P, Salaun PY, Di Nisio M, Bossuyt PM, Büller HR, Carrier M, Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis. BMJ OPEN 2017;7 (6):e015562 [PubMed]
van Es N, Le Gal G, Otten HM, Robin P, Piccioli A, Lecumberri R, Jara-Palomares L, Religa P, Rieu V, Rondina M, Beckers MM, Prandoni P, Salaun PY, Di Nisio M, Bossuyt PM, Büller HR, Carrier M, Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism A Systematic Review and Meta-analysis of Individual Patient Data. ANN INTERN MED 2017;167 (6):410-+ [PubMed]
van Es N, van der Hulle T, Büller HR, Klok FA, Huisman MV, Galipienzo J, Di Nisio M, Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism?. J THROMB HAEMOST 2017;15 (2):323-328 [PubMed]
Wang KL, Büller HR, Goto S, Lin CY, Lai EY, Chiu CC, Chiang CE, Giugliano RP, Extracranial arterial and venous thromboembolism in patients with atrial fibrillation: A meta-analysis of randomized controlled trials. HEART RHYTHM 2017;14 (4):599-605 [PubMed]
Wilts IT, Hutten BA, Meijers JCM, Spek CA, Büller HR, Kamphuisen PW, Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer. THROMB RES 2017;154:1-6 [PubMed]
Wilts IT, Le Gal G, den Exter PL, van Es J, Carrier M, Planquette B, Büller HR, Righini M, Huisman MV, Kamphuisen PW, Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism. THROMB RES 2017;152:49-51 [PubMed]
Ageno W, Büller HR, Falanga A, Hacke W, Hendriks J, Lobban T, Merino J, Milojevic IS, Moya F, van der Worp HB, Randall G, Tsioufis K, Verhamme P, Camm AJ, Managing reversal of direct oral anticoagulants in emergency situations Anticoagulation Education Task Force White Paper. THROMB HAEMOSTASIS 2016;116 (6):1003-1010 [PubMed]
Bleker SM, Beenen LFM, Di Nisio M, van Es N, Büller HR, Kraaijpoel N, Rutten A, Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots. THROMB RES 2016;147:46-51 [PubMed]
Bleker SM, Cohen AT, Büller HR, Agnelli G, Gallus AS, Raskob GE, Weitz JI, Curto M, Sisson M, Middeldorp S, Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trial. THROMB HAEMOSTASIS 2016;116 (6):1159-1164 [PubMed]
Bleker SM, van Es N, Kleinjan A, Büller HR, Kamphuisen PW, Aggarwal A, Beyer-Westendorf J, Camporese G, Cosmi B, Gary T, Ghirarduzzi A, Kaasjager K, Lerede T, Marschang P, Meijer K, Otten HM, Porreca E, Righini M, Verhamme P, van Wissen S, Di Nisio M, Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis. J THROMB HAEMOST 2016;14 (5):973-981 [PubMed]
Bleker SM, van Es N, van Gils L, Daams JG, Kleinjan A, Büller HR, Di Nisio M, Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review. THROMB RES 2016;140 (Suppl. 1):S81-S88 [PubMed]
Brekelmans MPA, Ageno W, Beenen LF, Brenner B, Buller HR, Chen CZ, Cohen AT, Grosso MA, Meyer G, Raskob G, Segers A, Vanassche T, Verhamme P, Wells PS, Zhang G, Weitz JI, Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. LANCET HAEMATOL 2016;3 (9):E437-E445 [PubMed]
Brekelmans MPA, Bleker SM, Bauersachs R, Boda Z, Büller HR, Choi Y, Gallus A, Grosso MA, Middeldorp S, Oh D, Raskob G, Schwocho L, Cohen AT, Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists. THROMB HAEMOSTASIS 2016;116 (1):155-161 [PubMed]
Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M [Contributors: Connolly SC, Crowther M, Eikelboom J, Gibson M, Milling TJ, Albaladejo P, Cohen A, Lopez-Sendon J, Middeldorp S, Schmidt J, Verhamme P, Beyer-Westendorf J, Wyse DG, Garcia D, Prins M, Nakamya J, Büller HR, Mahaffey K, Alexander J, Demchuk A, Raskob G, Schulman S, Meeks B, Zotova E, Holadyk-Gris I, Pinto T, Behr M, Lim T, Anand R, Bastani A, Caterino J, Clark C, Concha M, Cornell J, Eriksson E, Fermann G, Fulmer J, Goldstein J, Kereiakes D, Lotfipour S, Milling T, Moll S, Pallin D, Patel N, Refaai M, Rehman M, Schmaier A, Schwarz E, Shillinglaw W, Sinert R, Singer A, Takata T, Venkat A, Weinstein D, Welker J, Welsby I, Wiener S, Wilson J, Blostein M, van Keer L, Verschuren F, Coppens M, van Wissen S, Alikhan R, Breen K, Hall R]] , Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. NEW ENGL J MED 2016;375 (12):1131-1141 [PubMed]
Di Nisio M, Ageno W, Rutjes AWS, Pap AF, Büller HR, Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists. THROMB HAEMOSTASIS 2016;115 (2):424-432 [PubMed]
Di Nisio M, van Es N, Büller HR, Deep vein thrombosis and pulmonary embolism. LANCET 2016;388 (10063):3060-3073 [PubMed]
Elbers LPB, Boon HA, Moes MI, van Zaane B, Brandjes DPM, Fliers E, Büller HR, Cannegieter S, Gerdes VEA, Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery. EUR THYROID J 2016;5 (2):139-144 [PubMed]
Hendriksen J, Geersing GJ, Lucassen W, Erkens P, Stoffers J, van Weert H, Büller H, Hoes A, Moons K, Een bruikbare klinische beslisregel voor longembolie. HUISARTS WET 2016;59 (5):200-203
Hendriksen JMT, Lucassen WAM, Erkens PMG, Stoffers HEJH, van Weert HCPM, Büller HR, Hoes AW, Moons KGM, Geersing GJ, Ruling Out Pulmonary Embolism in Primary Care: Comparison of the Diagnostic Performance of "Gestalt" and the Wells Rule. ANN FAM MED 2016;14 (3):227-234 [PubMed]
Pépin M, Kleinjan A, Hajage D, Büller HR, Di Nisio M, Kamphuisen PW, Salomon L, Veyradier A, Stepanian A, Mahé I, ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer. J THROMB HAEMOST 2016;14 (2):306-315 [PubMed]
Raskob G, Ageno W, Cohen AT, Brekelmans MPA, Grosso MA, Segers A, Meyer G, Verhamme P, Wells PS, Lin M, Winters SM, Weitz JI, Büller HR, Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study. LANCET HAEMATOL 2016;3 (5):E228-E236 [PubMed]
Raskob GE, Gallus AS, Sanders P, Thompson JR, Agnelli G, Buller HR, Cohen AT, Ramacciotti E, Weitz JI, Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial. THROMB HAEMOSTASIS 2016;115 (4):809-816 [PubMed]
Raskob GE, van Es N, Segers A, Angchaisuksiri P, Oh D, Boda Z, Lyons RM, Meijer K, Gudz I, Weitz JI, Zhang G, Lanz H, Mercuri MF, Büller HR, Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial. LANCET HAEMATOL 2016;3 (8):E379-E387 [PubMed]
Schünemann HJ, Ventresca M, Crowther M, Briel M, Zhou Q, Garcia D, Lyman G, Noble S, Macbeth F, Griffiths G, DiNisio M, Iorio A, Beyene J, Mbuagbaw L, Neumann I, van Es N, Brouwers M, Brozek J, Guyatt G, Levine M, Moll S, Santesso N, Streiff M, Baldeh T, Florez I, Gurunlu Alma O, Solh Z, Ageno W, Marcucci M, Bozas G, Zulian G, Maraveyas A, Lebeau B, Buller H, Evans J, McBane R, Bleker S, Pelzer U, Akl EA, Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. BMJ OPEN 2016;6 (4):e010569 [PubMed]
van Es N, Bleker SM, Di Nisio M, Kleinjan A, Beyer-Westendorf J, Camporese G, Kamphuisen PW, Büller HR, Bossuyt PM, A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients. THROMB RES 2016;148:59-62 [PubMed]
van Es N, van der Hulle T, van Es J, den Exter PL, Douma RA, Goekoop RJ, Mos ICM, Galipienzo J, Kamphuisen PW, Huisman MV, Klok FA, Büller HR, Bossuyt PM, Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysis. ANN INTERN MED 2016;165 (4):253-261 [PubMed]
Verhamme P, Wells PS, Segers A, Ageno W, Brekelmans MPA, Cohen AT, Meyer G, Grosso MA, Raskob G, Weitz JI, Zhang G, Buller H, Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial. THROMB HAEMOSTASIS 2016;116 (4):747-753 [PubMed]
Agnelli G, Buller HR, Cohen A, Gallus AS, Lee TC, Pak R, Raskob GE, Weitz JI, Yamabe T, Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial. J THROMB HAEMOST 2015;13 (12):2187-2191 [PubMed]
Barreto DL, Hoekstra T, Halbesma N, Leegte M, Boeschoten EW, Dekker FW, Krediet RT [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, deFijter CWH, Frenken LAM, van Geelen JACA, Gorgels JPMC, Grave W, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , The Association of Effluent Ca125 with Peritoneal Dialysis Technique Failure. PERITON DIALYSIS INT 2015;35 (7):683-690 [PubMed]
Boom MS, Berghuis EM, Nieuwkerk PT, Pinedo S, Büller HR, When do patients prefer a direct oral anticoagulant over a vitamin K antagonist?. NETH J MED 2015;73 (8):368-372 [PubMed]
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HCW, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF [Contributors: Alonzo T, Altman DG, Azuara-Blanco A, Bachmann L, Blume J, Bossuyt PM, Boutron I, Bruns D, Büller H, Buntinx F, Byron S, Chang S, Cohen JF, Cooper R, de Groot J, Deeks J, Dendukuri N, Dinnes J, Fleming K, Gatsonis CA, Glasziou PP, Golub RM, Guyatt G, Heneghan C, Hilden J, Hooft L, Horvath R, Hunink M, Hyde C, Ioannidis J, Janes H, Kleijnen J, Knottnerus A, Korevaar A, Kressel HY, Lange S, Leeflang M, Lijmer JG, Lord S, Lumbreras B, Macaskill P, Magid E, Mallett S, McInnes M, McNeil B, McQueen M, Moher D, Moons K, Morris K, Mustafa R, Obuchowski N, Ochodo E, Onderdonk A, Overbeke J, Pai N, Peeling R, Pepe M, Petersen S, Price C, Ravaud P, Reitsma JB, Rennie D, Rifai N, Rutjes A, Schunemann H, Simel D, Simera I, Smidt N, Steyerberg E, Straus S, Summerskill W, Takwoingi Y, Thompson M, van de Bruel A, van Maanen H, Vickers A, Virgili G, Walter S, Weber W, Westwood M, Wilczynski N, Ziegler A]] , STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ-BRIT MED J 2015;351:h5527 [PubMed]
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HCW, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF [Contributors: Alonzo T, Altman DG, Azuara-Blanco A, Bachmann L, Blume J, Bossuyt PM, Boutron I, Bruns D, Büller H, Buntinx F, Byron S, Chang S, Cohen JF, de Groot RCJ, de Vet HCW, Deeks J, Dendukuri N, Dinnes J, Fleming K, Gatsonis CA, Glasziou PP, Golub RM, Guyatt G, Heneghan C, Hilden J, Hooft L, Horvath R, Hunink M, Hyde C, Ioannidis J, Irwig L, Janes H, Kleijnen J, Knottnerus A, Korevaar DA, Kressel HY, Lange S, Leeflang M, Lijmer JG, Lord S, Lumbreras B, Macaskill P, Magid E, Mallett S, McInnes M, Mc-Neil B, McQueen M, Moher D, Moons K, Morris K, Mustafa R, Obuchowski N, Ochodo E, Onderdonk A, Overbeke J, Pai N, Peeling R, Pepe M, Petersen S, Price C, Ravaud P, Reitsma JB, Rennie D, Rifai N, Rutjes A, Schunemann H, Simel D, Simera I, Smidt N, Steyerberg E, Straus S, Summerskill W, Takwoingi Y, Thompson M, van de Bruel A, van Maanen H, Vickers A, Virgili G, Walter S, Weber W, Westwood M, Whiting P, Wilczynski N, Ziegler A]] , STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. RADIOLOGY 2015;277 (3):826-832 [PubMed]
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HCW, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF [Contributors: Alonzo T, Altman DG, Azuara-Blanco A, Bachmann L, Blume J, Bossuyt PM, Boutron I, Bruns D, Büller H, Buntinx F, Byron S, Chang S, Cohen JF, Cooper R, de Groot J, de Vet HCW, Deeks J, Dendukuri N, Dinnes J, Fleming K, Gatsonis CA, Glasziou PP, Golub RM, Guyatt G, Heneghan C, Hilden J, Hooft L, Horvath R, Hunink M, Hyde C, Ioannidis J, Irwig L, Janes H, Kleijnen J, Knottnerus A, Korevaar DA, Kressel HY, Lange S, Leeflang M, Lijmer JG, Lord S, Lumbreras B, Macaskill P, Magid E, Mallett S, McInnes M, McNeil B, McQueen M, Moher D, Moons K, Morris K, Mustafa R, Obuchowski N, Ochodo E, Onderdonk A, Overbeke J, Pai N, Peeling R, Pepe M, Petersen S, Price C, Ravaud P, Reitsma JB, Rennie D, Rifai N, Rutjes A, Schunemann H, Simel D, Simera I, Smidt N, Steyerberg E, Straus S, Summerskill W, Takwoingi Y, Thompson M, van de Bruel A, van Maanen H, Vickers A, Virgili G, Walter S, Weber W, Westwood M, Whiting P, Wilczynski N, Ziegler A]] , STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. CLIN CHEM 2015;61 (12):1446-1452 [PubMed]
Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, Segers A, Verhamme P, Weitz JI [Contributors: Buller H, Weitz J, Gailani D, Segers A, Bhanot S, Prins M, Beenen L , Otten HM, Roos Y, Slagboom T, Verhamme P, Vandenbriele C, Vanassche T, Dani V, Bethune C, Schulz D, Shapiro C, Kwoh K, Jung B, Gawinek-Samelczak A, Kaemmer C, Angelov S, Stavrev V, Kinov P, Dessouki E, Abuzgaya F, Baurovskis A, Peredistijs A, Petronis S, Danilyak V, Driagin V, Kuropatkin G, Parfeev S, Safronov A, Ankin M, Korzh M, Olinichenko G, Polivoda A, Shevchenko V, Sulyma V]] , Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis. NEW ENGL J MED 2015;372 (3):232-240 [PubMed]
Büller HR, Gailani D, Weitz JI, Factor XI Antisense Oligonucleotide for Venous Thrombosis REPLY. NEW ENGL J MED 2015;372 (17):1672 [PubMed]
Di Nisio M, van Es N, Büller HR, Whole-Arm Ultrasound for Suspected Upper-Extremity Deep Venous Thrombosis in Outpatients. JAMA INTERN MED 2015;175 (11):1871 [PubMed]
Eerenberg ES, Middeldorp S, Levi M, Lensing AW, Büller HR, Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists. J THROMB HAEMOST 2015;13 (9):1590-1596 [PubMed]
Hendriksen JMT, Geersing GJ, Lucassen WAM, Erkens PMG, Stoffers HEJH, van Weert HCPM, Büller HR, Hoes AW, Moons KGM, Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care. BMJ-BRIT MED J 2015;351:h4438 [PubMed]
Lucassen WAM, Erkens PMG, Geersing GJ, Büller HR, Moons KGM, Stoffers HEJH, van Weert HCPM, Qualitative point-of-care D-dimer testing compared with quantitative D-dimer testing in excluding pulmonary embolism in primary care. J THROMB HAEMOST 2015;13 (6):1004-1009 [PubMed]
Nakamura M, Wang YQ, Wang C, Oh D, Yin WH, Kimura T, Miyazaki K, Abe K, Mercuri M, Lee LH, Segers A, Büller H, Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial. J THROMB HAEMOST 2015;13 (9):1606-1614 [PubMed]
Piccioli A. Cancer, thrombosis and low-molecular-weight heparins. S.l.: s.n.; 2015. 148p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam, onderzoek bij University of Padua, Padua, Department of Medical and Surgical Sciences. (Promotor(s): Büller H R; copromotor(s): Prandoni P)
Schapkaitz E, Jacobson BF, Manga P, Chitsike RS, Benade E, Haas S, Buller HR, Recommendations for the anticoagulation of pregnant patients with mechanical heart valves. SAMJ S AFR MED J 2015;105 (9):733-738 [PubMed]
Senoo K, Lip GYH, Lane DA, Büller HR, Kotecha D, Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial. STROKE 2015;46 (9):2523-2528 [PubMed]
Stuijver DJF, Romualdi E, van Zaane B, Bax L, Büller HR, Gerdes VEA, Squizzato A, Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis. INTERN EMERG MED 2015;10 (2):219-246 [PubMed]
ten Cate-Hoek AJ, Weitz JI, Gailani D, Meijer K, Philippou H, Bouman AC, Whitney Cheung Y, van Mens TE, Govers-Riemslag JW, Vries M, Bleker S, Biedermann JS, Stoof SCM, Buller HR, Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS). THROMB RES 2015;136 (Suppl. 1):S13-S18 [PubMed]
van Es N, Büller HR, Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations. HEMATOL-AM SOC HEMAT 2015;2015 (1):125-131 [PubMed]
van Es N, Di Nisio M, Bleker SM, Segers A, Mercuri MF, Schwocho L, Kakkar A, Weitz JI, Beyer-Westendorf J, Boda Z, Carrier M, Chlumsky J, Décousus H, Garcia D, Gibbs H, Kamphuisen PW, Monreal M, Ockelford P, Pabinger I, Verhamme P, Grosso MA, Büller HR, Raskob GE, Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study. THROMB HAEMOSTASIS 2015;114 (6):1268-1276 [PubMed]
Wendelboe AM, McCumber M, Hylek EM, Buller H, Weitz JI, Raskob G [Contributors: Angchaisuksiri P, Blanco AN, Hunt BJ, Kakkar A, Konstantinides SV, McLintock C, Ozaki Y]] , Global public awareness of venous thromboembolism. J THROMB HAEMOST 2015;13 (8):1365-1371 [PubMed]
Wilts IT, Bleker SM, van Es N, Büller HR, Di Nisio M, Kamphuisen PW, Safety of anticoagulant treatment in cancer patients. EXPERT OPIN DRUG SAF 2015;14 (8):1227-1236 [PubMed]
Büller HR, Edoxaban versus warfarin for venous thromboembolism. NEW ENGL J MED 2014;370 (1):80-81 [PubMed]
Buller HR, Halperin J, Hankey GJ, Pillion G, Prins MH, Raskob GE, Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study. J THROMB HAEMOST 2014;12 (6):824-830 [PubMed]
Cohen AT, Spiro TE, Spyropoulos AC, Desanctis YH, Homering M, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Tapson VF, Burton P, D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial. J THROMB HAEMOST 2014;12 (4):479-487 [PubMed]
Crobach MJT, Büller HR, Cannegieter SC, Tromboseprofylaxe bij ambulante patiënten met kanker?. NED TIJDSCHR GENEESKD 2014;158:A7419 [PubMed]
Debeij J, van Zaane B, Dekkers OM, Doggen CJM, Smit JWA, van Zanten AP, Brandjes DPM, Büller HR, Gerdes VEA, Rosendaal FR, Cannegieter SC, High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study. J THROMB HAEMOST 2014;12 (6):839-846 [PubMed]
Erkens PMG, Lucassen WAM, Geersing GJ, van Weert HCPM, Kuijs-Augustijn M, van Heugten M, Rietjens L, ten Cate H, Prins MH, Büller HR, Hoes AW, Moons KGM, Oudega R, Stoffers HEJH, Alternative diagnoses in patients in whom the GP considered the diagnosis of pulmonary embolism. FAM PRACT 2014;31 (6):670-677 [PubMed]
Farge-Bancel D, Bounameaux H, Brenner B, Büller HR, Kakkar A, Pabinger I, Streiff M, Debourdeau P, Implementing thrombosis guidelines in cancer patients: a review. RAMBAM MAIMONIDES MED J 2014;5 (4):e0041 [PubMed]
Kleinjan A, Di Nisio M, Beyer-Westendorf J, Camporese G, Cosmi B, Ghirarduzzi A, Kamphuisen PW, Otten HM, Porreca E, Aggarwal A, Brodmann M, Guglielmi MD, Iotti M, Kaasjager K, Kamvissi V, Lerede T, Marschang P, Meijer K, Palareti G, Rickles FR, Righini M, Rutjes AWS, Tonello C, Verhamme P, Werth S, van Wissen S, Büller HR, Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. ANN INTERN MED 2014;160 (7):451-457 [PubMed]
Kleinjan A, Hutten BA, Di Nisio M, Büller HR, Kamphuisen PW, Anticoagulant treatment of cancer patients with pulmonary embolism in the real world. Actual use of low-molecular-weight heparin in cancer. NETH J MED 2014;72 (9):467-472 [PubMed]
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JSR, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M [Contributors: Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Jimenez D, Ageno W, Agewall S, Asteggiano R, Bauersachs R, Becattini C, Bounameaux H, Büller HR, Davos CH, Geersing GJ, Sanchez MAG, Hendriks J, Kilickap M, Mareev V, Monreal M, Morais J, Popescu BA, Sanchez O, Spyropoulos AC, Skoro-Sajer N, Najafov R, Sudzhaeva S, de Pauw M, Baraković F, Tokmakova M, Skoric B, Rokyta R, Hansen ML, Elmet M, Harjola VP, Meyer G, Chukhrukidze A, Rosenkranz S, Androulakis A, Forster T, Fedele F, Sooronbaev T, Maca A, Ereminiene E, Micallef J, Andreasen A, Kurzyna M, Ferreira D, Petris AO, Dzemeshkevich S, Asanin M, Simkova I, Anguita M, Christersson C, Kostova N, Baccar H, Sade LE, Parkhomenko A, Pepke-Zaba J]] , 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). EUR HEART J 2014;35 (43):3033-3080 [PubMed]
Kuipers S, Venemans A, Middeldorp S, Büller HR, Cannegieter SC, Rosendaal FR, The risk of venous thrombosis after air travel: contribution of clinical risk factors. BRIT J HAEMATOL 2014;165 (3):412-413 [PubMed]
Kuipers S, Venemans-Jellema A, Cannegieter SC, van Haften M, Middeldorp S, Büller HR, Rosendaal FR, The incidence of venous thromboembolism in commercial airline pilots: a cohort study of 2630 pilots. J THROMB HAEMOST 2014;12 (8):1260-1265 [PubMed]
Mebazaa A, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Merli G, Schellong SW, Spyropoulos AC, Tapson VF, de Sanctis Y, Cohen AT, Predicting the risk of venous thromboembolism in patients hospitalized with heart failure. CIRCULATION 2014;130 (5):410-418 [PubMed]
Mos ICM, Douma RA, Erkens PMG, Kruip MJHA, Hovens MM, van Houten AA, Hofstee HMA, Kooiman J, Klok FA, Büller HR, Kamphuisen PW, Huisman MV, Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm. THROMB RES 2014;133 (6):1039-1044 [PubMed]
Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI, Thrombosis: a major contributor to global disease burden. ARTERIOSCL THROM VAS 2014;34 (11):2363-2371 [PubMed]
Raskob GE, Angchaisuksiri P, Blanco AN, Büller H, Gallus A, Hunt BJ, Hylek EM, Kakkar TL, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI, Thrombosis: a major contributor to global disease burden. SEMIN THROMB HEMOST 2014;40 (7):724-735 [PubMed]
Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, Christiansen AV, Friedman J, Le Maulf F, Peter N, Kearon C [Contributors: Schulman S, Eriksson H, Goldhaber S, Kakkar A, Kearon C, Mismetti P, Schellong S, Bergqvist D, Tijssen J, Prins M, Robben S, Büller H, Otten HM, Brandjes D, Peters R, Mac Gillavry MR, Gan E, Salem H, Baker R, Blomberry P, Curnow J, Annichino-Bizzacch JM, Brandao Panico MD, Timi Ribas JR, Fernandes Manenti ER, Miranda F Jr, Moraes J Jr, Raev D, Mollov M, Peneva M, Milanov S, Anderson D, Crowther M, Dolan S, Eikelboom J, Game M, Kahn S, Kassis J, Ritchie B, Solymoss S, Rodger M, Yeo E, Milot A, Klinke P, Chen W, Zhihong L, Chunxue B, Jinming L, Jiwei Z, Jie C, Jina K, Yuqi W, Zhongqi Y, Hua W, Kejing Y, Bonan L, Yadong Y, Changwei L, Jin Z, Yongcheng D, Spinar J, Maly R, Cizek V, Bercikova J, Cervinka P, Lang P, Jirka V, Oral I, Reichert P, Kotik L, Pojsl S, Klimovic T, Husted S, Nielsen H, Friis E, Skødebjerg Kristensen K, Mottier D, El Kouri D, Bleher Y, Leroux L, Boda Z, Sereg M, Riba M, Hiremath JS, Kareem S, Banker DN, Gadkari M, Parakh R, Suresh KR, Natarajan S, Jain A, Aggarwal PK, Patil CB, Durairaj N, Seshadri R, Thakore VM, Rai KM, Efrati S, Elias M, Gavish D, Grossman M, Lishner M, Lahavr M, Lugassy G, Nseir W, Zeltser D, Brenner B, Yeganeh S, Zanatta N, Pizzini AM, Di Salvo M, Novo S, Arosio E, Campanini M, Castellani S, Oh DY, Cho DK, Kim DI, Kwon TW, Yoon SS, Kim MH, Kwon SY, Cheong JW, Lee TS, Shokri AA, Looi TS, Chon Y, Chunn KY, Salleh R, Fijnheer R, Veth G, Dees A, Pruijt H, Lieverse AG, Jie GKS, van Marwijk-Kooij M, Simsek S, Hanna M, Jackson S, Ockelford P, Smith M, Sandset PM, Waage A, Fernandez L, Ma A, de Guia T, Ong-Garcia H, Lach L, Zawilska K, Gluszek S, Czarnobilski K, Gaciong Z, Chernyatina M, Tchumakov A, Staroverov I, Belentsov S, Katelnitsky I, Khamitov A, Zaporozhsky A, Degterev M, Khitaryan A, Heng LL, Robless PA, Kenny SYK, Poliacik P, Duris T, Szentivanyi M, Zubek V, Adler D, Smith C, Roux DL, van Rensburg J, Miller D, Ismail S, Roodt A, Vermooten IH, Villalta J, Nieto JA, Trujillo J, del Toro J, García Fuster MJ, Giménez A, Lozano P, Holmström M, Edmark M, Carlsson A, Torstensson I, Huang CH, Shyu KG, Chiang CE, Shen MC, Tsai CS, Wang SS, Sirijerachai C, Saetang S, Kanitsap N, Polprasert C, Mutirangura P, Boonbaichaiyapruck S, Leelasiri A, Kurtoglu M, Eren E, Bengisun U, Sakinci U, Karahan S, Islamoglu F, Kurt N, Aygun E, Skupyy O, Keeling D, Kesteven P, Cohen A, Maclean R, Thomas W, Masson JA, Bolster E, Beard T, Gasparis A, LaPerna LM, Gibson K, Curtis B, Chu CO, Bass P 3rd, Lavende R]] , Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. CIRCULATION 2014;129 (7):764-772 [PubMed]
Struijk-Mulder MC. Thromboprophylaxis in orthopaedic surgery. s.l.: s.n.; 2014. 140p. ISBN 97894616694904 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Verheyen CCPM, Ettema HB)
Struijk-Mulder MC, Ettema HB, Heyne RAJ, Rondhuis JJ, Büller HR, Verheyen CCPM, Venous thromboembolism during hip plaster cast immobilisation: review of the literature. NETH J MED 2014;72 (1):17-19 [PubMed]
Stuijver DJF, Piantanida E, van Zaane B, Galli L, Romualdi E, Tanda ML, Meijers JCM, Büller HR, Gerdes VEA, Squizzato A, Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study. HAEMOPHILIA 2014;20 (3):326-332 [PubMed]
van Es N, Coppens M, Schulman S, Middeldorp S, Büller HR, Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. BLOOD 2014;124 (12):1968-1975 [PubMed]
[Contributors: Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI]] , Thrombosis: A major contributor to global disease burden. THROMB RES 2014;134 (5):931-938 [PubMed]
[Contributors: Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI]] , Thrombosis: A major contributor to global disease burden. THROMB HAEMOSTASIS 2014;112 (5):843-852 [PubMed]
[Contributors: Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI]] , Thrombosis: a major contributor to the global disease burden. J THROMB HAEMOST 2014;12 (10):1580-1590 [PubMed]
Ageno W, Squizzato A, Wells PS, Büller HR, Johnson G, The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J THROMB HAEMOST 2013;11 (8):1597-1602 [PubMed]
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI [Contributors: Agnelli G, Buller H, Cohen A, Gallus A, Raskob G, Weitz J, Prins M, Brandjes D, Kolbach D, Limburg M, Mac Gillavry M, Otten JM, Peters R, Roos Y, Segers A, Slagboom T, Bounameaux H, Hirsh J, Samama MM, Wedel H, Curto M, Johnson M, Masiukiewicz U, Pak R, Porcari A, Sanders P, Sisson M, Sullivan B, Thompson J, Auerbach J, Cesario L, Crawford J, Gordon M, Noble M, Pennington A, Reinhold P, Simmons M, Urwin K, Ceresetto J, McRae S, Pabinger I, Pereira AH, Spencer F, Wang C, Zhang J, Gorican K, Husted SE, Mottier D, Harenberg J, Vértes A, Pinjala R, Zeltser D, Prandoni P, Sandset M, Torbicki A, Fijalkowska A, Alvares JP, Kirienko A, Shvarts Y, Sala LA, Jacobson B, Gudz I, Ortel T, Spyropoulos A, Beyer-Westendorf J, Sipos G, Bredikhin R, Della Siega A, Klinke W, Lawall H, Zwettler U, Prasol V, Cannon K, Vasylyuk S, Jin B, Prandoni P, Desai S, Zaichuk A, Katelnitskiy I, de Pellegrin A, Santonastaso M, Skupyy O, Pesant Y, Shvalb P, Spacek R, Visonà A, Alvarez Sala L, Borja V, Gudz I, Noori E, Sereg M, Ortel T, Braester A, Falvo N, Mottier D, Jacobson B, Vöhringer H, LaPerna L, Oliven A, Skalicka L, Bolster D, Haidar A, Schellong S, Vértes A, Smith S, Sergeev O, Pullman J, Torp-Pedersen C, Zimlichman R, Elias M, Fourie N, Pernod G, Panchenko E, Pendleton R, van Nieuwenhuizen E, Vinereanu D, Agnelli G, Becattini C, Manina G, Leduc J, Dunaj M, Frost L, Gavish D, Jakobsen T, Lishner M, Morales LS, Chochola J, Gubka O, Holaj R, Hussein O, Katona A, Sergeeva E, Bova C, Cepeda J, Cohen K, Sobkowicz B, Grzelakowski P, Husted S, Lupkovics G, Spencer F, Dedek V, Liu C, Puskas A, Ritchie B, Ambrosio G, Parisi R, Heuer H, Livneh A, Podpera I, Stanbro M, Caraco Y, Fulmer J, Ghirarduzzi A, Schmidt-Lucke J, Bergmann J, Cizek V, Leyden M, Stein R, Abramov I, Chong B, Colan D, Jindal R, Liu S, Pereira A, Porreca E, Salem H, Welker J, Yusen R, Dhar A, Gallus A, Podczeck-Schweighofer A, Shtutin O, Vital Durand D, Zeltser D, Zhang J, Balaji V, Correa J, Harenberg J, Kline J, Runyon M, Laszlo Z, Martelet M, Parakh R, Sandset PM, Schmidt J, Yeo E, Bhagavan N, Bura-Riviere A, Ferrer JM, Lacroix P, Lewczuk J, Pilger E, Sokurenko G, Yu H, Nikulnikov P, Pabinger-Fasching I, Sanchez-Diaz C, Schuller D, Shvarts Y, Suresh K, Wang C, Lobo S, Lyons R, Marschang P, Palla A, Schulman S, Spyropoulous A, Fraiz J, Gerasymov V, Lerner R, Llamas Esperón G, Manenti E, Masson J, Moreira R, Poy C, Rodoman G, Bruckner I, Gurghean A, Carrier M, Freire A, Gan E, Gibson K, Herold M, Hudcovic M, Kamath G, Koslow A, Meneveau N, Roos J, Zahn R, Balanda J, Bratsch H, Dolan S, Gould T, Hirschl M, Hoffmann U, Kaatz S, Shah V, Kadapatti K, Kræmmer Nielsen H, Lahav M, Natarajan S, Tuxen C, Tveit A, Alves C, Formiga A, Brudevold R, Cardozo M, Gorican K, Lorch D, Marais H, Mismetti P, Panico M, Pop C, Quist-Paulsen P, Stevens D, Tarleton G, Yoshida W, Cox M, Crispin P, Czekalski P, Ebrahim I, Game M, Ghanima W, Harrington D, Jackson D, Lee A, Matoska P, Meade A, Camargo AC, Nishinari K, Sanchez Llamas F, Tosetto A, Vejby-Christensen H, Basson M, Blombery P, Fu G, Jha V, Keltai K, Le Jeunne C, Lodigiani C, Ma Y, Nagy A, Neumeister A, Pinjala R, Shotan A, Wong T, Ying K, Anderson S, Brenner B, Carnovali M, Cerana S, Cunha C, Diaz-Castañon J, Graham M, Kirenko A, Palareti G, Rodriguez-Cintron W, Nathanson A, Rosenthal S, Sanders D, Scheinberg P, Schjesvold F, Torp R, van Zyl L, Venher I, Xia G, Brockmyre A, Chen Z, Hakki S, Hanefield C, Mügge A, Janczak D, Karpovych D, Lancaster G, Lavigne C, Lugassy G, Melaniuk M, Moran J, Oliver M, Schattner A, Staroverov I, Timi J, Vöhringer F, von Bilderling P, Warr T, White R, Wronski J, Wu C, Almeida C, Blum A, Bono J, Durán M, Erzinger F, Fu W, Jagadesan R, Jurecka W, Korban E, Nguyen D, Raval M, Willms D, Zevin S, Zhu H, Abdullah I, Achkar A, Albuquerque L, Ali M, Bai C, Bloomfield D, Chen J, Fajardo Campos P, Garcia Bragado F, Kobza I, Lindhoff-Last E, Lourenço A, Marchena Yglesias P, Marshall P, Siegel M, Mikhailova O, Oliva M, Pottier P, Pruszczyk P, Sauer M, Baloira A, Cromer M, D'Angelo A, Faucher J, Gutowski P, Hong S, Lissauer M, Lopes A, Lopes R, Maholtz M, Mesquita E, Miekus P, Mohan B, Ng H, Peterson M, Piovella F, Siragusa S, Srinivas R, Tiberio G, van Bellen B, Arutyunov G, Assi N, Baker R, Blanc F, Curnow J, Fu C, Gonzalez-Porras J, Guijarro Merino R, Gunasingam S, Gupta P, Laule M, Liu Z, Luber J, Serifilippi G, Paulson R, Shevela A, Simonneau G, Siu D, Sosa Liprandi M, Takács J, Tay J, Vora K, Witkiewicz W, Zhao L, Aquilanti S, Dabbagh O, Dellas C, Denaro C, Doshi A, Fijalkowska A, Flippo G, Giumelli C, Gomez Cerezo J, Han D, Harris L, Hofmann L Jr, Kamerkar D, Kaminski L, Kazimir M, Kloczko J, Ko Y, Koura F, Lavender R, Maly J, Margolis B, McRae S, Mos L, Sanchez-Escalante L, Solvang A, Soroka V, Szopinski P, Thawani H, Vickars L, Yip G, Zangroniz P]] , Oral Apixaban for the Treatment of Acute Venous Thromboembolism. NEW ENGL J MED 2013;369 (9):799-808 [PubMed]
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI [Contributors: Agnelli G, Buller H, Cohen A, Gallus A, Raskob G, Weitz J, Prins M, Brandjes D, Kolbach D, Limburg M, Mac Gillavry M, Otten JM, Peters R, Roos Y, Segers A, Slagboom T, Bounameaux H, Hirsh J, Samama MM, Wedel H, Curto M, Johnson M, Masiukiewicz U, Pak R, Porcari A, Sanders P, Sisson M, Sullivan B, Thompson J, Auerbach J, Cesario L, Gamero M, Gordon M, Griffiths A, Noble M, Ott J, Pennington A, Peffer A, Reinhold P, Simmons M, Urwin K, Ceresetto J, McRae S, Pabinger I, Pereira AH, Spencer F, Gorican K, Husted SE, Mottier D, Harenberg J, Pinjala R, Zeltser D, Imberti D, Sandset M, Torbicki A, Fijalkowska A, Albino JP, Kirienko A, Shvarts Y, Monreal M, Jacobson B, Dolan G, Gudz I, Ortel T, Spyropoulos A, Torbicki A, Fijalkowska A, Skupyy O, Beryer-Westendorf J, de Pellegrin A, Prasol V, Schellong S, Jacobson B, Falvo N, Abramov I, Cizek V, Husted S, Desai S, Gudz I, Barillari G, Sergeev O, Chetter I, Inbal A, McCollum C, Shvalb P, Torp-Pedersen C, Vasylyuk S, Kraemmer Nielsen H, Pernod G, Schmidt J, Bova C, Gerasymov V, Pabinger-Fasching I, Skalicka L, Zaichuk A, Achkar A, Bremmelgaard A, Chochola J, Gould T, Khalafallah A, Jakobsen T, Rose P, Zhukov B, Dedek V, Mirete Ferrer J, Pesant Y, Repin A, Salem H, Solis Morales L, Spacek R, Cannon K, Grzelakowski P, Jindal R, Pereira A, Zidkova E, Ambrosio G, Cardozo M, Dunaj M, Gallus A, Gavish D, Ghanima W, Harenberg J, Leduc JJ, Mismetti P, Panico M, Porreca E, Riera A, Bareford D, Chong B, Dvoryashina I, Gómez Cerezo J, Kobza I, Nielsen T, Pendleton R, Pullman J, Schiffman G, Stanbro M, Zwettler U, Aquilanti S, Bratsch H, Cohen K, Elias D, Gan E, Holaj R, Klinke W, Liu HSY, Sandset PM, van Nieuwenhuizen E, Álvarez-Sala LA, Basson M, Braester A, Bura-Riviere A, Calvo Vargas C, Cohen A, Correa J, Elias M, Frost L, Imberti D, Landolfi R, Marschang P, Moreira R, Mottier D, Natarajan S, Pottier P, Tosetto A, Tuxen C, Vöhringer HF, Alexander A, Barbarash O, Fajardo Campos P, Graham M, Gubka O, Hudcovic M, Hussein O, Jackson D, Katelnitskiy I, Lawall H, Monreal M, Palareti G, Poggio R, Roos J, Simonneau G, Smith SW, Szopinski P, Ortel T, Zimlichman R, Bridgers D, Colan D, Czekalski P, de Jong D, Fortinez JT, Garcia Bragado F, Harrington D, Izbicki G, Kadr H, Koslow A, Loftus I, Marais H, Neumeister A, Oliven A, Palla A, Pop C, Prandoni P, Puskas A, Sanchez Llamas F, Shotan A, Shvarts Y, Singh P, Tveit A, Baker R, Borja V, Brenner B, Brown H, Ceresetto J, Cha TJ, Cohen Y, D'Angelo A, Dhar A, Friis E, Hueur H, Jiménez Rodríguez Madridejos R, Karl J, Karrasch J, Lishner M, Manenti E, McRae S, Meneveau N, Nguyen D, Sanchez-Escalante L, Santoscoy Ibarra J, Sokurenko G, Staroverov I, Stein R, Abdullah I, Agnelli G, Alcocer Gamba M, Balanda J, Bruckner I, Calabuig Alborch J, Caraco Y, Comerota A, Cromer M, de Araujo Filho J, de los Rios Ibarra M, Diaz-Castañon J, Doshi A, Ebrahim I, Fessel WJ, Fletcher E, Fourie N, Fu C, Gutowski P, Haddad G, Hoffman U, Jardula M, Kvasnicka T, Lewczuk J, Leyden M, Livneh A, Lodigiani C, Lovell C, Miekus P, Paloma MJ, Parakh R, Raval M, Schmidt-Lucke J, Shtutin O, Soroka V, Stevens D, Sulik P, Tay JC, Vejby-Christensen H, Vinereanu D, Baghestanian M, Bono J, Cerana S, Freire A, Gibson K, Giumelli C, Iastrebner C, Karpenko A, Kelly A, Lacroix P, LaFata J, Lobo S, Macik BG, Marchena Yglesias P, Nishinari K, Pinjala R, Podczeck-Schweighofer A, Raby K, Sirpal S, Solymoss S, Spencer F, van Zyl L, Vargas Núñez JA, von Bilderling P, Warr T, Wronski J, Wurster M, Albino JA, Albuquerque L, Averill F, Baek SH, Bello F, Bergoeing M, Blanc FX, Bloomberg R, Bolster D, Brockmyre A, Calimano C, Checketts D, Cieplinski W, Chervu A, Collado F, Denaro C, Gaciong Z, Game M, Iskander A, Kaatz S, Kim DI, Koura F, Laguna F, Lanas Zanetti F, Lindhoff-Last E, Melaniuk M, Meade A, Murphy T, Ng HJ, Páramo Fernández JA, Patil C, Piovella F, Prisco D, Pruszczyk P, Reimers G, Rivera E, Rodriguez-Cintron W, Rosenthal S, Salbach P, Salvador D, Schuller D, Siragusa S, Staniszewski R, Torp R, Vora K, Yip G, Alfieri A, Belaji V, Bhagavan N, Carnovali M, Cobos Segarra J, Di Todaro F, Dowell A, Corder C, Crispin P, Cuadrado J, Flippo G, Fraiz J, Guillaumon A, Gvora T, Hakki S, Harris L, Ison R, Htun PT, Jasani R, Kates M, Kaminski L, Kamerkar D, Kirienko A, Kroger K, LaPerna L, Leiva J, Luber J, McCann A, McKenzie W, Menna Barreto S, Moran J, Nikulnikov P, Paliwal Y, Patel M, Pilger E, Renwick W, Shevela A, Starosiliz D, Stringam S, Spyropoulos A, To R, Updegrove J, van Bellen B, Waintrub M, White J, Yeo E, Zangroniz P, Zeltser D]] , Apixaban for Extended Treatment of Venous Thromboembolism. NEW ENGL J MED 2013;368 (8):699-708 [PubMed]
Apostolakis S, Guo Y, Lane DA, Buller H, Lip GYH, Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial. EUR HEART J 2013;34 (46):3572-3579 [PubMed]
Apostolakis S, Lane DA, Büller H, Lip GYH, Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial. THROMB HAEMOSTASIS 2013;110 (5):1074-1079 [PubMed]
Apostolakis S, Lane DA, Guo Y, Buller H, Lip GYH, Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients. J AM COLL CARDIOL 2013;61 (3):386-387 [PubMed]
Apostolakis S, Lane DA, Guo Y, Buller H, Lip GYH, Reply. J AM COLL CARDIOL 2013;61 (4):482-483 [PubMed]
Arts DL, Abu-Hanna A, Büller HR, Peters RJG, Eslami S, van Weert HCPM, Improving stroke prevention in patients with atrial fibrillation. TRIALS 2013;14 (1):193 [PubMed]
Berger J, Eikelboom JW, Quinlan DJ, Guyatt G, Büller HR, Sobieraj-Teague M, Harrington RA, Hirsh J, Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting. J THROMB HAEMOST 2013;11 (4):778-782 [PubMed]
Biere-Rafi S, Hutten BA, Squizzato A, Ageno W, Souverein PC, de Boer A, Gerdes VEA, Büller HR, Kamphuisen PW, Statin treatment and the risk of recurrent pulmonary embolism. EUR HEART J 2013;34 (24):1800-1806 [PubMed]
Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P [Contributors: Büller H, Agnelli G, Angchaisuksiri P, Banyai M, Bauersachs R, van Bellen B, Blüguermann J, Boda Z, Bounameaux H, Brenner B, Brighton T, Castañon JD, Chechulov P, Chlumský Y, Cohen A, Davidson B, Decousus H, Eriksson H, Gallus A, Gudz I, Jacobson B, Heng LL, Lyons R, Meijer K, Minar E, Monreal M, Nakamura M, Oh D, Öngen G, Parakh R, Piovella F, Raskob G, Rehm J, Sandset PM, Schellong S, Smith M, Sokurenko G, Tomkowski W, Torp-Pedersen C, Verhamme P, Wang C, Wang Y, Weitz J, Wells P, Yanushko V, Yin WH, Prins M, Beenen L , Brandjes D, MacGillavry M, Kaplowitz N, Otten HM, Pessayre D, Peters R, Roos Y, Slagboom T, Eikelboom J, Crowther M, Roberts R, Vanassche T, Vandenbriele C, Debaveye B, Segers A, Dani V, van Bergen P, Gerrits P, Mercuri M, van Kranen R, Lanz H, Grosso M, Schwocho L, Kappelhoff J, Franc J, Shi M, Zhang G, Lin M, Crerand W, Giordano C, Skinner M, Hurley S, Lovelace G, Barrier R, Betcher J, Alvarez C, Amuchastegui LM, Blüguermann J, Cassettari A, Ceressetto J, Hrabar N, Macin S, Mahuad C, Oberti P, Santini F, Baker RI, Blombery P, Brighton T, Carroll P, Chong B, Coughlin P, Crispin P, Fletcher J, Gallus A, Serisier DJ, Tran H, Chan N, Stafford L, Ward C, Baghestanian M, Kyrle PA, Eischer L, Traby L, Marschang P, Mathies R, Pilger E, Brodmann M, Roithinger F, Weltermann A, Adzerikho I, Davidovskaya E, Gorokhovsky S, Maslianski B, Kulik A, Yanushka A, de Vleeschauwer P, Debing E, Duchateau J, Gustin M, Hainaut P, Vandekerkhof J, Verhamme P, Peerlinck K, Verstraeten P, Wautrecht JC, Motte S, Annichino-Bizzacchi JM, Mello TBT, Menezes FH, Burihan M, Cavalcanti M, Correa J, Correa de Carvalho F, Cukier A, Manenti E, Manenti ER, Sacilotto R, Timi JM, van Bellen B, Kahn SR, Kovacs M, Langner AL, VanSpronsen H, Ritchie B, Shafai-Sarshar R, Shivakumar S, Anderson D, Robinson K, Gallant B, Wells P, Karovitch A, Scarvelis D, Carrier M, Bai CX, Chen RC, Cheng ZZ, Du YC, Hu XY, Gu YQ, Hao QL, Sun SB, Wang C, Jiang L, Liu CJ, Liu CW, Liu S, Wang XX, Ye XF, Ma Z, Qin ZQ, Qin XJ, Tian HY, Wang YQ, Shi ZY, Wen FQ, Wu Q, Yang YH, Kuang TG, Yang H, Ying KJ, Ma GF, Yuan YD, Yu J, Gong XW, Zhang FX, Zhang J, Zhang SX, Zhang JW, Zhang L, Zhao JC, Huang B, Zhao J, Chlumsky J, Hola D, Hirmerova J, Hutyra M, Klimsa Z, Holub M, Kovarova K, Lang P, Ryba M, Podoubský R, Matoska P, Mayer O, Patek F, Tupa M, Spacek R, Urbanova R, Blazejova S, Vitovec M, Andersen B, Brønnum-Schou J, Dominguez H, Egstrup K, Auscher S, Jeppesen J, Asferg C, Vishram J, Nielsen H, Galsgaard I, Michaelsen M, Haugaard-Nielsen B, Ostergaard O, Poulsen SH, Torp-Pedersen C, Masik S, Kadarik M, Meriste S, Paumets M, Laheäär M, Raidjuk L, Accassat S, Buchmuller A, Mismetti P, Achkar A, Aquilanti S, Rifaï A, Breuil N, Schmidt J, Brisot D, Brousse C, de la Fuentes PT, Chakra M, Crestani B, Desormais I, Lacroix P, Diamand JM, El Kouri D, Clairand R, Elias A, Ferrari E, Doyen D, Chiche O, Grange C, Guenneguez H, Lacut K, Couturaud F, Mottier D, Leroux L, Lorcerie B, de Maistre E, Berthier S, Mahe I, Martin M, Meneveau N, Meyer G, Sanchez O, Montaclair K, Pavic M, Pernod G, Imbert B, Quere I, Galanaud JP, Roy PM, Sevestre MA, Simoneau G, Stephan D, Aleil B, Mirea C, Trinh-Duc A, von Bilderling PB, Beyer-Westendorf J, Werth S, Köhler C, Halbritter K, Diehm C, Espinola-Klein C, Weisser G, Franke D, Heuer H, Horacek T, Kahrmann G, Kroening R, Lawall H, Roecken M, Schellong SM, Pomper L, Voigts B, Bernhard S, Frommhold R, Stellbrink C, Boda Z, Ilonczai P, Olah Z, Razso K, Schlammadinger A, Farkas K, Kolossváry E, Szabó I, Frankfurter Z, Gasztonyi B, Gurzó M, Klucsik Z, Kovacs A, Szigeti S, Varga C, Landi A, Nyirati G, Pecsvarady Z, Riba M, Sámson Z, Sipos G, Szigyártó M, Sebő N, Szabó TJ, Toth K, Agarwal S, Arneja J, Babhulkar S, Balaji R, Banker D, Bhagavan NK, Bhonagiri S, Mehta A, Dayasagar Rao V, Desai P, Desai SC, Chandrashekar AR, Singh R, Deshpande A, Dharmadhikari A, Durairaj N, Ghaisas N, Gupta S, Jain R, Jindal R, Kamerkar D, Kothiwale VA, Kothurkar A, Kulkarni R, Kumar S, Mody B, Nagabhushan KN, Pandharpurkar HK, Joshi S, Parakh R, Grover T, Patel J, Patel K, Dudhagra N, Pawar N, Penurkar M, Pinjala R, Rai K, Rao B, Raval M, Raval A, Mehta P, Ravi Kishore AG, Saravanan S, Shetty P, Srinivas A, Suresh KR, Sumanthraj K, Girija KR, Vinod MV, Gavish D, Ashkenazy B, Braester A, Caraco Y, Elias M, Goldstein L, Grossman E, Lahav M, Lishner M, Lugassy G, Oliven A, Rachmilevitz R, Tzoran I, Brenner B, Yeganeh S, Zeltser D, Zimlichman R, Ageno W, Barillari G, Pasca S, Bortoluzzi C, Cattaneo M, Falanga A, Ghirarduzzi A, Lodigiani C, Picchi C, Iosub DI, Porreca E, Prandoni P, Quintavalla R, Siragusa S, Akita T, Aoyama T, Fujimoto K, Hanzawa K, Ikeda U, Iwata H, Kobayashi T, Kondo K, Kurimoto T, Maeda H, Mo M, Munemasa M, Murakami H, Nishi Y, Nishibe T, Nishigami K, Nunohiro T, Obayashi T, Satoh T, Satokawa H, Shimizu K, Shiroma H, Sonoda M, Suzuki Y, Taniguchi S, Tsujita K, Yamada N, Yasuda C, Yoshida H, Chang HJ, Choi WI, Kwon KY, Rho BH, Choi JS, Hong YS, Joh JH, Kim DJ, Kim HS, Kim SH, Kim YK, Kim KU, Kim JY, Kwon TW, Lee TS, Lim SY, Mun YC, Oh DY, Park KH, Yun WS, Yoon HI, Diaz-Castañon J, Flota LF, Galindo J, Gomez Lara J, Jerjes-Sanchez C, Palomar-Lever A, Rodriguez D, Higareda I, Boersma WG, de Graaff CS, Oudeman L, Brans E, Bredie SJH, Dees A, Erdkamp F, Peters F, Fijnheer R, Gerdes VEA, Griffioen A, Jie KSG, Meijer K, Kooistra H, Wiewel-Verschueren S, Middeldorp S, Kamphuisen PW, van Es J, Eerenberg ES, Swart Heikens J, ten Cate H, ten Wolde M, Hes R, Atalay S, Harper P, Merriman E, Ockelford P, Hulton MH, Phillips J, Royle G, Ford A, Smith M, Ghanima W, Amundsen H, Sandset PM, Abola MT, Ganzon MS, Germar A, Checinski P, Kwasniewski A, Tomkowski W, Zechowicz T, Apartsin K, Arutyunov G, Barbarash O, Burov Y, Chechulov P, Varaksina E, Chernyatina M, Gladchenko M, Belikov L, Fokin A, Gubenko A, Igor K, Olga M, Kazakov Y, Kazakov A, Krasavin V, Linev K, Plechev V, Shesternya P, Shkurin V, Shvalb P, Sokurenko G, Sonkin I, Remizov A, Chernykh K, Staroverov I, Subbotin Y, Zeltser M, Seletsky A, Iliynykh A, Zilber A, Zubareva N, Tkachenko I, Pakhomova A, Raghuram J, Ng HJ, Sin K, Adler D, Weber F, van der Jagt R, Basson M, Becker J, Ellis G, Isaacs R, Jacobson B, Louw S, van Rensburg J, Siebert H, Skosana F, van Marle J, van Zyl L, le Roux R, Williams P, Cereto F, Garcia-Bragado F, Miranda RT, Carlsson A, Eriksson H, Villegas-Scivetti M, Ottosson E, Sjalander A, Torstensson I, Banyai M, Afarideh R, Gallino A, Mazzolai L, Righini M, Staub D, Chen CJ, Chiang CE, Wang KL, Chiu KM, Huang JH, Lai WT, Pai PY, Lin KH, Wang JH, Wu CC, Yin WH, Huang CL, Angchaisuksiri P, Kulpraneet M, Rojnuckarin P, Öngen G, Duman B, Ozkan S, Savas I, Selçuk T, Tuncay E, Gerasymov V, Gubka O, Gudz I, Voloshyn M, Nikulnikov P, Danylets A, Prasol V, Rusyn V, Sergeev O, Shtutin O, Skupyy O, Tatarin A, Venger I, Cohen AT, Patel R, Hunt BJ, Kesteven P, Robson L, MacCallum P, Nokes T, Rose P, Acs P, Gordan L, Bhatia A, Ali M, Amin D, Masson J, Gavi E, Ayele E, Ayeni O, Canosa R, Chavous D, Chen D, Comerota A, Concha M, Cunanan-Bush M, Daboul N, Daggubati S, Dang N, DiBella N, Driver A, Dulgeroff A, Fraiz J, Friedlander A, Galvez A, Jani C, Johnson S, Khandelwal P, Kingsley E, Kingsley J, Hutchinson L, Lavender R, Lyons R, Guzley G, Martinez R, Metjian A, Moran J, Nadar V, Pish R, Pullman J, Quaranta AJ, Ravi C, Refaai M, Rehm J, Richards D, Richwine R, Sachdeva S, Seibert A, Sharma A, Stricklin D, Tannenbaum A, Tin-U C, Vora K, Watkins D, Willms D]] , Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism. NEW ENGL J MED 2013;369 (15):1406-1415 [PubMed]
Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V [Contributors: Büller H, Cohen AT, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spiro T, Spyropoulos AC, Tapson V, Francis C, Kobayashi S, Leizorovicz A, Lowe G, Roberts R, Brandges D, Kolbach D, Limburg ML, Mac Gillavry MR, Otten HM, Peters RGJ, Prins M, Robben S, Voorend M, Hemmrich M, Li L, Meng I, Mühlhofer E, Beckmann H, Desanctis Y, Duszczyszyn A, Fielding L, Twomey T, Müller K, Byra W, Nessel C, Atkinson S, Bottaro FJ, Caberlotto O, Grand B, Hendler H, Hojman M, Mykietiuk A, Salerno R, Baker R, Carroll P, Chong B, Colquhoun D, Gan E, Hall S, Jackson D, Leyden M, Salem H, Serisier D, Balcke P, Bauer B, Bauer NC, Erlacher L, Fortunat W, Grafl E, Keil F, Kirchmair P, Pilger E, Schönherr HR, Siostrzonek P, Weidinger F, Weltermann A, Wenisch C, Blockmans D, Delobbe A, Hendrickx K, Jacquy C, Soupart A, Striekwold H, van Hoof ME, Vanden Abeele A, van Roey G, van Zandweghe L, Bizzacchi JMA, Cavalheiro C, Chamone D, Fiss E, Garicochea B, Lopes AC, Rocha Moreira RC, van Bellen B, Dimov D, Ivanov Y, Lyubenov L, Milanov S, Mincheva V, Nenkova S, Popov D, Taseva M, Bergeron C, Boulanger JM, Buck B, Daneault N, Desai H, Dube F, Kutsogiannis DJ, Miron MJ, Moddel G, Shuaib A, Silver F, Stotts G, Verreault S, Bugedo G, Torres H, Chen KN, Chen P, Chen RC, Chen Y, Gai L, Gao Q, Guo S, Hu T, Hua Q, Li H, Li J, Li W, Li YS, Liu C, Liu J, Liu Y, Qi G, Qin X, Shen C, Sun S, Sun Y, Wan Q, Wang C, Wang H, Wang Y, Wu C, Wu J, Wu S, Xian S, Xiu Q, Xu B, Yan X, Yang K, Yang L, Yang Y, Zhang DP, Zhang J, Zhang S, Zhao Y, Zhao Z, Zhou Y, Botero R, Cedano JE, Fajardo D, Gómez LF, Jaramillo CF, Rada R, Uribe LG, Velásquez JC, Bergovec M, Hajnsek S, Knezevic A, Samarzija M, Steiner R, Zupancic-Salek S, Fiksa J, Gorican K, Linhart A, Macel I, Mayer O, Prochazka V, Sedlacek J, Avnstrøm S, Nielsen H, Nielsen T, Østergaard OV, Tuxen C, Kolbassova O, Lember M, Marandi T, Uuetoa T, Karmakoski J, Lassila R, Aquilanti S, Bergmann JF, Brisot D, Debourdeau P, Duchemin A, Farge-Bancel D, Fournier C, Galinier M, Lacroix P, Lambert M, Le Jeunne C, Lorcerie B, Mahe I, Marquette CH, Mismetti P, Mottier D, Proust A, Quere I, Rihani R, Schmidt J, Stephan D, Vital-Durand D, Barth J, Beyer-Westendorf J, Borst M, Dormann A, Drouven FM, Espinola-Klein C, Heintges T, Hindahl H, Klotz T, Lawall H, Leschke M, Milstrey HR, Möbius-Winkler S, Mühlbauer B, Niederau C, Petermann W, Pohl C, Ringe JD, Sanner B, Scharrer I, Schmidt-Lucke JA, Schöffauer I, Stoelben E, Theelen W, Veltkamp R, vom Dahl J, Apsokardos S, Babalis D, Bassaris H, Karafoulidou A, Katsivas A, Panoutsopoulos G, Patsilinakos S, Skoutelis A, Toubis M, Vlastos F, Wong LKS, Wong RSM, Frankfurter Z, Nagy F, Jakab G, Kondakor I, Nikl J, Nyirati G, Szakacs Z, Szegedi N, Avvaru G, Bhairappa S, Cheviri AN, Gadkari M, Grant P, Kuchimanchi K, Kumar KP, Mahajan A, Naik A, Oomman A, Raghu C, Ramanathan RMPL, Talwar D, Whig J, Kalim H, Machfoed MH, Tambunan KL, Elias M, Elias N, Hayek T, Lishner M, Oren S, Osamah H, Sthoeger Z, Telman G, Zeltser D, Zimlichman R, Ageno W, Agnelli G, Berrettini M, Bondi M, Buzzoni R, Castaman G, de Blasio A, de Gaudenzi E, Falanga A, Fontanella A, Giorgi Pierfranceschi M, Landolfi R, Lodigiani C, Morra E, Parise P, Pini M, Pizzini A, Poggio R, Quintavalla R, Siragusa S, Violi F, Ando S, Fujimoto K, Fukui K, Funada J, Hataji O, Ibata H, Ichinose T, Ikefuji H, Imai S, Ito K, Kani H, Kato M, Momiyama Y, Nishi S, Mekaru S, Mio T, Nagaoka M, Nakagawa H, Nakamura Y, Okazaki O, Oshiro K, Ozawa T, Saito T, Sakagami S, Shimizu A, Shiohira Y, Tanaka E, Uchiyama T, Utsugisawa K, Tsuji T, Wada A, Yamada N, Bang SM, Chung CS, Kang DW, Kim YK, Lee YS, YeunOh D, Yoon BW, Aizsilniece I, Krievins D, Kupcs U, Pontaga N, Rozitis V, Stukena I, Alekniene B, Bagdonas A, Basijokiene V, Butkiene Z, Griskeviciene V, Gumbrevicius G, Norviliene R, Petrauskiene R, Stonkus S, Vitkauskas A, Muller P, Rauh S, Chin SP, Sim KH, Wan Azman BWA, Cardoza Amador JI, Gallegos Martínez J, Gómez Lara M, González Garza J, Hernández Gaeta DE, Herver Cabrera MJ, Nares Ochoa F, Perea Sánchez RA, Romero López C, Tanaka Chávez A, Vázquez López MÁ, Velasco Rodríguez VM, Dees A, de Kreuk AM, Fijnheer R, ten Cate H, Jackson S, Ockelford P, Simpson D, Ghanima WK, Schjesvold FH, Stokstad I, Torp R, Aziz Z, Rizvi N, Tayyab GN, Arrieta Días F, Castillo Leon R, Cotrina R, Moncada Vilela Z, Salas Pérez M, Salazar Candiotti OC, Ulloa Pérez VR, Biedrzycka M, Bojarska-Los M, Goch A, Gorska M, Gutowska-Jablonska M, Jahnz-Rozyk K, Krysiak W, Mirek-Bryniarska E, Ogorek M, Sydor A, Szczeklik A, Walasek L, Wrzesinski K, Zechowicz T, Bettencourt P, Ducla Soares J, Ferreira A, Ferreira F, Gomes F, Martins A, Mello e Silva A, Providência L, Rodrigues T, Santos F, Aroutynov G, Ershova O, Fedorova T, Glezer MG, Khatkova S, Moiseev V, Shilkina N, Sotnikov A, Chua G, Gan HW, Ng AWK, Ong TH, Tan RS, Tang OT, Gaspar L, Kovar F, Spisak V, Stevlik J, Szentivanyi M, Flezar M, Gorjup V, Jereb M, Sok M, Tratar G, Zvan B, Adler D, Bloy B, Dreosti LM, Engelbrecht JM, Janse van Rensburg H, Koegelenberg CFN, Nortje H, Quinton S, Rabie WJ, Rapoport BL, Roodt A, Smith C, Steenkamp FWFJ, van Nieuwenhuizen E, van Zyl L, Bisbe J, Castro A, Cereto Castro F, Conget F, Guil M, Monreal M, Nieto Rodríguez JA, Tirado Miranda R, Tolosa C, Trujillo Santos J, Villalta J, Bertholds E, Cwikiel M, Laska AC, Östergren J, Själander A, Svensson P, Timberg I, Torstensson I, Wiklund PG, Banyai M, Baumgartner I, Imhof A, Jeanneret C, Nussbaumer P, Schifferli JA, Chuang KYC, Guo BF, Lee JT, Lin YH, Shyu KG, Permpikul C, Pothirat C, Wattanathum A, Goker E, Ilerigelen B, Kucukoglu S, Nalbantgil S, Sirin H, Yilmaz U, Genyk S, Goncharova Y, Karpenko O, Korzh O, Koval V, Legkonogov O, Perepeliuk M, Polyakov A, Ryabichenko T, Skrebkov V, Sorkin V, Svyshchenko Y, Tseluyko V, Vakaliuk I, Vatutin M, Voronkov L, Cohen A, Durairaj R, Elliott M, Kesteven P, Luckit JK, Rafferty P, Scully M, Albrecht CR 3rd, Anderson S, Benninghoff M, Bidair M, Birch TA, Brensilver J, Chastain S, Chen D, Comerota AJ, Concha M, Conrad SA, Cox MJ, Daboul NY, Dexter J, Dietrich DW, Fei RH, Fontes ML, French WJ, Gonzales E, Hazelrigg MR, Heller BN, Heyder AM, Hill GT Jr, Jaffer AK, Jetty P, Johnson G, Kaatz S, Kazimir M, Lavender RC, Lawton CB, Lerner R, Light RW, Ling TG, Mahal S, Manos P, Masson J, Maynor K, McLafferty RB, Mehra P, Merli GJ, Minkowitz HS, Murray RM, Nadar V, Nathanson A, Patton WF, Peberdy M, Plautz M, Pokharel P, Quintana OE, Rajamani K, Rastogi P, Reiter WM, Reyes JA, Schuller D, Seibert A, Sharma A, Simmons J, Soff GA, Stein RW, Stoltz S, Suen J, Thurm C, Toe W, Updegrove JD, Ward JA, Waxman K, Welker J, Whittier FC, Wright PE Jr, Wun T, Yusen RD, Ziedalski TM]] , Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients. NEW ENGL J MED 2013;368 (6):513-523 [PubMed]
Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Büller HR, Bounameaux H, International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J THROMB HAEMOST 2013;11 (1):71-80 [PubMed]
de Jager DJ, Halbesma N, Krediet RT, Boeschoten EW, le Cessie S, Dekker FW, Grootendorst DC [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, van Geelen JACA, Gerlag PGG, Grave W, Gorgels JPMC, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Hovinga TKK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Is the decline of renal function different before and after the start of dialysis?. NEPHROL DIAL TRANSPL 2013;28 (3):698-705 [PubMed]
den Exter PL, van Es J, Klok FA, Kroft LJ, Kruip MJHA, Kamphuisen PW, Büller HR, Huisman MV, Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. BLOOD 2013;122 (7):1144-9; quiz 1329 [PubMed]
Di Nisio M, Squizzato A, Rutjes AWS, Buller HR, Zwinderman AH, Bossuyt PMM, Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review (vol 5, pg 296, 2007). J THROMB HAEMOST 2013;11 (10):1942
Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR, International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J THROMB HAEMOST 2013;11 (1):56-70 [PubMed]
Jacobson BF, Louw S, Büller H, Mer M, de Jong PR, Rowji P, Schapkaitz E, Adler D, Beeton A, Hsu HC, Wessels P, Haas S, Venous thromboembolism: prophylactic and therapeutic practice guideline. SAMJ S AFR MED J 2013;103 (4 Part 2):261-267 [PubMed]
Kleinjan A. Venous thrombosis in cancer patients: prediction, diagnosis and management. s.l.: s.n.; 2013. 225p. ISBN 9789461823175 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Kamphuisen PW; copromotor(s): Nieuwland R, Di Nisio M)
Kleinjan A, Aggarwal A, van de Geer A, Faselis C, Büller HR, Di Nisio M, Rickles FR, Kamphuisen PW, A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism. THROMB HAEMOSTASIS 2013;110 (5):959-965 [PubMed]
Lauw MN, van Doormaal FF, Middeldorp S, Buller HR, Cancer and venous thrombosis: current comprehensions and future perspectives. SEMIN THROMB HEMOST 2013;39 (5):507-514 [PubMed]
Lip GYH, Lane DA, Buller H, Apostolakis S, Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation: The AMADEUS Study. CHEST 2013;144 (6):1839-1847 [PubMed]
Lucassen WAM. Diagnostic strategy for excluding pulmonary embolism in primary care. s.l.: s.n.; 2013. 190p. ISBN 9789053356661 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van Weert HHCPM, Büller HR; copromotor(s): )
Lucassen WAM, Beenen LFM , Büller HR, Erkens PMG, Schaefer-Prokop CM, van den Berk IAH, van Weert HC, Concerns in using multi-detector computed tomography for diagnosing pulmonary embolism in daily practice. A cross-sectional analysis using expert opinion as reference standard. THROMB RES 2013;131 (2):145-149 [PubMed]
Lucassen WAM, Kuijs-Augustijn M, Erkens PMG, Geersing GJ, Büller HR, van Weert HCPM, The additional value of the CRP test in patients in whom the primary care physician excluded pulmonary embolism. EUR J GEN PRACT 2013;19 (3):143-149 [PubMed]
Majoor CJ , Kamphuisen PW, Zwinderman AH, ten Brinke A, Amelink M, Rijssenbeek-Nouwens L, Sterk PJ, Büller HR, Bel EH, Risk of deep vein thrombosis and pulmonary embolism in asthma. EUR RESPIR J 2013;42 (3):655-661 [PubMed]
Nguyen CD, Andersson C, Jensen TB, Gjesing A, Schjerning Olsen AM, Malta Hansen C, Büller H, Torp-Pedersen C, Gislason GH, Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study. BMJ OPEN 2013;3 (11):e003135 [PubMed]
Oudman I. Creatine kinase and blood pressure. Clinical and therapeutic implications. s.l.: s.n.; 2013. 216p. ISBN 9789461916563 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller H R; copromotor(s): Brewster LM)
Raskob G, Büller H, Prins M, Segers A, Shi M, Schwocho L, van Kranen R, Mercuri M, Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials. J THROMB HAEMOST 2013;11 (7):1287-1294 [PubMed]
Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ [Contributors: Schulman S, Eriksson H, Goldhaber S, Kakkar A, Kearon C, Mismetti P, Schellong S, Minar E, Bergqvist D, Tijssen J, Prins M, Büller H, Otten J, Mac Gillavry M, Brandjes D, Otten H, Peters R, Pol S, Burroughs A, Gilmore I, Bluguermann J, Bustos B, Carlevaro O, Cartasegna L, Cuello J, Gabito A, Gitelman P, Gutierrez Carrillo N, Hrabar A, Mackinon I, Santos D, Schygiel P, Sosa Liprandi M, Baker R, Blombery P, Gallus A, Gan E, McCann A, Salem H, Koppensteiner R, Kyrle P, Pilger E, Sturm W, Hainaut P, Verhamme P, Wautrecht JC, Zicot M, Bizzachi JA, Joyce M, Araújo G, de Araújo Filho JD, Panico MDB, Pereira A, Rocha Moreira R, Timi J, Yamashita E, Anastasov V, Georgiev G, Guirov K, Lozev I, Milanov S, Peneva M, Petrov V, Yordanov Y, Anderson D, Crowther M, Dolan S, Eikelboom J, Game M, Kahn S, Kassis J, Klinke P, Ritchie B, Rodger M, Solymoss S, Spencer F, Yeo E, Bai C, Liu C, Liu J, Shen H, Wan H, Wang C, Wang Y, Wen F, Ying K, Yuan Y, Zhang J, Zhang L, Zheng Q, Zhong N, Bercikova J, Cervinka P, Cizek V, Jirka V, Lang P, Maly R, Oral I, Prochazka P, Spinar J, Brønnum-Schou J, Friis E, Jensen S, Nielsen H, Skødebjerg Kristensen K, Wiemann O, Husted S, Kuusisto A, Lassila R, Melin J, Nikkilä M, Nousiainen T, Bost V, Buchmuller A, Guillot K, Lecomte F, Mottier D, Wahl D, Beyer-Westendorf J, Dormann A, Harenberg J, Hoffmann U, Maier M, Mietaschk A, Salbach P, Cohen A, Keeling D, Kesteven P, Maclean MR, Shah P, Katsenis K, Klonaris C, Liappis C, Mihailidis D, Acsady G, Boda Z, Farkas K, Jakucs J, Kollar L, Matyas L, Muranyi A, Riba M, Sereg M, Banker D, Durairaj N, Gadkari M, Grant P, Hiremath J, Kareem S, Mahajan R, Naik A, Parakh R, Rai K, Santhosh M, Sekar N, Srinivas A, Suresh K, Vijayaraghavan G, Brenner B, Efrati S, Mazen E, Gavish D, Grossman E, Lahav M, Lishner M, Lugassy G, Zeltser D, Barillari G, D' Angelo A, Palareti G, Santonasto M, Schenone A, Silingardi M, Testa S, Aldrett Lee E, Fontes Andrade J, Jaurrieta Valles J, Montaño-González E, Sánchez-Escalante LR, Dees A, Hamulyak K, Jie A, Kamphuisen P, Leebeek F, Nurmohamed M, Pruijt J, Wittebol S, Hanna M, Jackson S, Ockelford P, Smith M, Njaastad A, Sandseth P, Tveit A, Waage A, Czarnobilski K, Gaciong Z, Gluszek S, Krolczyk J, Zawilska K, Barata J, Capitao M, e Fernandes F, Martinez J, Providência L, Sarmento P, Belentsov S, Chernyatina M, Chernyavsky A, Degterev M, Fokin A, Gubenko A, Guz V, Katelnitsky I, Khamitov A, Khitaryan A, Khubulava G, Koulikovsky V, Nelaev V, Shkurin V, Smirnov G, Sokurenko G, Soroka V, Staroverov I, Zaporozhsky S, Duris T, Poliacik P, Spisak V, Szentivanyi M, Zubek V, Adler D, Le Roux D, Routier R, Siebert R, Sloane B, Smith C, del Toro J, García-Fuster M, Marco P, Mateo J, Monreal M, Nieto J J, Sedano C, Trujillo J, Villalta J, Aagesen J, Carlsson A, Lärfars G, Lindmarker P, Säfwenberg U, Själander A, Aslim E, Bengisun U, Calkavur T, Eren E, Karahan S, Karatepe O, Kurtoglu M, Sakinci U, Gubka O, Karpovych D, Mishalov V, Skupyy O, Bartkowiak A Jr, Bolster E, Burnett B, Comerota A, Fulco F, Gleeson J, Gossage J, Kaatz S, Kuehl S, Lahiri B, Masson J, Moll S, Nathanson A, Paulson R, Powell R, Seibert A, Vrooman P, Sandgren G, Wallin J, Kälebo P, Angerås U, Falk A, Eriksson B, Dellborg M, Eriksson P, Johansson P, Hansson PO, Nicol A, Jeffries B, Benson M, Kyrle PA, Hirschl M, Böhler K, de Vleeschauwer P, Haerens M, Duchateau J, Verstraeten P, Milot A, Kotik L, Roztocil K, Joerg I, Holy M, Cernosek B, Kasalova Z, Mandakova E, Povolny J, Matoska P, Hulinsky V, Podoubsky R, Votocek S, Zarubova D, Ellervee T, Lind J, Sukles K, Uebel P, Bauersachs R, Kemkes-Matthes B, Beyer J, Siragusa S, Bova C, Cortellaro M, Falanga A, Palla A, Pini M, Poggio R, Porro F, Prisco D, Tiraferri E, Villalta S, Visona A, Zanatta N, Mazzucconi MG, Porreca E, Cattaneo M, Di Minno G, Oh D, Kim CS, Kwon TW, Lee TS, Park JS, Hong YS, Yoon SS, Kim YK, Laucevicius A, Miliauskas S, Novikovs N, Zvirgzdins V, Meijer K, Nijziel MR, van Guldener C, van Essen GG, Ouwehand ME, Jie KSG, Swart-Heikens J, Viergever PP, Dullemond AC, Tomkowski W, Torbicki A, Psuja P, Staszkiewicz W, Szopinski P, Pruszczyk P, Ciostek P, Windyga J, Stepien J, Khamitov AA, Ng HJ, Elf J, Engquist L, Sharo S, Holmström M, Lapidus L, Cederin B, Brack T, Binkert M, Canova C, Franzeck U, Allmann JK, Zehnder T, Jeanneret C, Jäger K, Erni D, Banyai M, Rödel C, Engelbrecht J, Bruning A, van Rensburg H, Vermooten IH, Norasetthada L, Thungthong P, Angchaisuksiri P, Numbenjapon T, Cook R, Deck K, Evans B, Hearne S, Kaelin T, Kuno R, Pendelton R, Speer J, Yood R, Kahn R, Sheehan K, Feldman G, Chen YCJ, Fanning J, Hartley P, Kulback S, McIvor ME, LaPerna L, Gibson K, Vaid BR, Changlani M]] , Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. NEW ENGL J MED 2013;368 (8):709-718 [PubMed]
Struijk-Mulder MC, Ettema HB, Verheyen CCPM, Büller HR, Deep vein thrombosis after arthroscopic anterior cruciate ligament reconstruction: a prospective cohort study of 100 patients. ARTHROSCOPY 2013;29 (7):1211-1216 [PubMed]
Stuijver DJF, Majoor CJ , van Zaane B, Souverein PC, de Boer A, Dekkers OM, Büller HR, Gerdes VEA, Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. CHEST 2013;143 (5):1337-1342 [PubMed]
van der Hulle T, den Exter PL, Erkens PGM, van Es J, Mos ICM, ten Cate H, Kamphuisen PW, Hovens MMC, Büller HR, Klok FA, Huisman MV, Variable D-dimer thresholds for diagnosis of clinically suspected acute pulmonary embolism. J THROMB HAEMOST 2013;11 (11):1986-1992 [PubMed]
van Dijk S, van den Beukel TO, Kaptein AA, Honig A, le Cessie S, Siegert CE, Boeschoten EW, Krediet RT, Dekker FW [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, Grave W, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Hovinga TKK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , How baseline, new-onset, and persistent depressive symptoms are associated with cardiovascular and non-cardiovascular mortality in incident patients on chronic dialysis. J PSYCHOSOM RES 2013;74 (6):511-517 [PubMed]
van Es J, Douma RA, Kamphuisen PW, Gerdes VEA, Verhamme P, Wells PS, Bounameaux H, Lensing AWA, Büller HR, Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy. J THROMB HAEMOST 2013;11 (4):679-685 [PubMed]
van Es N, Bleker SM, Büller HR, Coppens M, New developments in parenteral anticoagulation for arterial and venous thromboembolism. BEST PRACT RES CL HA 2013;26 (2):203-213 [PubMed]
Verhamme P, Gunn S, Sonesson E, Peerlinck K, Vanassche T, Vandenbriele C, Ageno W, Glazer S, Prins M, Buller H, Tangelder M, Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial. THROMB HAEMOSTASIS 2013;109 (6):1091-1098 [PubMed]
Verkleij CJN , Stuijver DJF, van Zaane B, Squizzato A, Brandjes DPM, Büller HR, Meijers JCM, Gerdes VEA, Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia. THROMB HAEMOSTASIS 2013;109 (2):214-220 [PubMed]
Apostolakis S, Lane DA, Guo Y, Buller H, Lip GYH, Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation. J AM COLL CARDIOL 2012;60 (9):861-867 [PubMed]
Bendermacher BLW, Teijink JAW, Willigendael EM, Bartelink ML, Peters RJG, Langenberg M, Büller HR, Prins MH, Applicability of the ankle-brachial-index measurement as screening device for high cardiovascular risk: an observational study. BMC CARDIOVASC DISOR 2012;12 (1):59 [PubMed]
Biere-Rafi S, Tuinenburg A, Haak BW, Peters M, Huijgen R, de Groot E, Verhamme P, Peerlinck K, Visseren FLJ, Kruip MJHA, Laros-van Gorkom BAP, Gerdes VEA, Buller HR, Schutgens REG, Kamphuisen PW, Factor VIII deficiency does not protect against atherosclerosis. J THROMB HAEMOST 2012;10 (1):30-37 [PubMed]
Büller HR, Gallus AS, Pillion G, Prins MH, Raskob GE [Contributors: Büller HR, Gallus AS, Prins MH, Raskob G, Decousus H, Charbonnier B, Leizorovicz A, Laporte S, Quenet S, Brandjes DPM, Middeldorp S, Blüguermann J, Amuchastegui L, Ahuad Guerrero R, Oberti P, Alvarez C, Cassettari A, Santos D, Macin S, Santini F, Ward C, Coughlin P, Salem H, Gan E, Leyden M, Prosser I, Crispin P, Carroll P, Gallus A, McRae S, Waites J, Pilger E, Koppensteiner R, Kyrle P, Schinko H, Mrochek A, Mitkovskaya N, Prystrom A, Motte S, Ninane V, Delcroix M, Hainaut P, Schneider E, Saraiva J, Maia L, Barreto S, Fernandes Manenti E, Araujo G, Dutra O, Fiss E, Moreira R, Yankov K, Nenkova S, Ivanov Y, Kostov V, Bhargava R, Chan Y, Miron MJ, Cusson J, Ugarte S, Morales A, Andresen M, Lanas F, Arriagada G, Mendoza JJ, Zuñiga C, Sepulveda P, Wang C, Liu Z, Yuan Y, Ma Z, Fang B, Liu J, Bai C, Wu H, Yang L, Ying K, Kang J, Li Q, Cheng Z, Zhang J, Wang H, Xie C, Xia G, Du Y, Wu Q, Zhou X, Chen L, Yi Q, Wu C, Hao Q, Liu S, Xiong S, Jiang S, Zhao L, Xiao Q, Qin Z, Zhou J, Dennis R, Miserque N, Igueredo M, Londoño D, Hildebrando J, Granados M, Buitrago R, Solano MH, Pacheco Alvis PM, Botero R, Saenz O, Bergovec M, Padovan M, Vucic N, Samarzija M, Chlumsky J, Spacek R, Klimsa Z, Gregor P, Povolny J, Podpera I, Holm F, Lang P, Matoska P, Sabl P, Spinar J, Spac J, Husted S, Avnstrom S, Rasmussen S, Christensen A, Guindy R, Hassanein M, Paumets M, Meriste S, Ferrari E, Achkar A, Azarian R, Meneveau N, Lorut C, Mouallem J, Crestani B, Proton A, Salmeron S, Lerousseau L, Mottier D, Wahl D, Siafakas N, Papadimitriou D, Katis K, Katsaris G, Gaga A, Damianos A, Tipparaju S, Kalkunte S, Vidhut J, Kalashetti S, Mehta P, Talwar D, Ramanathan R, Mishra R, Zeltzer D, Lahav M, Brenner B, Caraco Y, Elias M, Piovella F, Barone M, Poggio R, Palla A, Ghirarduzzi A, Pini M, Lodigiani C, Prandoni P, Agnelli G, Imberti D, Scannapieco G, Salvi A, Bautista E, Diaz J, Mercado R, Ranero A, Rodriguez D, Jerjes C, Villeda-Espinoza E, van der Meer J, Ijfering W, van Marwijk Kooy M, Boersma W, van Leendert R, Kroon C, Dullemond-Westland A, Viergever P, Kuipers A, Grootenboers M, Creemers J, Pieters W, de Munck D, Timmer H, Jackson S, Sandset P, Meyer P, Kristiansen T, Portugal J, Paz E, Salazar D, Chavez W, Castillo L, de Guia T, Lenora F, Tomkowski W, Kloczko J, Rybak Z, Gaciong Z, Sobkowicz B, Pruszczyk P, Nizankowski R, Mirek-Bryniarska E, Kukla P, Reis A, França A, Cortez M, Sa J, Santos F, Marques MA, Gordeev I, Gendlin G, Yablonsky P, Sokurenko G, Soroka V, Lusov V, Markov V, Shvats Y, Katerlnitskiy I, Lapin O, Lyamina N, Subbotin Y, Kim I, Zilber E, Kchaisheva L, Poliacik P, Macek V, Pretorius JP, Abdullah I, Basson M, Bollinger C, Breedt J, Gani M, Jansen J, Le Roux G, Nortje H, van der Linder M, van Zyl L, Viljoen J, Bruning A, Pujol Farriols R, Raguer E, Nuffal D, Sanchez Rodriguez A, Eriksson H, Almgren T, Carlsson A, Elf J, Olsson CG, Aagesen J, Savas I, Sahin A, Erdogan Y, Ozhan M, Ongen G, Celikel T, Turker H, Arseven O, Tuncay E, Ozacar R, Gudz I, Nykonenko O, Skupyy O, Kovalskyy I, Prasol V, Cohen A, Rodriguez-Cintron W, Gurka D, Bradley J, Oliver G, Spyropoulos A, Lerner R, Fulmer J, Lu NP, Wright P, Han D, Servi R, Nadar V, Quaranta A, Gehring J, Ginsberg R, Jacobson A, Colan D, Vanway C, Gurza E, Braslow B, Shorr A, Rehm J, Martin J, Sellers M, Concha M, Gordon I, Pullman J, Moran J, Welker J, Panzarella P, Mullins M, Willms D, McGrew F, Turki M, Menajovsky L]] , Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. LANCET 2012;379 (9811):123-129 [PubMed]
Buller HR, Lensing AWA, Prins MH, Oral Rivaroxaban for Pulmonary Embolism REPLY. NEW ENGL J MED 2012;366 (26):2526-2527
Büller HR, Prins MH, Lensin AWA, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A [Contributors: Agnelli G, Berkowitz S, Bounameaux H, Büller HR, Cohen A, Gallus A, Lensing AWA, Misselwitz F, Haskell L, Prins MH, Raskob G, Schellong S, Bauersachs R, van Bellen B, Boda Z, Borris L, Brenner B, Brighton T, Chlumsky J, Davidson B, Decousus H, Eriksson H, Jacobson B, Kakkar A, Kwong YL, Lee LH, Meijer K, van der Meer J, Minar E, Monreal M, Piovella F, Sandset PM, Smith M, Tomkowski W, Verhamme P, Wang Y, Wells P, Brandjes D, Mac Gillavry M, Otten HM, Carlsson A, Laporte S, Schulman S, Gent M, Turpie A, Martinelli I, Segers A, Lensing AW, Muhlhofer E, Tewes M, Trajanovic M, Muller K, Kim C, Gebel M, Benson A, Pap AF, Godrie J, Horvat-Broecker A, Spadari G, Peters-Wulf C, Roig J, Baker R, Bianchi A, Blombery P, Brighton T, Campbell P, Carroll P, Geraghty R, Chong B, Ramanathan S, Archis C, Coughlin P, Salem H, Crispin P, Dean M, Soni R, Denaro C, Kubler P, Coghlan D, Gallus A, Gan TE, Tran H, Coleman C, Jackson D, Khalafallah A, Leahy M, Leyden M, Leyden D, Sturtz C, McCann A, Gibbs H, McRae S, Richards B, Ward C, Curnow J, Baghestanian M, Erdogmus B, Samaha E, Nikoupayan-Mofrad M, Hirschl M, Sturm W, Kirchmair R, Marschang P, Drexel H, Mathies R, Pilger E, Brodmann M, Weltermann A, Buche M, Demelenne J, Gustin M, Hainaut P, Pothen L, de Leersnyder J, Motte S, Schroë H, Sprynger M, Verhamme P, Peerlinck K, Delcroix M, Vermassen F, Verstraeten P, Smet V, Vossaert R, van Bellen B, Panico M, Costa C, Blondal J, Kovacs M, Wells P, Rodger M, Carrier M, Wong T, Bi J, Chen Z, Chen R, Jing ZC, He J, Liu C, Liu S, Long S, Ma Y, Shao Y, Wang Y, Wang C, Yang YH, Xie C, Xu J, Ying K, Zhihong L, Chlumsky J, Hola D, Jirat S, Vitovec M, Kovářová K, Gilík J, Dosál J, Mandakova E, Matoška P, Podpera I, Podperova M, Spacek R, Urbanova R, Tuxen C, Sukles K, Pietila K, Vesanen M, Achkar A, Agraou B, Aquilanti S, Rifaï A, Berremili T, Brisot D, Brousse C, Tarodo P, Bura A, Amid-Lacombe C, Malloizel J, Boulon C, Alavoine L, Crestani B, Mismetti P, Buchmuller A, Accassat S, Elias A, Elias M, Emmerich J, Ferrari E, Guérin T, Beaka P, Lacroix P, Szwebel TA, Benhamou Y, de Maistre E, Falvo N, Mahe I, Meneveau N, Schiele F, Meyer G, Sanchez O, Planquette B, Mottier D, Le Moigne E, Couturaud F, Parent F, Pernod G, Imbert B, Elkouri D, Dary M, Queguiner A, Quere I, Galanaud JP, Roy PM, de Boisjolly-Bonnefoi JM, Schmidt J, Breuil N, Heuser S, Sevestre MA, Simoneau G, Bergmann JF, Stephan D, Trinh-Duc A, Gaillardou A, Grange C, Fassier T, Wahl D, Baron Von Bilderling P, Bauersachs R, Kuhlencordt P, Beyer-Westendorf J, Halbritter K, Werth S, Diehm C, Lawall H, Eifrig B, Espinola-Klein C, Weisser G, Giannitsis E, Haering HU, Hasslacher C, Herrmann T, Hoffmann U, Czihal M, Horacek T, Ibe M, Bauer A, Kieback A, Landgraf H, Lindhoff-Last E, Malyar N, Petermann W, Potratz J, Ranft J, Röcken M, Schellong S, Pomper L, Frommhold R, Schwaiblmair M, Berghaus T, Taute B, Lau YK, Tse E, Boda Z, Olah Z, Farkas K, Kolossváry E, Gurzó M, Kis E, Kovács A, Landi A, Lupkovics G, Pecsvarady Z, Riba M, Sipos G, Parakh R, Sembiring R, Barton J, Goldstein L, Gavish D, Hoffman R, Hussein O, Inbal A, Lishner M, Elis A, Lugassy G, Varon D, Zeltser D, Rogowski O, Steinvil A, Zisman D, Ageno W, Ambrosio G, Cattaneo M, D'Angelo A, Ghirarduzzi A, Lotti M, Pierfranceschi MG, Lodigiani C, Martinelli I, Palareti G, Barone M, Beltrametti C, Porreca E, Prandoni P, Spiezia L, Quintavalla R, Cho WH, Ha JW, Kim HS, Park K, Sime I, Miliauskas S, Petrauskiene R, Sathar J, Beeker A, ten Cate H, de Groot M, Kamphuisen P, Douma R, Kooy MvM, Coenen J, Meijer K, Mäkelburg A, Knol M, Tichelaar V, Harper P, Knottenbelt E, Ockelford P, Young L, Royle G, Simpson D, Chunilal S, Smith M, Ghanima W, Foyn S, Sandset PM, Tveit A, Abola MT, Adamiec R, Gorski P, Kloczko J, Lewczuk J, Nowak M, Musial J, Tomkowski W, Wronski J, Ng HJ, Adler D, Becker JHR, Ellis G, Isaacs R, Bloy B, Allie R, Eckstein F, Jacobson B, van Rensburg JHJ, Schmidt S, Siebert H, Zyl L, Carrera M, del Campo F, Diego I, Garcia-Bragado F, Jiménez D, Sánchez-Álvarez J, Redondo M, Roman Sanchez P, Villalta J, Eriksson H, Villegas-Scivetti M, Jonson T, Tygesen H, Lapidus L, Ottosson E, Själander A, Asmis L, Banyai M, Heidemann M, Baumgartner I, Bounameaux H, Righini M, Frank U, Hayoz D, Periard D, Chang WT, Chiu K, Wang KY, Weng ZC, Angchaisuksiri P, Pothirat C, Rojnuckarin P, Cohen A, Solis J, Hunt BJ, Luckit J, Albrecht C, Banish D, Feinbloom D, Botnick W, Chen D, Dexter J, Ettinger N, Gleeson J, Jaffer A, Joseph S, Kennedy M, Krell K, Lavender R, Lyons RM, Moll S, Nadar V, Darrow K, Hardman V, Rathbun S, Rehm J, Rodriguez-Cintron W, Stevens K, Wright P, Ramaswamy M]] , Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism. NEW ENGL J MED 2012;366 (14):1287-1297 [PubMed]
Cohn DM, Hermanides J, DeVries JH, Kamphuisen PW, Kuhls S, Homering M, Hoekstra JBL, Lensing AWA, Büller HR, Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty Analysis from the RECORD trials. THROMB HAEMOSTASIS 2012;107 (2):225-231 [PubMed]
Eerenberg ES, Levi M, Büller HR, Contra: "Antidotes for novel anticoagulants?" - Do we really need them. THROMB HAEMOSTASIS 2012;108 (4):623-624 [PubMed]
Eerenberg ES, Sijpkens MK, Meijers JCM, Buller HR, Levi M, Kamphuisen PW, Response to Letters Regarding Article, "Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects". CIRCULATION 2012;125 (16):E616
Erkens PMG, ten Cate H, Büller HR, Prins MH, Benchmark for Time in Therapeutic Range in Venous Thromboembolism: A Systematic Review and Meta-Analysis. PLOS ONE 2012;7 (9):e42269 [PubMed]
Geersing GJ, Erkens PMG, Lucassen WAM, Büller HR, Cate HT, Hoes AW, Moons KGM, Prins MH, Oudega R, van Weert HCPM, Stoffers HEJH, Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study. BMJ-BRIT MED J 2012;345:e6564 [PubMed]
Hoogeveen EK, Halbesma N, Rothman KJ, Stijnen T, van Dijk S, Dekker FW, Boeschoten EW, de Mutsert R [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, Grave W, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Obesity and mortality risk among younger dialysis patients. CLIN J AM SOC NEPHRO 2012;7 (2):280-288 [PubMed]
Kleinjan A, van Doormaal FF, Prins MH, Büller HR, Otten JMMB, Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism. NETH J MED 2012;70 (7):311-317 [PubMed]
Kruidenier LM, Viechtbauer W, Nicolaï SP, Büller H, Prins MH, Teijink JAW, Treatment for intermittent claudication and the effects on walking distance and quality of life. VASCULAR 2012;20 (1):20-35 [PubMed]
Lucassen W, van Weert HC, Büller H, Clinical Decision Rules for Excluding Pulmonary Embolism RESPONSE. ANN INTERN MED 2012;156 (2):169-170 [PubMed]
Moret KE, Grootendorst DC, Dekker FW, Boeschoten EW, Krediet RT, Houterman S, Beerenhout CH, Kooman JP [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Grave W, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Agreement between different parameters of dialysis dose in achieving treatment targets: results from the NECOSAD study. NEPHROL DIAL TRANSPL 2012;27 (3):1145-1152 [PubMed]
Mos ICM, Douma RA, Erkens PMG, Nizet TAC, Durian MF, Hovens MM, van Houten AA, Hofstee HMA, Klok FA, ten Cate H, Ullmann EF, Büller HR, Kamphuisen PW, Huisman MV, Betrouwbaarheid klinische beslisregels bij diagnostiek van acute longembolie. NED TIJDSCHR GENEESKD 2012;156 (34):A4216 [PubMed]
Schapkaitz E, Sherman GG, Jacobson BF, Haas S, Buller HR, Davies V, Diar H, Peters M, Shuttleworth M, Velaphi S, Paediatric Anticoagulation Guidelines. SAMJ S AFR MED J 2012;102 (3):171-175 [PubMed]
Stuijver DJF. The hormonal influence on the haemostatic system and the risk of thrombosis. s.l.: s.n.; 2012. 351p. ISBN 9789461914606 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Brandjes DPM; copromotor(s): Gerdes VEA, van Zaane B)
Stuijver DJF, Debeij J, van Zaane B, Dekkers OM, Smit JWA, Büller HR, Rosendaal FR, Gerdes VEA, Cannegieter SC, Levels of prolactin in relation to coagulation factors and risk of venous thrombosis Results of a large population-based case-control study (MEGA-study). THROMB HAEMOSTASIS 2012;108 (3):499-507 [PubMed]
ten Cate-Hoek AJ, van der Velde EF, Toll DB, van Weert HCPM, Moons KGM, Büller HR, Hoes AW, Joore MA, Oudega R, Prins MH, Stoffers HEJH, Common alternative diagnoses in general practice when deep venous thrombosis is excluded. NETH J MED 2012;70 (3):130-135 [PubMed]
van Dijk S, van den Beukel TO, Dekker FW, le Cessie S, Kaptein AA, Honig A, Siegert CE, Boeschoten EW, Krediet RT, Verduijn M [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog BJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van der Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, Grave W, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Short-Term Versus Long-Term Effects of Depressive Symptoms on Mortality in Patients on Dialysis. PSYCHOSOM MED 2012;74 (8):854-860 [PubMed]
van Doormaal FF, Kleinjan A, Berckmans RJ, Mackman N, Manly D, Kamphuisen PW, Richel DJ, Büller HR, Sturk A, Nieuwland R, Coagulation activation anc microparticle-associated coagulant activity in cancer patients An exploratory prospective study. THROMB HAEMOSTASIS 2012;108 (1):160-165 [PubMed]
van Es J, Mos I, Douma R, Erkens P, Durian M, Nizet T, van Houten A, Hofstee H, ten Cate H, Ullmann E, Büller H, Huisman M, Kamphuisen PW, The combination of four different clinical decision rules and an age-adjusted D-dimer cut-off increases the number of patients in whom acute pulmonary embolism can safely be excluded. THROMB HAEMOSTASIS 2012;107 (1):167-171 [PubMed]
Beyer-Westendorf J, Büller H, External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?. J THROMB HAEMOST 2011;9 (11):2153-2158 [PubMed]
Biere-Rafi S. Association between cardiovascular risk factors, hyper- and hypocoagulability. s.l.: s.n.; 2011. 187p. ISBN 978949461691200 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Gerdes VEA, Kamphuisen PW)
Biere-Rafi S, Baarslag MA, Peters M, Kruip MJHA, Kraaijenhagen RA, den Heijer M, Büller HR, Kamphuisen PW, Cardiovascular risk assessment in haemophilia patients. THROMB HAEMOSTASIS 2011;105 (2):274-278 [PubMed]
Biere-Rafi S, Di Nisio M, Gerdes V, Porreca E, Souverein P, de Boer A, Büller H, Kamphuisen P, Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism. PHARMACOEPIDEM DR S 2011;20 (6):635-642 [PubMed]
Biere-Rafi S, Haak BW, Peters M, Gerdes VEA, Büller HR, Kamphuisen PW, The impairment in daily life of obese haemophiliacs. HAEMOPHILIA 2011;17 (2):204-208 [PubMed]
Buller HR, Combe S, New treatments of veinous thrombo-embolic disease. REV MED INTERNE 2011;32:10-12
Buller HR, Lensing AWA, Prins MH, Oral Rivaroxaban for Symptomatic Venous Thromboembolism REPLY. NEW ENGL J MED 2011;364 (12):1178
Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos A, Tapson V, Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J THROMB THROMBOLYS 2011;31 (4):407-416 [PubMed]
Combe S, Büller HR, Nouveaux traitements de la maladie thrombo-embolique veineuse. J MAL VASCUL 2011;36 (Suppl. 1):S16-S19 [PubMed]
de Peuter OR. The ABC of heart failure. Adrenergic receptors, beta-blockers and coagulation. s.l.: s.n.; 2011. 169p. ISBN 9789085592709 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Kamphuisen PW)
de Peuter OR, Lip GYH, Souverein PC, Klungel OH, de Boer A, Büller HR, Kamphuisen PW, Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study. EUR J HEART FAIL 2011;13 (5):489-495 [PubMed]
de Peuter OR, Souverein PC, Klungel OH, Büller HR, de Boer A, Kamphuisen PW, Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failure. EUR J HEART FAIL 2011;13 (2):220-226 [PubMed]
Douma RA, Mos ICM, Erkens PMG, Nizet TAC, Durian MF, Hovens MM, van Houten AA, Hofstee HMA, Klok FA, ten Cate H, Ullmann EF, Büller HR, Kamphuisen PW, Huisman MV [Contributors: Beenen LF , Bossuyt PMM, Büller HR, van den Dool EJ, Douma RA, Kamphuisen PW, Hofstee HMA, Kramer MHH, Hovens MM, Kaasjager K, Nizet TAC, Ullmann EF, Eikenboom HCJ, Heringhaus C, Huisman MV, Klok FA, van Kralingen KW, Kroft LJM, Mos ICM, de Roos A, Boomars K, ten Cate H, Erkens PMG, Durian MF, Kruip MJHA, van Houten AA]] , Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. ANN INTERN MED 2011;154 (11):709-718 [PubMed]
Drechsler C, Grootendorst DC, Boeschoten EW, Krediet RT, Wanner C, Dekker FW [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, Büller HR, de Charro FTH, de Fijter CWH, Doorenbos CJ, Fagel WJ, Feith GW, Frenken LAM, Gerlag PGG, Gorgels JPMC, Grave W, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, Parlevliet KJ, Raasveld MHM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, van Buren M, van den Dorpel MA, van der Boog PJM, van der Meulen J , van der Sande FM, van Es A, van Geelen JACA, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patients. NEPHROL DIAL TRANSPL 2011;26 (4):1340-1346 [PubMed]
Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M, Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. CIRCULATION 2011;124 (14):1573-1579 [PubMed]
Eerenberg ES, van Es J, Sijpkens MK, Büller HR, Kamphuisen PW, New anticoagulants: moving on from scientific results to clinical implementation. ANN MED 2011;43 (8):606-616 [PubMed]
Grootendorst DC, Michels WM, Richardson JD, Jager KJ, Boeschoten EW, Dekker FW, Krediet RT [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Grave W, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , The MDRD formula does not reflect GFR in ESRD patients. NEPHROL DIAL TRANSPL 2011;26 (6):1932-1937 [PubMed]
Janssen KJM, van der Velde EF, ten Cate AJ, Prins MH, van Weert HCPM, Stoffers HEJH, Büller HR, Oudega R, Hoes AW, Toll DB, Moons KGM, Optimisation of the diagnostic strategy for suspected deep-vein thrombosis in primary care. THROMB HAEMOSTASIS 2011;105 (1):154-160 [PubMed]
Lane DA, Kamphuisen PW, Minini P, Büller HR, Lip GYH, Bleeding risk in patients with atrial fibrillation: the AMADEUS study. CHEST 2011;140 (1):146-155 [PubMed]
Lucassen W, Geersing GJ, Erkens PMG, Reitsma JB, Moons KGM, Büller H, van Weert HC, Clinical decision rules for excluding pulmonary embolism: a meta-analysis. ANN INTERN MED 2011;155 (7):448-460 [PubMed]
Michels WM, van Dijk S, Verduijn M, le Cessie S, Boeschoten EW, Dekker FW, Krediet RT [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, Grave W, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Quality of life in automated and continuous ambulatory peritoneal dialysis. PERITON DIALYSIS INT 2011;31 (2):138-147 [PubMed]
Roach REJ, Roshani S, Meijer K, Hamulyák K, Lijfering WM, Prins MH, Büller HR, Middeldorp S, Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort study. BRIT J HAEMATOL 2011;153 (1):134-136 [PubMed]
Roshani S, Cohn DM, Stehouwer AC, Wolf H, van der Post JAM, Büller HR, Kamphuisen PW, Middeldorp S, Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study. BMJ OPEN 2011;1 (2):e000257 [PubMed]
Roshani S, Lijfering WM, Coppens M, Hamulyák K, Prins MH, Büller HR, Middeldorp S, Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism. NETH J MED 2011;69 (1):27-30 [PubMed]
Schroijen MA, Dekkers OM, Grootendorst DC, Noordzij M, Romijn JA, Krediet RT, Boeschoten EW, Dekker FW [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Grave W, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. BMC NEPHROL 2011;12 (1):69 [PubMed]
Squizzato A, van Zaane B, Gerdes VEA, Büller HR, The Influence of Pituitary, Adrenal, and Parathyroid Hormones on Hemostasis and Thrombosis. SEMIN THROMB HEMOST 2011;37 (1):41-48 [PubMed]
Tanck MWT, Wichers IM, Meijers JCM, Büller HR, Reitsma PH, Middeldorp S, Quantitative trait locus for protein C in a family with thrombophilia. THROMB HAEMOSTASIS 2011;105 (1):199-201 [PubMed]
van der Velde EF, Toll DB, ten Cate-Hoek AJ, Oudega R, Stoffers HEJH, Bossuyt PM, Büller HR, Prins MH, Hoes AW, Moons KGM, van Weert HCPM, Comparing the Diagnostic Performance of 2 Clinical Decision Rules to Rule Out Deep Vein Thrombosis in Primary Care Patients. ANN FAM MED 2011;9 (1):31-36 [PubMed]
van Doormaal FF, Di Nisio M, Otten HM, Richel DJ, Prins M, Buller HR, Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer. J CLIN ONCOL 2011;29 (15):2071-2076 [PubMed]
van Doormaal FF, Terpstra W, van der Griend R, Prins MH, Nijziel MR, van de Ree MA, Büller HR, Dutilh JC, ten Cate-Hoek A, van den Heiligenberg SM, van der Meer J, Otten JM, Is extensive screening for cancer in idiopathic venous thromboembolism warranted?. J THROMB HAEMOST 2011;9 (1):79-84 [PubMed]
van Es J, Eerenberg ES, Kamphuisen PW, Büller HR, How to prevent, treat, and overcome current clinical challenges of VTE. J THROMB HAEMOST 2011;9 (Suppl. 1):265-274 [PubMed]
van Sluis GL, Brüggemann LW, Esmon CT, Kamphuisen PW, Richel DJ, Büller HR, van Noorden CJF, Spek CA, Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation. CANCER LETT 2011;306 (1):106-110 [PubMed]
van Vlijmen EFW, Veeger NJGM, Middeldorp S, Hamulyák K, Prins MH, Büller HR, Meijer K, Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. BLOOD 2011;118 (8):2055-61; quiz 2375 [PubMed]
van Wissen M. Infections, coagulation annd thrombosis. s.l.: s.n.; 2011. 143p. ISBN 9789461082015 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Meijers JCM, Büller H R; copromotor(s): van Gorp ECM, Gerdes VEA)
van Wissen M, Keller TT, van Gorp ECM, Gerdes VEA, Meijers JCM, van Doornum GJJ, Büller HR, Brandjes DPM, Acute respiratory tract infection leads to procoagulant changes in human subjects. J THROMB HAEMOST 2011;9 (7):1432-1434 [PubMed]
van Zaane B, Squizzato A, Debeij J, Dekkers OM, Meijers JCM, van Zanten AP, Büller HR, Gerdes VEA, Cannegieter SC, Brandjes DPM, Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study. J THROMB HAEMOST 2011;9 (9):1816-1824 [PubMed]
van Zaane B, Squizzato A, Reuwer AQ, van Zanten AP, Twickler MTB, Dekkers OM, Cannegieter SC, Büller HR, Gerdes VEA, Brandjes DPM, Prolactin and Venous Thrombosis Indications for a Novel Risk Factor?. ARTERIOSCL THROM VAS 2011;31 (3):672-677 [PubMed]
Verhamme P, Tangelder M, Verhaeghe R, Ageno W, Glazer S, Prins M, Jacquemin M, Büller H [Contributors: Verhamme P, Jacquemin M, Glazer S, de Deene A, Gunn S, Büller H, Verhaeghe R, Ageno W, Prins M, Segers A, Buysschaert I, Peerlinck K, Angelov S, Boshnakov D, Kostadinov I, Rosmanov V, Stavrev V, Agar G, Brenner B, Nyska M, Salai M, Tauber C, Itzchaki M, Benkovich V, Zeltser D, Baurovskis A, Vigulis V, Peredistijs A, Skowronski J, Deszczynski J, Grecu DC, Petrec S, Lucaciu DO, Belenkiy IG, Kornilov NN, Kravtsov A, Parfeev SG, Dryagin VG, Kuropatkin GV, Safronov AA, Nikolaev NN, Sulyma VS, Chernyak VP, Polivoda ON]] , Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial. J THROMB HAEMOST 2011;9 (4):664-671 [PubMed]
Warkentin TE, Davidson BL, Büller HR, Gallus A, Gent M, Lensing AWA, Piovella F, Prins MH, Segers AEM, Kelton JG, Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE. CHEST 2011;140 (2):366-373 [PubMed]
[Contributors: Büller HR, Destors JM, Gallus A, Prins MH, Raskob G, Charbonnier B, Decousus H, Leizorovicz A, Laporte S, Brandjes DPMB, Middeldorp S, Pillion G, Ceresetto JM, Hendler H, Xavier DL, Santini F, del Carmen Gallo M, Coughlin P, Chong B, Leahy M, Ward C, Leyden M, Prosser I, Carroll P, Gan E, McRae S, Salem H, Pilger E, Koppensteiner R, Jurecka W, Forstner K, Hainaut P, Motte S, Vermassen F, Araujo GR, Timi JRR, Costa JA, Manenti F, Yoshida WB, Kovacs M, Delle Siega A, Rodger M, Miron MJ, Anderson D, Yeo E, Kassis J, Spacek R, Klimsa Z, Patek F, Matoska P, Maly J, Srnsky V, Cepelak C, Nielsen H, Noelsen HK, Avstrom S, Husted S, Tuxen C, Stender S, Azarian R, Leftheriotis G, Jego P, Achkar A, Zeltser D, Keidar S, Inbal A, Piovella F, Barone M, Prandoni P, Imberti D, Palaretti G, Jerjes C, Calvo C, van Marwijk Kooij M, Timmerman R, Mol J, ten Cate H, Kamphuisen P, Dullemond A, Kroon C, Veth D, Biesma D, van Leendert R, Ockelford P, Chunilal S, Szyber P, Strzelczyk J, Checinsli P, Nizankowki R, Cianciara J, Kloczko J, Tomkowski W, Gutowski P, Stupin V, Sokurenko G, Kirienko A, Baesukov A, Sokora V, Katelnitsky I, Didenko Y, Lukianov Y, Zatevakhin I, Gavrilenko A, van Zyl LJ, Basson MMD, Becker LHR, Siebert S, Engelbrecht JM, Otero DR, Paloma MJ, del Toro H, Kürşat Bozkurt A, Joseph S, Nadar V, Baird I, Han D, Jacobson A, Martin J, Smith D, Comerota A, Guza E, Wright P]] , Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis. J THROMB HAEMOST 2011;9 (1):92-99 [PubMed]
Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S, Oral Rivaroxaban for Symptomatic Venous Thromboembolism. NEW ENGL J MED 2010;363 (26):2499-2510
Biere-Rafi S, Zwiers M, Peters M, van der Meer J, Rosendaal FR, Büller HR, The effect of haemophilia and von Willebrand disease on arterial thrombosis: a systematic review. NETH J MED 2010;68 (5):207-214 [PubMed]
Bueller HR, Treating VTE: is there life after warfarin?. EUR J HAEMATOL 2010;85 (Suppl. 72):12-19
Cohn DM. Thrombophilia ad dies vitae. s.l.: s.n.; 2010. 184p. ISBN 9789090250052 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Middeldorp S, Kamphuisen PW)
Cohn DM, Repping S, Büller HR, Meijers JCM, Middeldorp S, Increased sperm count may account for high population frequency of factor V Leiden. J THROMB HAEMOST 2010;8 (3):513-516 [PubMed]
Di Nisio M, Ferrante N, de Tursi M, Iacobelli S, Cuccurullo F, Büller HR, Feragalli B, Porreca E, Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. THROMB HAEMOSTASIS 2010;104 (5):1049-1054 [PubMed]
Di Nisio M, van Sluis GL, Bossuyt PMM, Büller HR, Porreca E, Rutjes AWS, Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J THROMB HAEMOST 2010;8 (4):684-692 [PubMed]
Douma RA. Pulmonary embolism: advances in diagnosis and prognosis. s.l.: s.n.; 2010. 250p. ISBN 9789461080493 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller H R; copromotor(s): Kamphuisen PW, Gerdes VEA)
Douma RA, Hofstee HMA, Schaefer-Prokop C, van Waesberghe JHTM, Lely RJ, Kamphuisen PW, Gerdes VEA, Kramer MHH, Büller HR, Comparison of 4- and 64-slice CT scanning in the diagnosis of pulmonary embolism. THROMB HAEMOSTASIS 2010;103 (1):242-246 [PubMed]
Douma RA, Kamphuisen PW, Büller HR, Acute pulmonary embolism. Part 1: epidemiology and diagnosis. NAT REV CARDIOL 2010;7 (10):585-596 [PubMed]
Douma RA, Kessels JBF, Buller HR, Gerdes VEA, Knowledge of the D-dimer test result influences clinical probability assessment of pulmonary embolism. THROMB RES 2010;126 (4):E271-E275 [PubMed]
Douma RA, Kok MGM, Verberne LM, Kamphuisen PW, Büller HR, Incidental venous thromboembolism in cancer patients: prevalence and consequence. THROMB RES 2010;125 (6):E306-E309 [PubMed]
Douma RA, Le Gal G, Söhne M, Righini M, Kamphuisen PW, Perrier A, Kruip MJHA, Bounameaux H, Büller HR, Roy PM, Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts. BMJ-BRIT MED J 2010;340:c1475 [PubMed]
Douma RA, van Sluis GL, Kamphuisen PW, Söhne M, Leebeek FWG, Bossuyt PMM, Büller HR, Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients Explanations and potential ameliorations. THROMB HAEMOSTASIS 2010;104 (4):831-836 [PubMed]
Gibson NS, Douma RA, Squizzato A, Söhne M, Büller HR, Gerdes VEA, Application of a decision rule and a D-dimer assay in the diagnosis of pulmonary embolism. THROMB HAEMOSTASIS 2010;103 (4):849-854 [PubMed]
Gibson NS, Sohne M, Gerdes VEA, Meijers JCM, Buller HR, Clinical usefulness of prothrombin fragment 1+2 in patients with suspected pulmonary embolism. THROMB RES 2010;125 (1):97-99 [PubMed]
Kaandorp SP, Goddijn M, van der Post JAM, Hutten BA, Verhoeve HR, Hamulyák K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DNM, Büller HR, van der Veen F, Middeldorp S, Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. NEW ENGL J MED 2010;362 (17):1586-1596 [PubMed]
Klok FA, Cohn DM, Middeldorp S, Scharloo M, Büller HR, van Kralingen KW, Kaptein AA, Huisman MV, Quality of life after pulmonary embolism: validation of the PEmb-QoL Questionnaire. J THROMB HAEMOST 2010;8 (3):523-532 [PubMed]
Lijfering WM, Middeldorp S, Veeger NJGM, Hamulyák K, Prins MH, Büller HR, van der Meer J, Risk of Recurrent Venous Thrombosis in Homozygous Carriers and Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A. CIRCULATION 2010;121 (15):1706-1712 [PubMed]
Lucassen WAM, Douma RA, Toll DB, Buller HR, van Weert HCPM, Excluding pulmonary embolism in primary care using the Wells-rule in combination with a point-of care D-dimer test: a scenario analysis. BMC FAM PRACT 2010;11 (1):64 [PubMed]
Mäkelburg ABU, Veeger NJGM, Middeldorp S, Hamulyák K, Prins MH, Büller HR, Lijfering WM, Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study. HAEMATOLOGICA 2010;95 (6):1030-1033 [PubMed]
Rensing KL, Houttuijn Bloemendaal FM, Weijers EM, Richel DJ, Büller HR, Koolwijk P, van der Loos CM, Twickler TB, von der Thüsen JH, Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?. DIABETOLOGIA 2010;53 (5):966-970 [PubMed]
Schreijer AJM, Hoylaerts MF, Meijers JCM, Lijnen HR, Middeldorp S, Büller HR, Reitsma PH, Rosendaal FR, Cannegieter SC, Explanations for coagulation activation after air travel. J THROMB HAEMOST 2010;8 (5):971-978 [PubMed]
Shurlock B, Bueller HR, Spotlight: Harry R. Buller, MD, PhD. CIRCULATION 2010;122 (23):F133-F137
Squizzato A. Thyroid disease and haemostasis. A relatonship with clinical implcations?. S.l.: s.n.; 2010. 203p. ISBN 9789090253817 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Ageno W; copromotor(s): Gerdes VEA, Brandjes DPM, Cannegieter SC)
Squizzato A, Micieli E, Galli M, Gibson N, Gerdes VEA, Dentali F, Buller H, Ageno W, Venco A, Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice. THROMB RES 2010;125 (2):134-136 [PubMed]
Struijk-Mulder MC, Ettema HB, Verheyen CC, Büller HR, Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery. J THROMB HAEMOST 2010;8 (4):678-683 [PubMed]
Struijk-Mulder MC, van Wijhe W, Sze YK, Knollema S, Verheyen CC, Büller HR, Fritschy WM, Ettema HB, Death and venous thromboembolism after lower extremity amputation. J THROMB HAEMOST 2010;8 (12):2680-2684 [PubMed]
Surie S, Gibson NS, Gerdes VEA, Bouma BJ, van Eck-Smit BLF, Buller HR, Bresser P, Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism. THROMB RES 2010;125 (5):E202-E205 [PubMed]
van Doormaal FF, Atalay S, Brouwer HJ, van der Velde EF, Büller HR, van Weert HC, Idiopathic Superficial Thrombophlebitis and the Incidence of Cancer in Primary Care Patients. ANN FAM MED 2010;8 (1):47-50 [PubMed]
van Doormaal FF, Büller HR, Heparin and Survival in Cancer Patients. HEMATOL ONCOL CLIN N 2010;24 (4):777-+ [PubMed]
van Doormaal FF, Cohen AT, Davidson BL, Decousus H, Gallus AS, Gent M, Piovella F, Prins MH, Raskob GE, Büller HR, Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial. THROMB HAEMOSTASIS 2010;104 (1):86-91 [PubMed]
van Es J, Douma RA, Gerdes VEA, Kamphuisen PW, Büller HR, Acute pulmonary embolism. Part 2: treatment. NAT REV CARDIOL 2010;7 (11):613-622 [PubMed]
van Sluis GL. Cancer, haemostasis and coagulans. s.l.: s.n.; 2010. 249p. ISBN 9789090252124 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, van Noorden CJF; copromotor(s): Spek CA, Richel DJ)
van Sluis GL, Büller HR, Spek CA, The role of activated protein C in cancer progression. THROMB RES 2010;125 (Suppl. 2):S138-S142 [PubMed]
van Zaane B. Hormones, haemostasis en the risk of thrombosis. s.l.: s.n.; 2010. 295p. ISBN 9789090253718 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller H R, Ageno W; copromotor(s): Gerdes VEA, Brandjes DPM, Cannegieter SC)
van Zaane B, Nur E, Squizzato A, Gerdes VEA, Büller HR, Dekkers OM, Brandjes DPM, Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J THROMB HAEMOST 2010;8 (11):2483-2493 [PubMed]
van Zaane B, Squizzato A, Huijgen R, van Zanten AP, Fliers E, Cannegieter SC, Büller HR, Gerdes VEA, Brandjes DPM, Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. BLOOD 2010;115 (22):4344-4349 [PubMed]
Wichers IM. Unsolved issues in etiology and treatment of venous thrombosis. s.l.: s.n.; 2010. 188p. ISBN 9789490122980 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Middeldorp S, Tanck MWT)
Abdelmalik N, Ruhé HG, Barwari K, van den Dool EJ, Meijers JCM, Middeldorp S, Büller HR, Schene AH, Kamphuisen PW, Het effect van de selectieve serotonineheropnameremmer paroxetine op de bloedplaatjesfunctie wordt beïnvloed door een SLC6A4-serotoninetransporterpolymorfisme. NED TIJDSCHR HEMATOL 2009;6 (6):211-219
Büller HR, ten Cate-Hoek AJ, Hoes AW, Joore MA, Moons KGM, Oudega R, Prins MH, Stoffers HEJH, Toll DB, van der Velde EF, van Weert HCPM, Safely Ruling Out Deep Venous Thrombosis in Primary Care. ANN INTERN MED 2009;150 (4):229-235 [PubMed]
de Mutsert R, Grootendorst DC, Boeschoten EW, Brandts H, van Manen JG, Krediet RT, Dekker FW [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Grave W, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients. AM J CLIN NUTR 2009;89 (3):787-793 [PubMed]
de Peuter OR, Kok WEM, Torp-Pedersen C, Büller HR, Kamphuisen PW, Systolic Heart Failure: A Prothrombotic State. SEMIN THROMB HEMOST 2009;35 (5):497-504 [PubMed]
de Peuter OR, Lussana F, Peters RJG, Büller HR, Kamphuisen PW, A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure. NETH J MED 2009;67 (9):284-294 [PubMed]
Djurabi RK, Klok FA, Nijkeuter M, Kaasjager K, Kamphuisen PW, Kramer MHH, Kruip MJHA, Leebeek FWG, Büller HR, Huisman MV, Comparison of the clinical usefulness of two quantitative D-Dimer tests in patients with a low clinical probability of Pulmonary Embolism. THROMB RES 2009;123 (5):771-774 [PubMed]
Douma RA, Gibson NS, Gerdes VEA, Büller HR, Wells PS, Perrier A, Le Gal G, Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism. THROMB HAEMOSTASIS 2009;101 (1):197-200 [PubMed]
Douma RA, Kamphuisen PW, Rijnders AJM, ten Wolde M, Büller HR, An alternative diagnostic strategy in young women with suspected pulmonary embolism. J THROMB HAEMOST 2009;7 (4):725-727 [PubMed]
Drechsler C, de Mutsert R, Grootendorst DC, Boeschoten EW, Krediet RT, le Cessie S, Wanner C, Dekker FW [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, Büller HR, de Charro FTH, de Fijter CWH, Doorenbos CJ, Fagel WJ, Feith GW, Frenken LAM, Gerlag PGG, Gorgels JPMC, Grave W, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, Parlevliet KJ, Raasveld MHM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, van Buren M, van den Dorpel MA, van der Boog PJM, van der Meulen J , van der Sande FM, van Es A, van Geelen JACA, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Association of body mass index with decline in residual kidney function after initiation of dialysis. AM J KIDNEY DIS 2009;53 (6):1014-1023 [PubMed]
Ettema HB, Mulder MC, Nurmohamed MT, Buller HR, Verheyen CCPM, Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey. ACTA ORTHOP 2009;80 (1):109-112 [PubMed]
Folkeringa N, Korteweg FJ, Veeger NJGM, Middeldorp S, Hamulyak K, Prins MH, Erwich JJHM, Büller HR, van der Meer J, Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study. THROMB RES 2009;123 (3):511-514 [PubMed]
Gibson NS, Schellong SM, El Kheir DY, Beyer J, Gallus AS, Mc Rae S, Schutgens REG, Piovella F, Gerdes VEA, Buller HR, Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study. J THROMB HAEMOST 2009;7 (12):2035-2041 [PubMed]
Hermanides J, Cohn DM, DeVries JH, Kamphuisen PW, Huijgen R, Meijers JCM, Hoekstra JBL, Büller HR, Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study. J THROMB HAEMOST 2009;7 (6):945-949 [PubMed]
Jacobson BF, Louw S, Mer M, Haas S, Büller HR, Abdul-Carim ATO, Adler D, Beaton A, de Jong PR, van der Jagt D, Levy B, Pearl J, Schapkaitz E, Wessels P, Venous thromboembolism--prophylactic and therapeutic practice guideline. SAMJ S AFR MED J 2009;99 (6):467-8, 470-3 [PubMed]
Jong E, Louw S, Meijers JCM, de Kruif MD, ten Cate H, Büller HR, Mulder JW, van Gorp ECM, The Hemostatic Balance in HIV-Infected Patients with and without Antiretroviral Therapy: Partial Restoration with Antiretroviral Therapy. AIDS PATIENT CARE ST 2009;23 (12):1001-1007 [PubMed]
Kamphuisen PW, Rosendaal FR, Büller HR, Hemostatic abnormalities and arterial thrombosis. SEMIN THROMB HEMOST 2009;35 (5):449-450 [PubMed]
Krekel NMA, Coppens M, Büller HR, Middeldorp S, Reliability of questionnaires on the use of thromboprophylaxis. J THROMB HAEMOST 2009;7 (6):1042-1043 [PubMed]
Kuipers S. Air travel and venous thrombosis. Leiden: s.n.; 2009. 117p. ISBN 978-94-90122-49-2 Proefschrift Rijksuniversiteit Leiden, Faculteit Geneeskunde, onderzoek in AMC-UvA. (Promotor(s): Rosendaal FR, Büller HR; copromotor(s): Middeldorp S, Cannegieter SC)
Lijfering WM, Brouwer JLP, Veeger NJGM, Bank I, Coppens M, Middeldorp S, Hamulyak K, Prins MH, Buller HR, van der Meer J, Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. BLOOD 2009;113 (21):5314-5322 [PubMed]
Lijfering WM, Veeger NJGM, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J, A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. BLOOD 2009;114 (10):2031-2036 [PubMed]
Lussana F, Caberlon S, Pagani C, Kamphuisen PW, Büller HR, Cattaneo M, Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review. THROMB RES 2009;124 (4):409-417 [PubMed]
Mäkelburg ABU, Lijfering WM, Middeldorp S, Hamulyák K, Veeger NJGM, Prins MH, Büller HR, van der Meer J, Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - A prospective family cohort study in asymptomatic subjects. THROMB HAEMOSTASIS 2009;101 (1):209-212 [PubMed]
Niers TMH, Brüggemann LW, van Sluis GL, Liu RD, Versteeg HH, Büller HR, van Noorden CJF, Reitsma PH, Spek CA, Richel DJ, Long-term thrombin inhibition promotes cancer cell extravasation in a mouse model of experimental metastasis. J THROMB HAEMOST 2009;7 (9):1595-1597 [PubMed]
Noordzij M, Voormolen NMC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, Korevaar JC [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, Grave W, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Verstappen VMC, Vincent HH, Vos PF]] , Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients. NEPHROL DIAL TRANSPL 2009;24 (5):1580-1587 [PubMed]
Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ [Contributors: Schulman S, Eriksson H, Goldhaber S, Kakkar A, Kearon C, Mismetti P, Schellong S, Minar E, Bergqvist D, Tijssen J, Prins M, Büller H, Otten J, Peters R, Mac Gillavry M, Pol S, Burroughs A, Gilmore I, Bluguermann J, Carlevaro O, Dipaola L, Gitelman P, Santos D, Schygiel P, Baker R, Blombery P, Gallus A, Gan E, Gibbs H, Salem H, Baghestanian M, Pilger E, Sturm W, Debing E, Gadisseur A, Hainaut P, Verhamme P, Wautrecht JC, Zicot M, Bizzachi JMA, Araujo G, de Araujo JD, Panico FMDB, Nagato Y, Pereira AH, Leao PP, Ramaciotti E, Moreira RCR, Timi J, Anderson D, Crowther M, Dolan S, Eikelboom J, Spencer F, Game M, Kahn S, Kassis J, Klinke P, Kovacs M, Milot A, Ritchie B, Rodger M, Solymoss S, Villeneuve J, Yeo E, Cervinka P, Homza M, Hrdy P, Klimsa Z, Lang P, Maly R, Oral I, Reichert P, Spinar J, Varejka P, Vladimir J, Brønnum-Schou J, Jensen S, Jensen SE, Kristensen KS, Nielsen H, Wiemann O, Bost V, Buchmuller A, Guillot K, Laurent P, Lecomte F, Mottier D, Quere I, Wahl D, Beyer J, Dormann A, Hoffmann U, Maier M, Mietaschk A, Katsenis K, Klonaris C, Liappis C, Acsady G, Berhes I, Boda Z, Farkas K, Jakucs J, Kollar L, Matyas L, Riba M, Sereg M, Aggarwal R, Banker D, Bharani A, Gadkari M, Hiremath J, Jain A, Kareem S, Lyengar S, Parakh R, Sekar N, Srinivas A, Suresh K, Vujay T, Brenner B, Efrati S, Elias M, Gavish D, Grossman E, Lahav M, Lishner M, Zeltser D, Agnelli G, Cimminiello C, Palareti G, Prandoni P, Santonastaso M, Silingardi M, Lee EA, Andrade JMF, Valles JJ, Biesma D, Dees A, Fijnheer R, Hamulyak K, Kramer MHH, Leebeek FWG, Lieverse L, Nurmohamed MT, Chunilal S, Jackson S, Ockelford P, Smith M, Njaastad AM, Sandseth PM, Tveit A, Waage A, Barata J, Capitao M, Fernandes FE, Leitão A, Providência L, Alohin DI, Belentsov S, Chernyatina M, Chernyavsky A, Fokin A, Gubenko A, Guz VAV, Katelnitsky I, Khamitov AAA, Khitaryan A, Khubulava G, Mikhailov I, Shkurin V, Staroverov I, Tchumakov A, Zaporozhsky A, Duris T, Poliacik P, Spisak V, Szentivanyi M, Zubek V, Adler D, Kelbe D, Le Roux D, Pieterse A, Routier R, Siebert R, Sloane B, Smith C, van Rensburg H, del Toro J, García-Fuster MJ, Mateo J, Monreal M, Nieto JA, Sánchez-Molini P, Sedano C, Trujillo J, Valle R, Villalta J, Aagesen J, Carlsson A, Johansson L, Lärfars G, Lindmarker P, Säfvenberg U, Själander A, Bengisun U, Calkavur T, Guney MR, Karahan S, Kurtoglu M, Sakinci U, Gubka A, Mishalov V, Skupyy O, Cohen A, Keeling D, Kesteven P, MacCallum P, Maclean R, Shah P, Watson H, Bartkowiak A, Bolster E, Botnick WC, Burnett B, Chervu A, Comerota AJ, Dy NM, Fulco FA, Gossage JR, Kaatz S, Lahiri B, Lerner RG, Masson JA, Moll S, Morganroth M, Patel K, Paulson R, Powell R, Samson R, Seibert A, Spyropoulos A, Vrooman PS Jr]] , Dabigatran versus warfarin in the treatment of acute venous thromboembolism. NEW ENGL J MED 2009;361 (24):2342-2352 [PubMed]
ten Cate-Hoek AJ, Toll DB, Büller HR, Hoes AW, Moons KGM, Oudega R, Stoffers HEJH, van der Velde EF, van Weert HCPM, Prins MH, Joore MA, Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual. J THROMB HAEMOST 2009;7 (12):2042-2049 [PubMed]
van Beek EJR, Büller HR, Oudkerk M, editors, Deep Vein Thrombosis and Pulmonary Embolism. S.l.: Wiley-Blackwell; 2009. 562p. ISBN 978-0-470-51717-8(H/B)
van Dijk S, Scharloo M, Kaptein AA, Thong MSY, Boeschoten EW, Grootendorst DC, Krediet RT, Dekker FW, Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, van Geelen JACA, Gerlag PGG, Grave W, Gorgels JPMC, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF, Patients' representations of their end-stage renal disease: relation with mortality. NEPHROL DIAL TRANSPL 2009;24 (10):3183-3185 [PubMed]
van Doormaal FF. Venous thromboembolism, coagulation and cancer. s.l.: s.n.; 2009. 229p. ISBN 978909490122454 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Richel DJ; copromotor(s): Otten JMMB)
van Doormaal FF, Kleinjan A, Di Nisio M, Büller HR, Nieuwland R, Cell-derived microvesicles and cancer. NETH J MED 2009;67 (7):266-273 [PubMed]
van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AWA, Piovella F, Prins MH, Büller HR, Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. THROMB HAEMOSTASIS 2009;101 (4):762-769 [PubMed]
van Sluis GL, Buller HR, Treatment of Cancer-Associated Venous Thrombosis. CANCER INVEST 2009;27 (Suppl. 1):1-6
van Sluis GL, Niers TMH, Esmon CT, Tigchelaar W, Richel DJ, Buller HR, van Noorden CJF, Spek CA, Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement. BLOOD 2009;114 (9):1968-1973 [PubMed]
van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MTB, Fliers E, Gerdes VEA, Büller HR, Brandjes DPM, Hypercoagulable State in Cushing's Syndrome: A Systematic Review. J CLIN ENDOCR METAB 2009;94 (8):2743-2750 [PubMed]
van Zaane B, Reuwer AQ, Büller HR, Kastelein JJP, Gerdes VEA, Twickler MTB, Hormones and Cardiovascular Disease: A Shift in Paradigm with Clinical Consequences?. SEMIN THROMB HEMOST 2009;35 (5):478-487 [PubMed]
Wichers IM, Tanck MWT, Meijers JCM, Lisman T, Reitsma PH, Rosendaal FR, Büller HR, Middeldorp S, Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia. THROMB HAEMOSTASIS 2009;101 (3):465-470 [PubMed]
Abdelmalik N, Ruhé HG, Barwari K, van den Dool EJ, Meijers JCM, Middeldorp S, Büller HR, Schene AH, Kamphuisen PW, Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J THROMB HAEMOST 2008;6 (12):2168-2174 [PubMed]
Bernardi E, Camporese G, Buller HR, Siragusa S, Imberti D, Berchio A, Ghirarduzzi A, Verlato F, Anastasio R, Prati C, Piccioli A, Pesavento R, Bova C, Maltempi P, Zanatta N, Cogo A, Cappelli R, Bucherini E, Cuppini S, Noventa F, Prandoni P, Serial 2-point ultrasonography plus D-Dimer vs whole-leg color-coded doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis - A randomized controlled trial. JAMA-J AM MED ASSOC 2008;300 (14):1653-1659 [PubMed]
Bousser MG, Bouthier J, Büller HR, Cohen AT, Crijns H, Davidson BL, Halperin J, Hankey G, Levy S, Pengo V, Prandoni P, Prins MH, Tomkowski W, Thorp-Pedersen C, Wyse DG, Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. LANCET 2008;371 (9609):315-321 [PubMed]
Buller H, A higher international normalized ratio may be better for your patient. CAN MED ASSOC J 2008;179 (3):217 [PubMed]
Buller H, Deitchman D, Prins M, Segers A [Contributors: Büller H, Brenner B, Brighton T, Chlumsky J, Davidson B, Decousus H, Eriksson H, Jacobson B, van der Meer J, Minar E, Piovella F, Tomkowski W, Prins M, Baarslag H, Brandjes D, Bergqvist D, Laporte S, Mismetti P, Baker R, Blombery P, Chong B, Gallus A, Gan E, Salem H, Hirschl M, Pilger E, Kovarova K, Malý J, Matoska P, Patek F, Spacek R, Vitovec M, Zak J, Emmerich J, Lacroix P, Mottier D, Quere I, Roy P, Schmidt J, Elias M, Gavish D, Hoffman R, Hussein O, Lishner M, Lugassy G, Schliamser L, Shpilberg O, Varon D, Zeltser D, Ambrosio G, Ghirarduzzi A, Imberti D, Porreca E, Prandoni P, Jawien A, Nizankowski R, Skorski M, Witkiewicz W, Zawilska K, Engelbrecht J, v Marle J, Wright N, Aagesen J, Agren A, Jonson T, Lärfars G, Wallen T, ten Cate H, Kooy MvM, Middeldorp S, de Swart K, Garcia D, Lyons R, Rehm J, Spyropoulos A]] , Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study. J THROMB HAEMOST 2008;6 (8):1313-1318 [PubMed]
Büller HR, Halperin JL, Bounameaux H, Prins M, Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants. J THROMB HAEMOST 2008;6 (2):227-229 [PubMed]
Buller HR, Lensing AWA, Prins MH, Agnelli G, Cohen A, Gallus AS, Misselwitz F, Raskob G, Schellong S, Segers A, A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. BLOOD 2008;112 (6):2242-2247 [PubMed]
Coppens M. Thrombophilia. s.l.: s.n.; 2008. 135p. ISBN 9789090227450 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Buller HR; copromotor(s): Middeldorp S)
Douma RA, Kamphuisen PW, Huisman MV, Büller HR, False normal results on multidetector-row spiral computed tomography in patients with high clinical probability of pulmonary embolism. J THROMB HAEMOST 2008;6 (11):1978-1979 [PubMed]
Ettema HB. Some dilemmas in orthopedic thromboprophylaxis. s.l.: s.n.; 2008. 206p. ISBN 9789071382765 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Verheyen CCPM)
Ettema HB, Kollen BJ, Verheyen CCPM, Büller HR, Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials. J THROMB HAEMOST 2008;6 (7):1093-1098 [PubMed]
Folkeringa N, Coppens M, Veeger NJGM, Bom VJJ, Middeldorp S, Hamulyak K, Prins MH, Büller HR, van der Meer J, Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels. THROMB HAEMOSTASIS 2008;100 (1):38-44 [PubMed]
Gibson NS. The diagnosis and prognosis of venous thromboembolism. Variations on a theme. s.l.: s.n.; 2008. 173p. ISBN 9789090233857 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Gerdes VEA, Söhne M)
Gibson NS, Sohne M, Gerdes VEA, Nijkeuter M, Buller HR, The importance of clinical probability assessment in interpreting a normal d-dimer in patients with suspected pulmonary embolism. CHEST 2008;134 (4):789-793 [PubMed]
Gibson NS, Sohne M, Kruip MJHA, Tick LW, Gerdes VE, Bossuyt PM, Wells PS, Buller HR, Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. THROMB HAEMOSTASIS 2008;99 (1):229-234 [PubMed]
Klok FA, Djurabi RK, Nijkeuter M, Eikenboom HCJ, Leebeek FWG, Kramer MHH, Kaasjager K, Kamphuisen PW, Büller HR, Huisman MV, High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity. BRIT J HAEMATOL 2008;140 (2):218-222 [PubMed]
Levi M, Hovingh GK, Cannegieter SC, Vermeulen M, Büller HR, Rosendaal FR, Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. BLOOD 2008;111 (9):4471-4476 [PubMed]
Lijfering WM, Coppens M, Veeger NJGM, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J, Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels. THROMB RES 2008;123 (2):244-250 [PubMed]
Louw S, Jacobson BF, Büller H, Human immunodeficiency virus infection and acute deep vein thromboses. CLIN APPL THROMB-HEM 2008;14 (3):352-355 [PubMed]
Lussana F, Painter RC, Ocke MC, Buller HR, Bossuyt PM, Roseboom TJ, Prenatal exposure to the Dutch famine is associated with a preference for fatty foods and a more atherogenic lipid profile. AM J CLIN NUTR 2008;88 (6):1648-1652 [PubMed]
Niers TMH. Coagulation, angiogenesis and cancer. s.l.: s.n.; 2008. 199p. ISBN 9789064642579 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Richel DJ, van Noorden CJ; copromotor(s): Büller HR, Spek CA)
Nijkeuter M, Kwakkel-van Erp JM, Kruip MJHA, Sohne M, Büller HR, Leebeek FWG, Huisman MV, Incidence of diagnosis of subsegmental pulmonary emboli using multidetector row and single-detector row computed tomography. J THROMB HAEMOST 2008;6 (2):384-386 [PubMed]
Nijkeuter M, Tick LW, Sohne M, Kruip MJHA, Buller HR, Leebeek FWG, Kramer MHH, Klok FA, Prins MH, Huisman MV, Excluding pulmonary embolism without imaging tests - Can our diagnostic algorithm be optimized?. THROMB HAEMOSTASIS 2008;100 (6):1203-1206 [PubMed]
Stein PD, Sostman HD, Bounameaux H, Buller HR, Chenevert TL, Dalen JE, Goodman LR, Gottschalk A, Hull RD, Leeper KV Jr, Pistolesi M, Raskob GE, Wells PS, Woodard PK, Challenges in the diagnosis of acute pulmonary embolism. AM J MED 2008;121 (7):565-571 [PubMed]
Thong MSY, Kaptein AA, Benyamini Y, Krediet RT, Boeschoten EW, Dekker FW [Contributors: Apperloo AJ, Bijlsma JA , Boekhout M, Boer WH, van der Boog PJM, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CWH, Frenken LAM, Grave W, van Geelen JACA, Gerlag PGG, Gorgels JPMC, Huisman RM, Jager KJ, Jie K, Koning-Mulder WAH, Koolen MI, Kremer Hovinga TK, Lavrijssen ATJ, Luik AJ, van der Meulen J , Parlevliet KJ, Raasveld MHM, van der Sande FM, Schonck MJM, Schuurmans MMJ, Siegert CEH, Stegeman CA, Stevens P, Thijssen JGP, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF]] , Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study. AM J KIDNEY DIS 2008;52 (1):111-117 [PubMed]
Tick LW, Nijkeuter M, Kramer MHH, Hovens MMC, Büller HR, Leebeek FWG, Huisman MV, High D-dimer levels increase the likelihood of pulmonary embolism. J INTERN MED 2008;264 (2):195-200 [PubMed]
van Doormaal FF, Büller HR, Middeldorp S, Development in anticoagulant therapy. CRIT REV ONCOL HEMAT 2008;66 (2):145-154 [PubMed]
Wichers IM, Haighton M, Büller HR, Middeldorp S, A retrospective analysis of patients treated for superficial vein thrombosis. NETH J MED 2008;66 (10):423-427 [PubMed]
Bank I, van de Poel MHW, Coppens M, Hamulyák K, Prins MH, van der Meer J, Veeger NJGM, Büller HR, Middeldorp S, Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study. THROMB HAEMOSTASIS 2007;98 (5):1040-1044 [PubMed]
Bendermacher BLW, Teijink JAW, Willigendael EM, Bartelink ML, Peters RJG, de Bie RA, Buller HR, Boiten J, Langenberg M, Prins MH, A clinical prediction model for the presence of peripheral arterial disease - the benefit of screening individuals before initiation of measurement of the ankle-brachial index: an observational study. VASC MED 2007;12 (1):5-11 [PubMed]
Biemond BJ, Perzborn E, Friederich PW, Levi M, Buetehorn U, Buller HR, Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939) - an oral, direct factor Xa inhibitor. THROMB HAEMOSTASIS 2007;97 (3):471-477 [PubMed]
Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, Pillion G, Piovella F, Prins MH, Raskob GE, Extended prophylaxis of venous thromboembolism with idraparinux. NEW ENGL J MED 2007;357 (11):1105-1112 [PubMed]
Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, Pillion G, Piovella F, Prins MH, Raskob GE, Idraparinux versus standard therapy for venous thromboembolic disease. NEW ENGL J MED 2007;357 (11):1094-1104 [PubMed]
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire Geneeskunde, 3e herziene druk. Alphen aan de Rijn: Van Zuiden Communications; 2007. 405p. ISBN 978-90-8523-151-6
Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW, Cancer and thrombosis: from molecular mechanisms to clinical presentations. J THROMB HAEMOST 2007;5 (Suppl. 1):246-254 [PubMed]
Coppens M, Folkeringa N, Teune MJ, Hamulyak K, van der Meer J, Prins MH, Buller HR, Middeldorp S, Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutation: reply to a rebuttal. J THROMB HAEMOST 2007;5 (9):1992-1994 [PubMed]
Coppens M, Folkeringa N, Teune MJ, Hamulyak K, van der Meer J, Prins MH, Buller HR, Middeldorp S, Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations. J THROMB HAEMOST 2007;5 (7):1444-1448 [PubMed]
Coppens M, Schreijer AJM, Berger FH, Cannegieter SC, Rosendaal FR, Bueller HR, Mechanical prophylaxis for travellers' thrombosis: a comparison of three interventions that promote venous outflow. J THROMB HAEMOST 2007;5 (7):1556-1567 [PubMed]
Coppens M, van Mourik JA, Eckmann CM, Buller HR, Middeldorp S, Current practise of testing for inherited thrombophilia. J THROMB HAEMOST 2007;5 (9):1979-1981 [PubMed]
Davidson BL, Bueller HR, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob GE, Segers AEM, Lensing AWA, Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials. J THROMB HAEMOST 2007;5 (6):1191-1194 [PubMed]
Dinh T, Nieuwlaat R, Tieleman RG, Buller HR, Mensing van Charante NA, Prins MH, Crijns HJGM, Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey. INT J CLIN PRACT 2007;61 (1):24-31 [PubMed]
Di Nisio M. Thrombosis and cancer: advances in diagnosis and prognosis. s.l.: s.n.; 2007. 212p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Richel DJ, Buller HR; copromotor(s): Middeldorp S)
Di Nisio M, Squizzato A, Rutjes AWS, Büller HR, Zwinderman AH, Bossuyt PMM, Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J THROMB HAEMOST 2007;5 (2):296-304 [PubMed]
Douma RA, Kamphuisen PW, Buller HR, Clinical decision rules in the diagnostic work-up of patients with clinically suspected pulmonary embolism. IMAGING DECIS 2007;11 (3):8-13
Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Kälebo P, Christiansen AV, Hantel S, Hettiarachchi R, Schnee J, Büller HR, Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J THROMB HAEMOST 2007;5 (11):2178-2185 [PubMed]
Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Prins MH, Hettiarachchi R, Hantel S, Schnee J, Bueller HR, Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. LANCET 2007;370 (9591):949-956 [PubMed]
Gibson NS, Buller HR. Longembolieën in: van der Wall EE, Van de Werf F, Zijlstra F, editors. Cardiologie. Houten: Bohn Stafleu van Loghum; 2008. 2de herziene druk, p. 435-442
Kuipers S, Cannegieter SC, Middeldorp S, Robyn L, Buller HR, Rosendaal FR, The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations. PLOS MED 2007;4 (9):e290-1514 [PubMed]
Kuipers S, Schreijer AJM, Cannegieter SC, Bueller HR, Rosendaal FR, Middeldorp S, Travel and venous thrombosis: a systematic review. J INTERN MED 2007;262 (6):615-634 [PubMed]
Lijfering WM, Coppens M, van de Poel MHW, Middeldorp S, Hamulyak K, Bank I, Veeger NJGM, Prins MH, Bueller HR, van der Meer J, The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects. THROMB HAEMOSTASIS 2007;98 (2):457-463 [PubMed]
Niers TMH, Di Nisio M, Klerk CPW, Baarslag HJ, Bueller HR, Biemond BJ, Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study. J THROMB HAEMOST 2007;5 (9):1878-1882 [PubMed]
Niers TMH, Klerk CPW, DiNisio M, van Noorden CJF, Büller HR, Reitsma PH, Richel DJ, Mechanisms of heparin induced anti-cancer activity in experimental cancer models. CRIT REV ONCOL HEMAT 2007;61 (3):195-207 [PubMed]
Nijkeuter M, Erp HKV, Sohne M, Tick LW, Kruip MJHA, Ullmann EF, Kramer MHH, Buller HR, Prins MH, Leebeek FWG, Huisman MV, Clinically suspected acute recurrent pulmonary embolism: a diagnostic challenge. THROMB HAEMOSTASIS 2007;97 (6):944-948 [PubMed]
Nijkeuter M, Sohne M, Tick LW, Kamphuisen PW, Kramer MHH, Laterveer L, van Houten AA, Kruip MJHA, Leebeek FWG, Buller HR, Huisman MV, The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study. CHEST 2007;131 (2):517-523 [PubMed]
Sohne M, Buller HR. Pijn op de borst in: Hovingh GK, Somsen GA, editors. Probleemgeoriënteerd denken in de cardiologie en vasculaire geneeskunde; een praktijkboek voor de opleiding en de kliniek. Utrecht: De Tijdstroom; 2007., p. 239-248
Squizzato A, Gerdes VEA, Ageno W, Büller HR, The coagulation system in endocrine disorders: a narrative review. INTERN EMERG MED 2007;2 (2):76-83 [PubMed]
Squizzato A, Romualdi E, Buller HR, Gerdes VEA, Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic review. J CLIN ENDOCR METAB 2007;92 (7):2415-2420 [PubMed]
Squizzato A, Romualdi E, Piantanida E, Gerdes VEA, Bueller HR, Tanda M, Bartalena L, Venco A, Ageno W, Subclinical hypothyroidism and deep venous-thrombosis - A pilot cross-sectional study. THROMB HAEMOSTASIS 2007;97 (5):803-806 [PubMed]
Squizzato A, Vitale J, Gerdes VE, Romualdi E, Büller HR, Ageno W, Recurrent deep venous thrombosis during optimal anticoagulation and overt hyperthyroidism: a case report. BLOOD COAGUL FIBRIN 2007;18 (8):801-803 [PubMed]
Tulevski II, ten Wolde M, van Veldhuisen DJ, Mulder JWM, van der Wall EE, Büller HR, Mulder BJM, Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. INT J CARDIOL 2007;116 (2):161-166 [PubMed]
van der Velde EF, Wichers IM, Toll DB, van Weert HCPM, Bueller HR, Feasibility and accuracy of a rapid 'point-of-care' D-dimer test performed with a capillary blood sample. J THROMB HAEMOST 2007;5 (6):1327-1330 [PubMed]
van Wissen M, Keller TT, Ronkes B, Gerdes VEA, Zaaijer HL, van Gorp ECM, Brandjes DPM, Levi M, Buller HR, Influenza infection and risk of acute pulmonary embolism. THROMB J 2007;5 (1):16 [PubMed]
Bendermacher BLW, Teijink JAW, Willigendael EM, Bartelink ML, Büller HR, Peters RJG, Boiten J, Langenberg M, Prins MH, Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule. BRIT J GEN PRACT 2006;56 (533):932-937 [PubMed]
Bresser P, Büller HR, Wat is de rol van bedrust bij de behandeling van longembolie?. LONGARTSEN VADEMECUM 2006;9 (15):16 okt
Coppens M, van de Poel MH, Bank I, Hamulyak K, van der Meer J, Veeger NJ, Prins MH, Buller HR, Middeldorp S, A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation. BLOOD 2006;108 (8):2604-2607 [PubMed]
Coppens M, van Doormaal FF, Schreijer AJM, Rosendaal FR, Büller HR, Intermittent mechanical compression for prevention of travellers' thrombosis. J THROMB HAEMOST 2006;4 (8):1836-1838 [PubMed]
de Pont ACJM. Anticoagulation in severe sepsis and the multiple organ dysfunction syndrome. S.l.: s.n.; 2006. 147p. ISBN 9789090204062 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Vroom MB, Büller HR; copromotor(s): Levi MM, de Jonge E)
de Pont ACJM, Bakhtiari K, Hutten BA, de Jonge E, Vlasuk GP, Rote WE, Levi M, Büller HR, Meijers JCM, Endotoxaemia induces resistance to activated protein C in healthy humans. BRIT J HAEMATOL 2006;134 (2):213-219 [PubMed]
de Pont ACJM, Bouman CSC, Bakhtiari K, Schaap MCL, Nieuwland R, Sturk A, Hutten BA, de Jonge E, Vroom MB, Meijers JCM, Büller HR, Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis. ASAIO J 2006;52 (4):416-422 [PubMed]
Di Nisio M, Rutjes AWS, Büller HR, Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis. J THROMB HAEMOST 2006;4 (1):52-57 [PubMed]
El Kheir DYM. Further optimization of the diagnostic management of deep venous thrombosis. S.l.: s.n.; 2006. 112p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Gerdes VEA)
Ettema HB, Hoppener MR, Veeger NJGM, Büller HR, van der Meer J, Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study. J THROMB HAEMOST 2006;4 (6):1411-1413 [PubMed]
Gerdes VEA, Kwa VIH, ten Cate H, Brandjes DPM, Büller HR, Stam J, Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. ATHEROSCLEROSIS 2006;186 (1):166-172 [PubMed]
Gibson NS, Büller HR, Could D-dimer provide a definitive diagnosis in patients with suspected pulmonary embolism?. NAT CLIN PRACT CARD 2006;3 (12):654-655 [PubMed]
Hoppener MR, Ettema HB, Henny CP, Verheyen CCPM, Büller HR, Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study of 335 patients. ACTA ORTHOP 2006;77 (5):767-771 [PubMed]
Keller TT. Acute respiratory tract infections and (athero)thrombotic disease. S.l.: s.n.; 2006. 211p. ISBN 90-9021309-0 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Levi MM; copromotor(s): Brandjes DPM, Gerdes VEA)
Keller TT, van der Sluijs KF, de Kruif MD, Gerdes VEA, Meijers JCM, Florquin S, van der Poll T, van Gorp ECM, Brandjes DPM, Büller HR, Levi M, Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. CIRC RES 2006;99 (11):1261-1269 [PubMed]
Kruip MJHA, Söhne M, Nijkeuter M, Kwakkel-van Erp HM, Tick LW, Halkes SJM, Prins MH, Kramer MHH, Huisman MV, Büller HR, Leebeek FWG, A simple diagnostic strategy in hospitalized patients with clinically suspected pulmonary embolism. J INTERN MED 2006;260 (5):459-466 [PubMed]
Kuipers S, Cannegieter SC, Middeldorp S, Rosendaal FR, Büller HR, Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences. J THROMB HAEMOST 2006;4 (11):2373-2376 [PubMed]
Levi M, Rosendaal FR, Büller HR, Diepe veneuze trombose en longembolie door een vliegreis. NED TIJDSCHR GENEESKD 2006;150 (45):2474-2478 [PubMed]
Levi M, Vink R, van den Brink RBA, Büller HR, Perioperatieve interruptie van antistolling bij patiënten met boezemfibrilleren en met mechanische hartklepprothesen. HART BULL 2006;37 (1):9-12
Miller A, Campbell I, Fennerty T, Raskob GE, Büller HR, Duration of warfarin in pulmonary embolism. CHEST 2006;130 (1):299; author reply 299-299; author reply 300 [PubMed]
Nijkeuter M, Prins MH, Buller HR, Huisman MV, An algorithm for managing suspected pulmonary embolism - Reply. JAMA-J AM MED ASSOC 2006;295 (22):2604
Schreijer AJM, Cannegieter SC, Buller HR, Rosendaal FR, Activation of coagulation system during air travel - Reply. LANCET 2006;368 (9529):26
Schreijer AJM, Cannegieter SC, Meijers JCM, Middeldorp S, Büller HR, Rosendaal FR, Activation of coagulation system during air travel: a crossover study. LANCET 2006;367 (9513):832-838 [PubMed]
Sohne M, Kruip MJHA, Nijkeuter M, Tick L, Kwakkel H, Halkes SJM, Huisman MV, Buller HR, Accuracy of clinical decision rule, D-dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism. J THROMB HAEMOST 2006;4 (5):1042-1046 [PubMed]
Söhne M, ten Wolde M, Boomsma F, Reitsma JB, Douketis JD, Büller HR, Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. J THROMB HAEMOST 2006;4 (3):552-556 [PubMed]
van Belle A, Büller HR, Huisman MV, Huisman PM, Kaasjager K, Kamphuisen PW, Kramer MHH, Kruip MJHA, Kwakkel-van Erp JM, Leebeek FWG, Nijkeuter M, Prins MH, Sohne M, Tick LW, Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA-J AM MED ASSOC 2006;295 (2):172-179 [PubMed]
van der Heiden PLJ, Prins MH, de Monyé W, van Strijen MLJ, Banga JD, Postmus PE, ten Wolde M, Büller HR, Brandjes DPM, Huisman MV, Pulmonary embolism as a first clinical sign of occult malignancy: a prospective follow-up study. THROMB HAEMOSTASIS 2006;95 (3):584-585 [PubMed]
van Sluis GL, Söhne M, El Kheir DY, Tanck MW, Gerdes VEA, Büller HR, Family history and inherited thrombophilia. J THROMB HAEMOST 2006;4 (10):2182-2187 [PubMed]
van Weert H, Dolan G, Wichers I, de Vries C, ter Riet G, Buller H, Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? A historic follow-up study in primary care. J FAM PRACTICE 2006;55 (1):52-57 [PubMed]
van Weert H, Dolan G, Wichers I, de Vries C, ter Riet G, Büller HR, Oppervlakkige tromboflebitis verhoogt het risico op een veneuze trombose. HUISARTS WET 2006;49 (8):414-417
Vink R, Levi M, Büller HR, Het ALIFE-onderzoek: herhaalde miskramen en het mogelijke nut van antistollingsbehandeling bij vrouwen met en zonder erfelijke trombofilie. INTERNISTEN VADEMECUM 2006;11 (6):-
Bank I, Libourel EJ, Middeldorp S, Hamulyák K, van Pampus ECM, Koopman MMW, Prins MH, van der Meer J, Büller HR, Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. J THROMB HAEMOST 2005;3 (1):79-84 [PubMed]
Büller H, General discussion. PATHOPHYSIOL HAEMO T 2005;34 (Suppl. 1):31-34 [PubMed]
Büller H, Agnelli G, Anticoagulation management - Time to change? Introduction. PATHOPHYSIOL HAEMO T 2005;34 (Suppl. 1):1 [PubMed]
Buller HR, Sohne M, Middeldorp S, Treatment of venous thromboembolism. J THROMB HAEMOST 2005;3 (8):1554-1560 [PubMed]
Büller HR, Vanderschueren S, Mini-symposium: What's new in venous thromboembolism?. EUR J INTERN MED 2005;16 (4):229
de Booys M, Levi M, Peters R, Büller H, Machtstrijd om vergoeding clopidogrel. Ingegraven posities ondermijnen patiëntenbelang. MED CONTACT 2005;60 (42):1684-ev
de Pont ACJM, Bakhtiari K, Hutten BA, de Jonge E, Vroom MB, Meijers JCM, Büller HR, Levi M, Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study. CRIT CARE 2005;9 (5):R490-R497 [PubMed]
Di Nisio M, Bijsterveld NR, Meijers JCM, Levi M, Büller HR, Peters RJG, Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes. J AM COLL CARDIOL 2005;46 (8):1582-1583 [PubMed]
Di Nisio M, Buller HR, Porreca E, Do low-molecular-weight heparins improve the survival of cancer patients?. NAT CLIN PRACT ONCOL 2005;2 (12):612-613 [PubMed]
Di Nisio M, Klerk CPW, Meijers JCM, Büller HR, The prognostic value of the D-dimer test in cancer patients treated with and without low-molecular-weight heparin. J THROMB HAEMOST 2005;3 (7):1531-1533 [PubMed]
Di Nisio M, Middeldorp S, Büller HR, Direct thrombin inhibitors. NEW ENGL J MED 2005;353 (10):1028-1040 [PubMed]
Di Nisio M, Niers TM, Reitsma PH, Buller HR, Plasma cytokine and P-selectin levels in advanced malignancy - Prognostic value and impact of low-molecular weight heparin administration. CANCER-AM CANCER SOC 2005;104 (10):2275-2281 [PubMed]
Di Nisio M, Nisio MD, ten Wolde M, Meijers JC, Meijers JCM, Buller HR, Effects of high plasma lipoprotein (a) levels on tissue factor pathway inhibitor and the protein C pathway. J THROMB HAEMOST 2005;3 (9):2123-2125 [PubMed]
Di Nisio M, Otten HM, Piccioli A, Lensing AWA, Prandoni P, Büller HR, Prins MH, Decision analysis for cancer screening in idiopathic venous thromboembolism. J THROMB HAEMOST 2005;3 (11):2391-2396 [PubMed]
Di Nisio M, Sohne M, Kamphuisen PW, Büller HR, D-dimer test in cancer patients with suspected acute pulmonary embolism. J THROMB HAEMOST 2005;3 (6):1239-1242 [PubMed]
Dörffler-Melly J, Koopman MMW, Prins MH, Büller HR, Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. COCHRANE DB SYST REV 2005;2005 (1):CD002071 [PubMed]
Douketis JD, Leeuwenkamp O, Grobara P, Johnston M, Söhne M, ten Wolde M, Büller H, The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism. J THROMB HAEMOST 2005;3 (3):508-513 [PubMed]
Eriksson BI, Dahl OE, Büller HR, Hettiarachchi R, Rosencher N, Bravo ML, Ahnfelt L, Piovella F, Stangier J, Kälebo P, Reilly P, A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J THROMB HAEMOST 2005;3 (1):103-111 [PubMed]
Ettema HB, Hoppener MR, Henny CP, Büller HR, Verheyen CCPM, Compliance of Dutch orthopedic departments with national guidelines on thromboprophylaxis. A survey of Dutch orthopedic thromboprohylaxis. ACTA ORTHOP 2005;76 (1):99-103 [PubMed]
Gerdes VEA, Büller HR. Hemostase en trombose in: Reitsma WD, Elte JWF, Overbosch D, editors. Differentiële diagnostiek in de interne geneeskunde. S.l.: Bohn Stafleu Van Loghum; 2005., p. 313-326
Gibson NS, Sohne M, Buller HR, Prognostic value of echocardiography and spiral computed tomography in patients with pulmonary embolism. CURR OPIN PULM MED 2005;11 (5):380-384 [PubMed]
Hoppener MR. Venous thrombosis; etiology, diagnosis and prophylaxis in surgery. S.l.: s.n.; 2005. 131p. ISBN 9789090198064 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Henny CP, Kraaijenhagen RA)
Hoppener MR, Büller HR, New anticoagulants and thromboprophylaxis. BRIT J SURG 2005;92 (3):259-261 [PubMed]
Hoppener MR, Ettema HB, Henny CP, Verheyen CCPM, Büller HB, Symptomatic deep vein thrombosis and immobilization after day-care arthroscopy of the knee. J THROMB HAEMOST 2005;3 (1):185-187 [PubMed]
Jansen ACM, van Aalst-Cohen ES, Hutten BA, Büller HR, Kastelein JJP, Prins MH, Guidelines were developed for data collection from medical records for use in retrospective analyses. J CLIN EPIDEMIOL 2005;58 (3):269-274 [PubMed]
Klerk CPW. Cancer, coagulation and thrombotics. S.l.: s.n.; 2005. 232p. ISBN 90 5170 987 0 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): van Noorden CJF, Büller HR; copromotor(s): Richel DJ, Smorenburg SM)
Klerk CPW, Smorenburg SM, Otten HM, Lensing AWA, Prins MH, Piovella F, Prandoni P, Bos MMEM, Richel DJ, van Tienhoven G, Büller HR, The effect of low molecular weight heparin on survival in patients with advanced malignancy. J CLIN ONCOL 2005;23 (10):2130-2135 [PubMed]
Levi M, Peters M, Büller HR, Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review. CRIT CARE MED 2005;33 (4):883-890 [PubMed]
Libourel EJ, Bank I, Veeger NJGM, Hamulyàk K, Middeldorp S, Prins MH, Büller HR, van der Meer J, Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study. BLOOD COAGUL FIBRIN 2005;16 (2):135-140 [PubMed]
Nieuwdorp M, Stroes ESG, Meijers JCM, Büller H, Hypercoagulability in the metabolic syndrome. CURR OPIN PHARMACOL 2005;5 (2):155-159 [PubMed]
Reitsma PH, van der Heijden JF, Groot AP, Rosendaal FR, Büller HR, A C1173T dimorphism in the VKORC1 gene determines coumarin Sensitivity and bleeding risk. PLOS MED 2005;2 (10):996 e312-998 [PubMed]
Segers AEM, Prins MH, Lensing AWA, Buller HR, Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies?. J THROMB HAEMOST 2005;3 (5):1099-1102 [PubMed]
Söhne M. The diagnosis and perognosis of pulmonary embolism. S.l.: s.n.; 2005. 183p. ISBN 9090198024 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Gerdes VEA)
Söhne M, Kamphuisen PW, van Mierlo PJWB, Büller HR, Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in- and outpatients. THROMB HAEMOSTASIS 2005;94 (1):206-210 [PubMed]
Squizzato A, Gerdes VEA, Brandjes DPM, Büller HR, Stam J, Thyroid diseases and cerebrovascular disease. STROKE 2005;36 (10):2302-2310 [PubMed]
Squizzato A, Gerdes VEA, Büller HR, Effects of human cytomegalovirus infection on the coagulation system. THROMB HAEMOSTASIS 2005;93 (3):403-410 [PubMed]
Tormene D. Thrombophilia and thrombosis in adults and children. S.l.: s.n.; 2005. 160p. ISBN 88-87264-92-9 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Prandoni P; copromotor(s): Lensing AWA, Simioni P)
van Strijen MJL, ten WM, Pattynama PMT, Postmus PE, Büller HR, Kieft GJ, Banga JD, Huisman MV, Diagnostiek bij longembolie; de beste strategieën volgens de resultaten van een grote Nederlandse multicenterstudie. NED TIJDSCHR GENEESKD 2005;149 (11):568-576 [PubMed]
van Strijen MJL, ten Wolde M, Pattynama PMT, Postmus PE, Buller HR, Kieft GJ, Banga JD, Huisman MV, Diagnostiek bij longembolie; de beste strategieën volgens de resultaten van een grote Nederlandse multicenterstudie. NED TIJDSCHR GENEESKD 2005;149 (21):1190
Vink R, Rienstra M, van Dongen CJJ, Levi M, Büller HR, Crijns HJ, van Gelder IC, Risk of thromboembolism and bleeding after general surgery in patients with atrial fibrillation. AM J CARDIOL 2005;96 (6):822-824 [PubMed]
Wichers IM, Di Nisio M, Büller HR, Middeldorp S, Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. HAEMATOLOGICA 2005;90 (5):672-677 [PubMed]
Willigendael EM, Teijink JAW, Bartelink ML, Langenberg M, Welten RJTJ, Büller HR, Prins MH, Combined training of GPs and practice-assistants on peripheral arterial disease: positive effects after six months. FAM PRACT 2005;22 (5):520-522 [PubMed]
Willigendael EM, Teijink JAW, Bartelink ML, Peters RJG, Büller HR, Prins MH, Smoking and the patency of lower extremity bypass grafts: A meta-analysis. J VASC SURG 2005;42 (1):67-74 [PubMed]
Baarslag HJ, Koopman MMW, Hutten BA, Linthorst Homan MW, Büller HR, Reekers JA, van Beek EJR, Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremity: survival, risk factors and post-thrombotic syndrome. EUR J INTERN MED 2004;15 (8):503-507 [PubMed]
Bank I, Libourel EJ, Middeldorp S, van Pampus ECM, Koopman MMW, Hamulyák K, Prins MH, van der Meer J, Büller HR, Prothrombin 20210A mutation - A mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. ARCH INTERN MED 2004;164 (17):1932-1937 [PubMed]
Bank I, Scavenius MPRB, Büller HR, Middeldorp S, Social aspects of genetic testing for factor V leiden mutation in healthy individuals and their importance for daily practice. THROMB RES 2004;113 (1):7-12 [PubMed]
Bijsterveld NR, Vink R, van Aken BE, Fennema H, Peters RJG, Meijers JCM, Büller HR, Levi M, Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers. BRIT J HAEMATOL 2004;124 (5):653-658 [PubMed]
Büller HR, Has time come for screening for occult cancer in patients with venous thromboembolism?. J THROMB HAEMOST 2004;2 (6):874-875 [PubMed]
Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE, Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. CHEST 2004;126 (3 Suppl):401S-428S [PubMed]
Büller HR, Cohen AT, Lensing AWA, Monreal M, Prins MH, Schulman S, Lassen MR, van Amsterdam RGM, A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in dep vein thrombosis. A phase II evaluation. J THROMB HAEMOST 2004;2 (1):47-53
Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AEM, Cariou R, Leeuwenkamp O, Lensing AWA, Fondaparinux or Enoxaparin for the initial treatment of symptomatic deep venous thrombosis - A randomized trial. ANN INTERN MED 2004;140 (11):867-873 [PubMed]
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde; 2e herz dr. Alphen a/d Rijn: van Zuiden; 2004. -p.
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde; 2e herz. dr. Alphen/ad Rijn: Van Zuiden; 2004. -p.
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde; 2e herz. dr. Alphen a/d Rijn: Van Zuiden; 2004. -p.
de Pont ACJM, Moons AHM, de Jonge E, Meijers JCM, Vlasuk GP, Rote WE, Büller HR, van der Poll T, Levi M, Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia. J THROMB HAEMOST 2004;2 (1):65-70 [PubMed]
Di Nisio M, Squizzato A, Klerk CPW, Richel DJ, Büller HR, Antithrombotic therapy and cancer. CURR OPIN HEMATOL 2004;11 (3):187-191 [PubMed]
El Kheir D, Büller H, One-time comprehensive ultrasonography to diagnose deep venous thrombosis: is that the solution?. ANN INTERN MED 2004;140 (12):1052-1053 [PubMed]
Gerdes VEA. Atherosclerosis; aspects of a multicultural disease. S.l.: s.n.; 2004. 97p. ISBN 90 5170 794 0 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, ten Cate H; copromotor(s): Brandjes DPM)
Gerdes VEA, Kremer Hovinga HA, ten Cate H, Macgillavry MR, Leijte A, Reitsma PH, Brandjes DPM, Büller HR, Homocysteine and markers of coagulation and endothelial cell activation. J THROMB HAEMOST 2004;2 (3):445-451 [PubMed]
Gerdes VEA, Kremer Hovinga JA, ten Cate H, Brandjes DPM, Büller HR, Soluble thrombomodulin in patients with established atherosclerosis. J THROMB HAEMOST 2004;2 (1):200-201 [PubMed]
Hoppener MR, Kraaijenhagen RA, Hutten BA, Büller HR, Peters RJG, Levi M, Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis. J THROMB HAEMOST 2004;2 (8):1316-1320 [PubMed]
Klerk CPW, Otten JMMB, Büller HR, Zin van screenen op kanker bij veneuze thrombo-embolie. NED TIJDSCHR HEMATOL 2004;- (1):3-7
Klerk CPW, Smorenburg SM, Büller HR. Antimalignant properties of antithrombotic agents in: Lugassy G, Falanga A, Kakkar AK, Rickles FR, editors. Thrombosis and cancer. London: Dunitz; 2004., p. 207-222
Leclercq MGL, Kruip MJHA, Mac Gillavry MR, van Marwijk Kooy M, Büller HR, Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism. J THROMB HAEMOST 2004;2 (7):1204-1206 [PubMed]
Levi M, van der Poll T, Büller HR, Bidirectional relation between inflammation and coagulation. CIRCULATION 2004;109 (22):2698-2704 [PubMed]
Libourel EJ, Baljé-Volkers Degrees CP, Hamulyàk K, Prins MH, Middeldorp S, Büller HR, van der Meer J, High factor VIII plasma levels as a risk factor for venous thrombosis: no evidence of inheritance from a family cohort study. HAEMATOLOGICA 2004;89 (1):118-120 [PubMed]
Melis F, Vandenbrouke JP, Büller HR, Colly LP, Bloemenkamp KWM, Estimates of risk of venous thrombosis during pregnancy and puerperium are not influenced by diagnostic suspicion and referral basis. AM J OBSTET GYNECOL 2004;191 (3):825-829 [PubMed]
Middeldorp S, van de Poel MH, Bank I, Hamulyák K, Libourel EJ, Koopman MMW, Prins MH, van der Meer J, Büller HR, Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications. THROMB HAEMOSTASIS 2004;92 (4):787-790 [PubMed]
Moons AHM, Bijsterveld NR, Koch KT, Meijers JCM, Tijssen JGP, van der Poll T, Büller HR, Peters RJG, Inhibition of the tissue factor pathway of coagulation by recombinant nematode anticoagulant protein c2 during elective coronary stent implantation. NETH HEART J 2004;12 (2):48-54
Söhne M, ten Wolde M, Büller HR, Biomarkers in pulmonary embolism. CURR OPIN CARDIOL 2004;19 (6):558-562 [PubMed]
ten Wolde M, Hagen PJ, Macgillavry MR, Pollen IJ, Mairuhu ATA, Koopman MMW, Prins MH, Hoekstra OS, Brandjes DPM, Postmus PE, Büller HR, Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study. J THROMB HAEMOST 2004;2 (7):1110-1117 [PubMed]
ten Wolde M, Söhne M, Quak E, Mac Gillavry MR, Büller HR, Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. ARCH INTERN MED 2004;164 (15):1685-1689 [PubMed]
van der Heijden JF. Risk factors for bleeding during treatment with anti-thrombotics. S.l.: s.n.; 2004. 160p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Reitsma PH, Vermeulen M; copromotor(s): Büller HR)
van der Heijden JF, Rekké B, Hutten BA, van der Meer FJM, Remkes MGH, Vermeulen M, Büller HR, Reitsma PH, Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX. J THROMB HAEMOST 2004;2 (7):1104-1109 [PubMed]
van Dongen CJJ. An evidence based approach to optimizing anticoagulant strategies. S.l.: s.n.; 2004. -p. ISBN - [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Bossuyt PMM, Prins MH; copromotor(s): Büller HR, Hutten BA)
Vink R. Management of antithrombotic therapy in venous and arterial thromboembolism. S.l.: s.n.; 2004. 165p. ISBN - [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Levi MM, Büller HR; copromotor(s): van den Brink RBA)
Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, Sijbrands EJG, Kastelein JJP, Efficacy and safety of statin therapy in children with familial hypercholesterolemia - A randomized controlled trial. JAMA-J AM MED ASSOC 2004;292 (3):331-337 [PubMed]
Willigendael EM, Teijink JAW, Bartelink ML, Boiten J, Büller HR, Prins MH, Peripheral arterial disease: the gap between common practice and the Dutch College of General Practitioners guideline. EUR J GEN PRACT 2004;10 (3):106-107 [PubMed]
Willigendael EM, Teijink JAW, Bartelink ML, Boiten J, Moll FL, Büller HR, Prins MH, Peripheral arterial disease: Public and patient awareness in the Netherlands. EUR J VASC ENDOVASC 2004;27 (6):622-628 [PubMed]
Willigendael EM, Teijink JAW, Bartelink ML, Kuiken BW, Boiten J, Moll FL, Büller HR, Prins MH, Influence of smoking on incidence and prevalence of peripheral arterial disease. J VASC SURG 2004;40 (6):1158-1165 [PubMed]
Bank I. Aetiology and treatment of venous thromboembolism. S.l.: s.n.; 2003. 196p. ISBN 90-09017115-0 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Middeldorp S)
Bank I, Libourel EJ, Middeldorp S, van der Meer J, Büller HR, High rate of skin complications due to low-molecular-weight heparins in pregnant women. J THROMB HAEMOST 2003;1 (4):859-861 [PubMed]
Bank I, Mac Gillavry MR, Brandjes DPM, Büller HR, Does the location of deep venous thrombosis of the leg determine the risk of the post-thrombotic syndrome?. J THROMB HAEMOST 2003;1 (9):2058-2059 [PubMed]
Bank I, Tick LW, Hutten BA, Kramer MHH, Middeldorp S, Büller HR, Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis. PATHOPHYSIOL HAEMO T 2003;33 (4):192-196 [PubMed]
Bernardi E. Diagnostic and therapeutic management of venous and arterial disease. s..l.: s.n.; 2003. 206p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Prandoni P; copromotor(s): Lensing AWA, Prins MH)
Bijsterveld NR. Heparin derivatives in acute coronary syndromes. S.l.: s.n.; 2003. 146p. ISBN 90 5170 696 0 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Levi MM; copromotor(s): Peters RJG)
Bijsterveld NR, Moons AH, Meijers JCM, Levi M, Büller HR, Peters RJG, The impact on coagulation of an intravenous loading dose in addition to a subcutaneous regimen of low-molecular-weight heparin in the initial treatment of acute coronary syndromes. J AM COLL CARDIOL 2003;42 (3):424-427 [PubMed]
Büller HR, Factor Xa is a superior target to factor IIa for antithrombotic therapies. SEMIN THROMB HEMOST 2003;29 (Suppl. 1):37 [PubMed]
Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, van den Berg-Segers AEM, Cariou R, Leeuwenkamp O, Lensing AWA, Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. NEW ENGL J MED 2003;349 (18):1695-1702 [PubMed]
Buller HR, Prins MH, Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism - The editorialists reply. NEW ENGL J MED 2003;349 (22):2167
Büller HR, Prins MH, Secondary prophylaxis with warfarin for venous thromboembolism. NEW ENGL J MED 2003;349 (7):702-704 [PubMed]
de Pont ACJM, Bouman CSC, de Jonge E, Vroom MB, Büller HR, Levi M, Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis. INTENS CARE MED 2003;29 (7):1205 [PubMed]
Dörffler-Melly J, Büller HR, Koopman MM, Prins MH, Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. COCHRANE DB SYST REV 2003;2003 (4):CD000536 [PubMed]
Dörffler-Melly J, Koopman MM, Adam DJ, Büller HR, Prins MH, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. COCHRANE DB SYST REV 2003;2003 (3):CD000535 [PubMed]
Ettema HB, Hoppener MR, Büller HR, Henny CP, Verheyen CC, Tromboseprofylaxe in de orthopedische chirurgie: inzichten en onzekerheden. NED TIJDSCHR GENEESKD 2003;147 (38):1842-1847 [PubMed]
Ettema HB, Hoppener MR, Büller HR, Henny CP, Verheyen CCPM, [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties]. NED TIJDSCHR GENEESKD 2003;147 (38):1856-1860
Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, Büller HR, Levi M, Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. LANCET 2003;361 (9353):201-205 [PubMed]
Gerdes VEA, Verkooyen RP, Kwa VIH, de Groot E, van Gorp ECM, ten Cate H, Brandjes DPM, Büller HR, Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis. ATHEROSCLEROSIS 2003;167 (1):65-71 [PubMed]
Harenberg J, Riess H, Büller HR, Brom J, Weidinger G, Huisman MV, Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin. HAEMATOLOGICA 2003;88 (10):1157-1162 [PubMed]
Haverkamp D, Hutten BA, Büller HR, Gallus AS, Lensing AWA, Prins MH, The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism. J THROMB HAEMOST 2003;1 (1):69-73 [PubMed]
Kamphuisen PW, ten Wolde M, Jacobs EMG, Ullmann EF, Büller HR, Screening of high factor VIII levels is not recommended in patients with recently diagnosed pulmonary embolism. J THROMB HAEMOST 2003;1 (10):2239-2240 [PubMed]
Klerk CPW, Smorenburg SM, Büller HR, Thrombosis prophylaxis in patient populations with a central venous catheter - A systematic review. ARCH INTERN MED 2003;163 (16):1913-1921 [PubMed]
Koopman MMW, Büller HR, Short- and long-acting synthetic pentasaccharides. J INTERN MED 2003;254 (4):335-342 [PubMed]
Kraaijenhagen RA, Wallis J, Koopman MMW, de Groot MR, Piovella F, Prandoni P, Büller HR, Can causes of false-normal D-dimer test [SimpliRED] results be identified?. THROMB RES 2003;111 (3):155-158 [PubMed]
Kruip MJHA, Leclercq MGL, van der Heul C, Prins MH, Büller HR, Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies - A systematic review. ANN INTERN MED 2003;138 (12):941-951 [PubMed]
Leclercq MGL, Lutisan JG, van Marwijk Kooy M, Kuipers BF, Oostdijk AHJ, van der Leur JJCM, Büller HR, Ruling out clinically suspected pulmonary embolism by assessment of clinical probability and D-dimer levels: a management study. THROMB HAEMOSTASIS 2003;89 (1):97-103 [PubMed]
Levi M, Dörffler-Melly J, Reitsma P, Buller H, Florquin S, van der Poll T, Carmeliet P, Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. BLOOD 2003;101 (12):4823-4827 [PubMed]
Levi M, Peters RJG, Piek JJ, Büller HR, Nieuwe anticoagulantia. NED TIJDSCHR GENEESKD 2003;147 (19):909-915 [PubMed]
Locadia M, Sprangers MAG, de Haes HCJM, Büller HR, Prins MH, Quality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosis. THROMB HAEMOSTASIS 2003;90 (1):101-107 [PubMed]
Middeldorp S, Büller HR, Prins MH, Risk for venous thromboembolism in carriers of the factor V Leiden mutation - In response. ANN INTERN MED 2003;138 (1):76-77
Moons AHM. The extrinsic coagulation pathway in coronary artery disease and endotoxemia. S.l.: s.n.; 2003. 163p. ISBN 90-9016907-5 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Peters RJG)
Moons AHM, Peters RJG, Bijsterveld NR, Piek JJ, Prins MH, Vlasuk GP, Rote WE, Büller HR, Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty. J AM COLL CARDIOL 2003;41 (12):2147-2153 [PubMed]
Prins MH, Büller HR, When do we need what evidence?. J CLIN EPIDEMIOL 2003;56 (8):709-710 [PubMed]
Rosendaal FR, Büller HR, Kesteven P, Toff WD, Long haul flights and deep vein thrombosis: Who is at risk?. BRIT J HAEMATOL 2003;120 (2):367 [PubMed]
Selten JP, Büller H, Clozapine and venous thromboembolism: further evidence. J CLIN PSYCHIAT 2003;64 (5):609 [PubMed]
Tans G, Bouma BN, Büller HR, Rosing J, Changes of hemostatic variables during oral contraceptive use. SEMIN VASC MED 2003;3 (1):61-68 [PubMed]
ten Wolde M. Management of venous thromboembolism. Etiology, diagnosis, prognosis and treatment. S.l.: s.n.; 2003. 148p. ISBN 90-9016716-1 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR; copromotor(s): Koopman MMW)
ten Wolde M, Koopman MMW, Büller HR. Fibrinolytic therapy in venous thromboembolism in: Verheugt FWA, editor. Fibrinolytic therapy in clinical practice. London: Martin Dunitz; 2003., p. 131-149
ten Wolde M, Kraaijenhagen RA, Schiereck J, Hagen PJ, Mathijssen JJ, Mac Gillavry MR, Koopman MMW, Büller HR, Travel and the risk of symptomatic venous thromboembolism. THROMB HAEMOSTASIS 2003;89 (3):499-505 [PubMed]
ten Wolde M, Tulevski II, Mulder JWM, Söhne M, Boomsma F, Mulder BJM, Büller HR, Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. CIRCULATION 2003;107 (16):2082-2084 [PubMed]
van Dongen CJJ, Prins MH, Büller HR, Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. NEW ENGL J MED 2003;349 (4):398-400; author reply 398-400 [PubMed]
van Dongen CJJ, Vink R, Hutten BA, Büller HR, Prins MH, The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event - A meta-analysis. ARCH INTERN MED 2003;163 (11):1285-1293 [PubMed]
van Dongen CJ, Vink R, Hutten BA, Buller HR, Prins MH, Recurrent thromboembolism after treatment with vitamin k antagonists. ARCH INTERN MED 2003;163 (22):2793 [PubMed]
van Wissen S. Aggressive lipid lowering in patients with familial hypercholesterolaemia. S.l.: s.n.; 2003. 150p. ISBN 90 5170 690 1 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP, Stalenhoef AFH; copromotor(s): Büller HR)
Vink R, Kraaijenhagen RA, Hutten BA, van den Brink RBA, de Mol BA, Büller HR, Levi M, The optimal intensity of vitamin K antagonists in patients with mechanical heart valves - A meta-analysis. J AM COLL CARDIOL 2003;42 (12):2042-2048 [PubMed]
Vink R, Kraaijenhagen RA, Levi M, Büller HR, Individualized duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model. J THROMB HAEMOST 2003;1 (12):2523-2530 [PubMed]
Bijsterveld NR, Moons AH, Boekholdt SM, van Aken BE, Fennema H, Peters RJG, Meijers JCM, Büller HR, Levi M, Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. CIRCULATION 2002;106 (20):2550-2554 [PubMed]
Bijsterveld NR, Moons AH, Meijers JCM, Tijssen JGP, Büller HR, Levi M, Peters RJG, Rebound thrombin generation after heparin therapy in unstable angina - A Randomized comparison between unfractionated and low-molecular-weight heparin. J AM COLL CARDIOL 2002;39 (5):811-817 [PubMed]
Büller HR, Diagnostiek bij aanwijzingen voor longembolie: nog niet optimaal. NED TIJDSCHR GENEESKD 2002;146 (44):2073-2074 [PubMed]
Büller HR, Terecht, te laat, gevaarlijk: redactioneel. NIEUWSBRIEF VASC GENEESKD 2002;1 (voorjaar):3
Büller HR, Treatment of symptomatic venous thromboembolism: Improving outcomes. SEMIN THROMB HEMOST 2002;28 (Suppl. 2):41-48 [PubMed]
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde. Alphen a/d Rijn: Van Zuiden communications; 2002. 356p. ISBN 90 76906 34 3
Büller HR, Kastelein JJP, Stroes ESG, editors, Vasculaire geneeskunde. S.l.: Van Zuiden Communications; 2002. -p.
de Jongh S. Familial hypercholesterolemia in childhood. S.l.: s.n.; 2002. 159p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP, Heymans HSA; copromotor(s): Bakker HD, Büller HR)
de Monyé W, Sanson BJ, Büller HR, Pattynama PMT, Huisman MV, The performance of two rapid quantitative D-dimer assays in 287 patients with clinically suspected pulmonary embolism. THROMB RES 2002;107 (6):283-286 [PubMed]
de Monyé W, Sanson BJ, Mac Gillavry MR, Pattynama PMT, Büller HR, van den Berg-Huysmans AA, Huisman MV, Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. AM J RESP CRIT CARE 2002;165 (3):345-348 [PubMed]
de Sauvage Nolting PRW. Genetics and therapy of familial hypercholesterolemia. S.l.: s.n.; 2002. 173p. ISBN 90 6464 085 8 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP, Büller HR; copromotor(s): )
Dörffler-Melly J, de Jonge E, Pont AC, Meijers J, Vroom MB, Büller HR, Levi M, Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. LANCET 2002;359 (9309):849-850 [PubMed]
Gerdes VEA, ten Cate H, de Groot E, Kwa VIH, Prins MH, Reitsma PH, Büller HR, Brandjes DPM, Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis. ATHEROSCLEROSIS 2002;163 (1):135-140 [PubMed]
Kraaijenhagen RA, Piovella F, Bernardi E, Verlato F, Beckers EAM, Koopman MMW, Barone M, Camporese G, Potter van Loon BJ, Prins MH, Prandoni P, Büller HR, Simplification of the diagnostic management of suspected deep vein thrombosis. ARCH INTERN MED 2002;162 (8):907-911 [PubMed]
Kruip MJHA, Slob MJ, Schijen JHEM, van der Heul C, Büller HR, Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism - A prospective management study. ARCH INTERN MED 2002;162 (14):1631-1635 [PubMed]
Libourel EJ, Bank I, Meinardi JR, Baljé -Volkers CP, Hamulyak K, Middeldorp S, Koopman MMW, van Pampus ECM, Prins MH, Büller HR, van der Meer J, Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism. HAEMATOLOGICA 2002;87 (10):1068-1073 [PubMed]
Meinardi JR, Middeldorp S, de Kam PJ, Koopman MMW, van Pampus ECM, Hamulyák K, Prins MH, Büller HR, van der Meer J, The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders. BRIT J HAEMATOL 2002;116 (3):625-631 [PubMed]
Middeldorp S, Büller HR, Vandenbroucke JP, Helmerhorst FM, Rosendaal FR, Nadelige cardiovasculaire effecten van postmenopauzale hormonale suppletie. NED TIJDSCHR GENEESKD 2002;146 (45):2123-2127 [PubMed]
Middeldorp S, van der Meer J, Hamulyák K, Büller HR, A rebuttal: Counseling pregnant women with factor V Leiden homozygosity: Use absolute instead of relative risks. THROMB HAEMOSTASIS 2002;87 (2):360-361 [PubMed]
Monreal M, Büller H, Lensing AWA, Bonet M, Roncales J, Muchart J, Fraile M, Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study. THROMB HAEMOSTASIS 2002;88 (6):938-942 [PubMed]
Moons AHM, Peters RJG, Cate HT, Bauer KA, Vlasuk GP, Büller HR, Levi M, Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees. THROMB HAEMOSTASIS 2002;88 (4):627-631 [PubMed]
Otten JMMB. Thrombosis and cancer. A two way association. S.l.: s.n.; 2002. 135p. ISBN 90 51 70 649 9 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Prins MH; copromotor(s): van Noorden CJF, Richel DJ)
Otten JMMB, Smorenburg SM, de Meij MA, van der Schoor CA, Brandjes DPM, Büller HR, Screening for cancer in patients with idiopathic venous thromboembolism: The clinical practice. PATHOPHYSIOL HAEMO T 2002;32 (2):76-79 [PubMed]
Strebel N, Prins M, Agnelli G, Büller HR, Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?. ARCH INTERN MED 2002;162 (13):1451-1456 [PubMed]
ten Wolde M, Kraaijenhagen RA, Prins MH, Büller HR, The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis. ARCH INTERN MED 2002;162 (16):1880-1884 [PubMed]
Trip MD. The spectrum of premature atherosclerosis: from single gene to complex genetic disorder. S.l.: s.n.; 2002. 248p. ISBN 90-9016460-X [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Kastelein JJP; copromotor(s): Büller HR, Reitsma PH)
Turpie AGG, Büller HR, Benefit of selective factor inhibition. SEMIN THROMB HEMOST 2002;28 (Suppl. 2):49-50 [PubMed]
Turpie AGG, Büller HR, New standards in antithrombotic therapy: Concepts, clinical evidence, and applications: iIntroduction. SEMIN THROMB HEMOST 2002;28 (Suppl. 2):1-2
Umans-Eckenhausen MAW. Genetic insights, clinical efficacy and practical implications of genetic screening for familial hypercholesterolemia. S.l.: s.n.; 2002. 165p. ISBN 90 5170 657 X [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Büller HR, Kastelein JJP; copromotor(s): Defesche JC)
van der Heijden JF, Hutten BA, Büller HR, Prins MH, Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. COCHRANE DB SYST REV 2002;2002 (1):CD002001 [PubMed]
van der Heijden JF, Remkes MGH, Büller HR, Vermeulen M, Treatment with vitamin K antagonists: Frequency of indications and appropriateness of continuation. PATHOPHYSIOL HAEMO T 2002;32 (3):111-114 [PubMed]
van Ommen CH. Venous thromboembolic disease in childhood epidemiology, risk factors and outcome. S.l.: s.n.; 2002. 143p. ISBN 90 901 5658 5 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Heymans HSA, Büller HR, Peters M; copromotor(s): )
van Ommen CH, Ottenkamp J, Lam J, Brennickmeier M, Heijmans HSA, Büller HR, Peters M, The risk of postthrombotic syndrome in children with congenital heart disease. J PEDIATR-US 2002;141 (4):582-586 [PubMed]
van Wijk FH, Wolf H, Piek JMJ, Büller HR, Administration of low molecular weight heparin within two hours before caesarean section increases the risk of wound haematoma. BJOG-INT J OBSTET GY 2002;109 (8):955-957 [PubMed]
Weitz JI, Buller HR, Direct thrombin inhibitors in acute coronary syndromes - Present and future. CIRCULATION 2002;105 (8):1004-1011 [PubMed]
Boekholdt SM, Bijsterveld NR, Moons AHM, Levi M, Büller HR, Peters RJG, Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. CIRCULATION 2001;104 (25):3063-3068 [PubMed]
de Graaff JC, Ubbink DT, Büller HR, Jacobs MJ, The diagnosis of deep venous thrombosis using laser Doppler skin perfusion measurements. MICROVASC RES 2001;61 (1):49-55 [PubMed]
de Jonge E, Levi M, Büller HR, Berends F, Kesecioglu J, Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. INTENS CARE MED 2001;27 (11):1825-1829 [PubMed]
Fisher LD, Gent M, Büller HR, Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo. AM HEART J 2001;141 (1):26-32 [PubMed]
Friederich PW, Levi M, Bauer KA, Vlasuk GP, Rote WE, Breederveld D, Keller T, Spataro M, Barzegar S, Büller HR, Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects. CIRCULATION 2001;103 (21):2555-2559 [PubMed]
Hartmann IJ, Prins MH, Büller HR, Banga JD, Acute pulmonary embolism: impact of selection bias in prospective diagnostic studies. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism. THROMB HAEMOSTASIS 2001;85 (4):604-608 [PubMed]
Lee A, Agnelli G, Büller H, Ginsberg J, Heit J, Rote W, Vlasuk G, Costantini L, Julian J, Comp P, van der Meer J, Piovella F, Raskob G, Gent M, Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. CIRCULATION 2001;104 (1):74-78 [PubMed]
Mac Gillavry MR, Büller HR, Brandjes DP, The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism. THROMB HAEMOSTASIS 2001;86 (2):726 [PubMed]
Mac Gillavry MR, Lijmer JG, Sanson BJ, Büller HR, Brandjes DP, Diagnostic accuracy of triage tests to exclude pulmonary embolism. THROMB HAEMOSTASIS 2001;85 (6):995-998 [PubMed]
Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J, Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis. BLOOD COAGUL FIBRIN 2001;12 (8):713-720 [PubMed]
Middeldorp S, Libourel EJ, Hamulyák K, van der Meer J, Büller HR, The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. BRIT J HAEMATOL 2001;113 (2):553-555 [PubMed]
Middeldorp S, Meinardi JR, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR, A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. ANN INTERN MED 2001;135 (5):322-327 [PubMed]
Middeldorp S, Prins MH, Büller HR, Geen indicatie voor trombofilieonderzoek bij patiënten met idiopathische veneuze trombo-embolie en hun familieleden. NED TIJDSCHR GENEESKD 2001;145 (22):1047-1051 [PubMed]
Middeldorp S, Rosing J, Bouma BN, Büller HR, Effecten van orale anticonceptiva van de tweede en de derde generatie op de hemostase. NED TIJDSCHR GENEESKD 2001;145 (6):252-256 [PubMed]
Smorenburg SM, Vink R, Otten HM, Swaneveld F, Büller HR, The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis. THROMB HAEMOSTASIS 2001;86 (6):1586-1587 [PubMed]
Tulevski II, Hirsch A, Sanson BJ, Romkes H, van der Wall EE, van Veldhuisen DJ, Büller HR, Mulder BJ, Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. THROMB HAEMOSTASIS 2001;86 (5):1193-1196 [PubMed]
Vandenbroucke JP, Bloemenkamp KW, Helmerhorst FM, Büller HR, Rosendaal FR, Diagnostic suspicion and referral bias in studies of venous thromboembolism and oral contraceptive use. EUR J CONTRACEP REPR 2001;6 (1):56-57 [PubMed]
van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HS, Peters M, Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J PEDIATR-US 2001;139 (5):676-681 [PubMed]
van Pampus MG, Wolf H, Koopman MM, van den Ende A, Buller HR, Reitsma PH, Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome. HYPERTENS PREGNANCY 2001;20 (3):291-298 [PubMed]
Wells PS, Büller HR, Outpatient treatment of patients with pulmonary embolism. SEMIN VASC MED 2001;1 (2):229-234 [PubMed]
Bank I, Büller HR, Geeft direct postoperatief toegediende laagmoleculaire heparine voldoende tromboseprofylaxe?. NED TIJDSCHR GENEESKD 2000;144 (42):2031 [PubMed]
Bank I, Middeldorp S, Büller HR, Hereditary and acquired thrombophilia. SEMIN RESP CRIT CARE 2000;21 (6):483-491 [PubMed]
Berghout A, Oudkerk M, Hicks SG, Teng TH, Pillay M, Büller HR, Active implementation of a consensus strategy improves diagnosis and management in suspected pulmonary embolism. QJM-INT J MED 2000;93 (6):335-340 [PubMed]
Bijsterveld NR, Middeldorp S, Berends F, Büller HR, Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination. J THROMB THROMBOLYS 2000;9 (3):263-269 [PubMed]
Broekhuizen-de Gast HS, Tiel-van Buul MM, Ubbink M, van Eck-Smit BL, Büller HR, van Beek EJ, De waarde van de 'niet-diagnostische' longscan--verdere classificatie naar de kans op longembolie niet betrouwbaar. NED TIJDSCHR GENEESKD 2000;144 (32):1537-1542 [PubMed]
Büller HR, van der Meer J, Oudkerk M, CBO-richtlijn 'Diepveneuze trombose en longembolie'; herziening van eerdere richtlijnen. NED TIJDSCHR GENEESKD 2000;144 (32):1531-1537 [PubMed]
Cromheecke ME, Levi M, Colly LP, de Mol BJ, Prins MH, Hutten BA, Mak R, Keyzers KC, Büller HR, Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. LANCET 2000;356 (9224):97-102 [PubMed]
de Groot MR, Njo TL, van Marwijk Kooy M, Büller HR, Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome. CLIN LAB 2000;46 (11-12):575-581 [PubMed]
de Groot MR, Oostdijk AH, Engelage AH, van Marwijk Kooy M, Büller HR, Changes in perfusion scintigraphy in the first days of heparin therapy in patients with acute pulmonary embolism. EUR J NUCL MED 2000;27 (10):1481-1486 [PubMed]
de Groot MR, Turkstra F, van Marwijk Kooy M, Oostdijk AH, van Beek EJ, Büller HR, Value of chest X-ray combined with perfusion scan versus ventilation/perfusion scan in acute pulmonary embolism. THROMB HAEMOSTASIS 2000;83 (3):412-415 [PubMed]
Friederich PW, Geerdink MG, Spataro M, Messelink EJ, Henny CP, Büller HR, Levi M, The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study. BLOOD COAGUL FIBRIN 2000;11 (Suppl. 1):S129-S132 [PubMed]
Friederich PW, Keller TT, Biemond BJ, Peters RJ, Hornberger W, Büller HR, Levi M, Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor. THROMB HAEMOSTASIS 2000;84 (5):858-864 [PubMed]
Ginsberg JS, Turkstra F, Buller HR, MacKinnon B, Magier D, Hirsh J, Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study. ARCH INTERN MED 2000;160 (5):669-672 [PubMed]
Girolami B, Bernardi E, Prins MH, ten Cate JW, Prandoni P, Simioni P, Andreozzi GM, Girolami A, Büller HR, Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. EUR J VASC ENDOVASC 2000;19 (4):370-380 [PubMed]
Harenberg J, Schmidt JA, Koppenhagen K, Tolle A, Huisman MV, Büller HR, Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators. THROMB HAEMOSTASIS 2000;83 (5):652-656 [PubMed]
Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Büller HR, Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J CLIN ONCOL 2000;18 (17):3078-3083 [PubMed]
Kraaijenhagen RA, Haverkamp D, Koopman MM, Prandoni P, Piovella F, Büller HR, Travel and risk of venous thrombosis. LANCET 2000;356 (9240):1492-1493 [PubMed]
Kraaijenhagen RA, in't Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Büller HR, High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. THROMB HAEMOSTASIS 2000;83 (1):5-9 [PubMed]
Mac Gillavry MR, de Monyé W, Lijmer JG, Nieuwenhuizen W, Büller HR, Huisman MV, Brandjes DP, Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonary embolism. ANTELOPE-Study Group. THROMB HAEMOSTASIS 2000;83 (6):892-895 [PubMed]
Mac Gillavry MR, Sanson BJ, Büller HR, Brandjes DP, Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism: is a more extensive assessment of compressibility useful?. THROMB HAEMOSTASIS 2000;84 (6):973-976 [PubMed]
Mac Gillavry MR, Sanson BJ, de Monyé W, Lijmer JG, Huisman MV, Büller HR, Nieuwenhuizen W, Brandjes DP, Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism. ANTELOPE-Study Group. THROMB HAEMOSTASIS 2000;84 (3):474-477 [PubMed]
Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN, Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. THROMB HAEMOSTASIS 2000;84 (1):9-14 [PubMed]
Middeldorp S, Büller HR, How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation. THROMB HAEMOSTASIS 2000;84 (5):740-741 [PubMed]
Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR, Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. THROMB HAEMOSTASIS 2000;84 (1):4-8 [PubMed]
Sanson BJ, Lijmer JG, Mac Gillavry MR, Turkstra F, Prins MH, Büller HR, Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. ANTELOPE-Study Group. THROMB HAEMOSTASIS 2000;83 (2):199-203 [PubMed]
Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Büller HR, Rosing J, A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. THROMB HAEMOSTASIS 2000;84 (1):15-21 [PubMed]
van der Heijden JF, Hutten BA, Büller HR, Prins MH, Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. COCHRANE DB SYST REV 2000;2000 (4):CD002001 [PubMed]
van der Heijden JF, Kraaijenhagen RA, Büller HR, The risk of recurrent venous thrombosis. NEW ENGL J MED 2000;342 (3):214-215 [PubMed]
van der Heijden JF, Prins MH, Büller HR, For the initial treatment of venous thromboembolism: are all low-molecular-weight heparin compounds the same?. THROMB RES 2000;100 (2):V121-V130 [PubMed]
van der Heijden JF, Prins MH, Büller HR, Low-molecular-weight heparins: are they interchangeable?. HAEMOSTASIS 2000;30 (Suppl. 2):148-57; discussion 146-7 [PubMed]
van der Velde EF, Kraaijenhagen RA, van Weert HC, Turkstra F, Büller HR, Survey of the management of deep vein thrombosis in general practice in the Netherlands. NETH J MED 2000;57 (4):135-141 [PubMed]
Wallis JW, Kruip M, de Jongh-Leuvenink J, Büller HR, A comparative study of two rapid D-dimer tests for the exclusion of pulmonary embolism in symptomatic patients. THROMB HAEMOSTASIS 2000;84 (5):925 [PubMed]
Anand SS, Bates S, Ginsberg JS, Levine M, Buller H, Prins M, Haley S, Kearon C, Hirsh J, Gent M, Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times. ARCH INTERN MED 1999;159 (17):2029-2032 [PubMed]
Bijsterveld NR, Hettiarachchi R, Peters R, Prins MH, Levi M, Büller HR, Low-molecular weight heparins in venous and arterial thrombotic disease. THROMB HAEMOSTASIS 1999;82 (Suppl. 1):139-147 [PubMed]
Bloemenkamp KW, Rosendaal FR, Büller HR, Helmerhorst FM, Colly LP, Vandenbroucke JP, Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. ARCH INTERN MED 1999;159 (1):65-70 [PubMed]
de Groot MR, van Marwijk Kooy M, Pouwels JG, Engelage AH, Kuipers BF, Büller HR, The use of a rapid D-dimer blood test in the diagnostic work-up for pulmonary embolism: a management study. THROMB HAEMOSTASIS 1999;82 (6):1588-1592 [PubMed]
Girolami B, Bernardi E, Prins MH, ten Cate JW, Hettiarachchi R, Prandoni P, Girolami A, Büller HR, Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. ARCH INTERN MED 1999;159 (4):337-345 [PubMed]
Girolami B, Bernardi E, Prins MH, ten Cate JW, Prandoni P, Hettiarachchi R, Marras E, Stefani PM, Girolami A, Büller HR, Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis. THROMB HAEMOSTASIS 1999;81 (5):715-722 [PubMed]
Hettiarachchi RJ, Smorenburg SM, Ginsberg J, Levine M, Prins MH, Büller HR, Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread. THROMB HAEMOSTASIS 1999;82 (2):947-952 [PubMed]
Hutten BA, Prins MH, Redekop WK, Tijssen JG, Heisterkamp SH, Büller HR, Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists. THROMB HAEMOSTASIS 1999;82 (4):1260-1263 [PubMed]
Kruip MJ, Slob MJ, Büller HR, van der Heul C, A prospective clinical study on the feasibility and safety of a combined noninvasive/pulmonary angiography strategy in patients with suspected pulmonary embolism: an interim analysis. CLIN APPL THROMB-HEM 1999;5 (4):222-225 [PubMed]
Kuijer PM, Hutten BA, Prins MH, Büller HR, Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. ARCH INTERN MED 1999;159 (5):457-460 [PubMed]
Lensing AW, Prandoni P, Prins MH, Büller HR, Deep-vein thrombosis. LANCET 1999;353 (9151):479-485 [PubMed]
Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briët E , Büller HR, Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. LANCET 1999;354 (9194):1940-1947 [PubMed]
Levi M, Hart W, Büller HR, Fysische diagnostiek--het teken van Homans. NED TIJDSCHR GENEESKD 1999;143 (37):1861-1863 [PubMed]
Levi M, Middeldorp S, Büller HR, Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism. CARDIOVASC RES 1999;41 (1):21-24 [PubMed]
Mainardi JR, Pelsma PM, Koning H, van der Meer J, Middeldorp S, Büller HR, Hamulyák K, Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis. BLOOD 1999;94 (5):1828-1829 [PubMed]
Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J, Increased risk for fetal loss in carriers of the factor V Leiden mutation. ANN INTERN MED 1999;130 (9):736-739 [PubMed]
Moons KG, van Es GA, Michel BC, Büller HR, Habbema JD, Grobbee DE, Redundancy of single diagnostic test evaluation. EPIDEMIOLOGY 1999;10 (3):276-281 [PubMed]
Peters RJ, Moons AH, Büller HR, Trombocytenreceptoren: huidige inzichten en behandelingsmogelijkheden. NED TIJDSCHR GENEESKD 1999;143 (39):1952-1957 [PubMed]
Planès A, Samama MM, Lensing AW, Büller HR, Barre J, Vochelle N, Beau B, Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin. THROMB HAEMOSTASIS 1999;81 (1):22-25 [PubMed]
Prins MH, Hutten BA, Koopman MM, Büller HR, Long-term treatment of venous thromboembolic disease. THROMB HAEMOSTASIS 1999;82 (2):892-898 [PubMed]
Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G, Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. LANCET 1999;354 (9195):2036-2040 [PubMed]
Sanson BJ, Büller H, Is there a role for thrombolytic therapy in venous thromboembolism?. HAEMOSTASIS 1999;29 (Suppl. S1):81-83 [PubMed]
Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E, Brenner B, Dulitzky M, Nielsen JD, Boda Z, Turi S, Mac Gillavry MR, Hamulyák K, Theunissen IM, Hunt BJ, Büller HR, Safety of low-molecular-weight heparin in pregnancy: a systematic review. THROMB HAEMOSTASIS 1999;81 (5):668-672 [PubMed]
Sanson BJ, Meinders AJ, Kraaijenhagen RA, van Beek EJ, Büller HR, Requirements for appropriate evaluation of diagnostic tests in suspected pulmonary embolism. MONALDI ARCH CHEST DIS 1999;54 (5):417-421 [PubMed]
Sanson BJ, Meinders AJ, Kraaijenhagen RA, van Beek EJ, Büller HR, Requirements for appropriate evaluation of diagnostic tests in suspected pulmonary embolism. HAEMATOLOGICA 1999;84 (Suppl. EHA-4):78-81 [PubMed]
Sanson BJ, Simioni P, Tormene D, Moia M, Friederich PW, Huisman MV, Prandoni P, Bura A, Rejto L, Wells P, Mannucci PM, Girolami A, Büller HR, Prins MH, The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. BLOOD 1999;94 (11):3702-3706 [PubMed]
Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, Gavasso S, Huisman MV, Büller HR, ten Cate JW, Girolami A, Prins MH, Incidence of venous thromboembolism in families with inherited thrombophilia. THROMB HAEMOSTASIS 1999;81 (2):198-202 [PubMed]
Smorenburg SM, Hettiarachchi RJ, Vink R, Büller HR, The effects of unfractionated heparin on survival in patients with malignancy--a systematic review. THROMB HAEMOSTASIS 1999;82 (6):1600-1604 [PubMed]
Smorenburg SM, Vink R, te Lintelo M, Tigchelaar W, Maas A, Büller HR, van Noorden CJ, In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis. CLIN EXP METASTAS 1999;17 (5):451-456 [PubMed]
ten Cate JW, Büller HR, Klinisch onderzoekers en farmaceutische industrie. Een relatie met voor- en nadelen. NED TIJDSCHR GENEESKD 1999;143 (30):1572-1576 [PubMed]
ten Cate JW, Büller HR, Randomised evaluation of treatment modalities in thromboembolic disorders. HAEMATOLOGICA 1999;84 (Suppl. EHA-4):85-87 [PubMed]
Turkstra F, Karemaker R, Kuijer PM, Prins MH, Büller HR, Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?. THROMB HAEMOSTASIS 1999;81 (3):345-348 [PubMed]
van Pampus MG, Dekker GA, Wolf H, Huijgens PC, Koopman MM, von Blomberg BM, Büller HR, High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. AM J OBSTET GYNECOL 1999;180 (5):1146-1150 [PubMed]
van Pampus MG, Koopman MM, Wolf H, Büller HR, Prins MH, van den Ende A, Lipoprotein(a) concentrations in women with a history of severe preeclampsia--a case control study. THROMB HAEMOSTASIS 1999;82 (1):10-13 [PubMed]
Wittekoek ME , de Groot E, Prins MH, Trip MD, Büller HR, Kastelein JJ, Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease. ATHEROSCLEROSIS 1999;146 (2):271-279 [PubMed]
Büller HR, Outpatient therapy with low-molecular-weight heparins: new perspectives for treatment of deep vein thrombosis. HAEMOSTASIS 1998;28 (Suppl. 3):91-94 [PubMed]
Büller HR, Kraaijenhagen RA, Koopman MM, Early discharge strategies following venous thrombosis. VASC MED 1998;3 (1):47-50 [PubMed]
Büller H, ten Cate JW, Primary venous thromboembolism and cancer screening. NEW ENGL J MED 1998;338 (17):1221-1222 [PubMed]
Chamuleau SA, de Winter RJ, Levi M, Adams R, Büller HR, Prins MH, Lie KI, Peters RJ, Low molecular weight heparin as an adjunct to thrombolysis for acute myocardial infarction: the FATIMA study. Fraxiparin Anticoagulant Therapy in Myocardial Infarction Study Amsterdam (FATIMA) Study Group. HEART 1998;80 (1):35-39 [PubMed]
Cogo A, Lensing AW, Koopman MM, Piovella F, Siragusa S, Wells PS, Villalta S, Büller HR, Turpie AG, Prandoni P, Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ-BRIT MED J 1998;316 (7124):17-20 [PubMed]
de Groot MR, Büller HR, ten Cate JW, van Marwijk Kooy M, Use of a heparin nomogram for treatment of patients with venous thromboembolism in a community hospital. THROMB HAEMOSTASIS 1998;80 (1):70-73 [PubMed]
Hettiarachchi RJ, Lok J, Prins MH, Büller HR, Prandoni P, Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis. CANCER-AM CANCER SOC 1998;83 (1):180-185 [PubMed]
Hettiarachchi RJ, Prins MH, Lensing AW, Buller HR, Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism. CURR OPIN PULM MED 1998;4 (4):220-225 [PubMed]
Koopman MM, Büller HR, Low-molecular-weight heparins in the treatment of venous thromboembolism. ANN INTERN MED 1998;128 (12 Part 1):1037-1039 [PubMed]
Kraaijenhagen RA, Lensing AW, Wallis JW, van Beek EJ, ten Cate JW, Büller HR, Diagnostic management of venous thromboembolism. BAILLIERES CLIN HAEMATOL 1998;11 (3):541-586 [PubMed]
Levi M, Peters RJ, Büller HR, Weight watching in cardiology: low molecular weight heparin for acute coronary syndromes. CARDIOVASC RES 1998;37 (3):564-566 [PubMed]
Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR, The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. ANN INTERN MED 1998;128 (1):15-20 [PubMed]
Turkstra F, van Beek EJ, Büller HR, Observer and biological variation of a rapid whole blood D-dimer test. THROMB HAEMOSTASIS 1998;79 (1):91-93 [PubMed]
van den Belt AG, Bossuyt PM, Prins MH, Gallus AS, Büller HR, Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group. THROMB HAEMOSTASIS 1998;79 (2):259-263 [PubMed]
Biemond BJ, Friederich PW, Koschinsky ML, Levi M, Sangrar W, Xia J, Büller HR, ten Cate JW, Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo. CIRCULATION 1997;96 (5):1612-1615 [PubMed]
Brandjes DP, Büller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, ten Cate JW, Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. LANCET 1997;349 (9054):759-762 [PubMed]
Graafsma YP, Prins MH, Lensing AW, de Haan RJ, Huisman MV, Büller HR, Bleeding classification in clinical trials: observer variability and clinical relevance. THROMB HAEMOSTASIS 1997;78 (4):1189-1192 [PubMed]
Kraaijenhagen RA, Lensing AW, Lijmer JG, Prandoni P, Prins MH, Ginsberg JS, Buller HR, Diagnostic strategies for the management of patients with clinically suspected deep-vein thrombosis. CURR OPIN PULM MED 1997;3 (4):268-274 [PubMed]
Kuijer PM, Turkstra F, van Beek EJ, ten Cate JW, Büller HR, A survey of the diagnostic and therapeutic management of patients with suspected pulmonary embolism in the Netherlands. NETH J MED 1997;50 (6):261-266 [PubMed]
Michel BC, Kuijer PM, McDonnell J, van Beek EJ, Rutten FF, Büller HR, The role of a decision rule in symptomatic pulmonary embolism patients with a non-high probability ventilation-perfusion scan. THROMB HAEMOSTASIS 1997;78 (2):794-798 [PubMed]
Moons KG, Stijnen T, Michel BC, Büller HR, van Es GA, Grobbee DE, Habbema JD, Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curves. MED DECIS MAKING 1997;17 (4):447-454 [PubMed]
tenCate JW, Buller HR, Gent M, Hirsh J, Prins MH, Baildon R, Lensing AWA, Anderson DR, vanBeek EJR, Fiesinger JN, Tijssen JGP, vanBarneveld A, Eimers LT, Graafsma YP, Hettiarachchi R, Hutten B, Redekop K, Haley S, LIberale L, Finch T, Whittaker S, Wilkinson L, Prandoni P, Villalta S, Girolami B, Bagatella P, Rossi L, Girolami A, Piovella F, Barone M, Beltrametti C, Serafini S, Siragusa S, Ascari E, Kovacs MJ, Morrow B, Kovacs J, Kuijer PMM, Koopman MMW, Jagt H, Weitz J, Kearon C, Biagioni L, Haas S, Lossner F, Spengel FA, Berger M, Demers C, Poulin J, vanderMeer J, Que GTH, Smid WM, Robinson KS, Boyle E, Leclerc JR, StJacques B, Finkenbine S, Gallus AS, Cohlan D, Rich C, Brandjes DPM, Hoefnagel CA, deRijk M, Turkstra F, Desjardins L, CoteDesjardins J, Couture L, Ruel M, Villenueve J, Geerts WH, Jay RM, Code EKI, Turpie AGG, Johnson J, Nguyen P, Cusson JR, Roy S, Wells PS, Bormanis J, Goudie D, Cruickshank M, vonLewinski M, Monreal M, Sahuquillo JC, Lafoz E, Simonneau G, Parent F, Jagot J, Douketis JD, Kinnon K, Ginsberg JS, BrillEdwards P, Donovan D, Ockelford PA, Kassis J, Bornais S, Planchon B, Elkouri D, Pistorius MA, Escribano M, Garrido G, Chesterman CN, Chong BH, Pritchard S, Cade JF, Bynon T, Stanford J, Brien WM, Palmer B, Faivre R, Petiteau B, Manucci PM, Moia M, Bucciarelli P, Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. NEW ENGL J MED 1997;337 (10):657-662 [PubMed]
Turkstra F, Koopman MM, Büller HR, The treatment of deep vein thrombosis and pulmonary embolism. THROMB HAEMOSTASIS 1997;78 (1):489-496 [PubMed]
Turkstra F, Kuijer PM, van Beek EJ, Brandjes DP, ten Cate JW, Büller HR, Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. ANN INTERN MED 1997;126 (10):775-781 [PubMed]
van Beek EJ, Kuijer PM, Büller HR, Brandjes DP, Bossuyt PM, ten Cate JW, The clinical course of patients with suspected pulmonary embolism. ARCH INTERN MED 1997;157 (22):2593-2598 [PubMed]
van den Belt AG, Sanson BJ, Simioni P, Prandoni P, Büller HR, Girolami A, Prins MH, Recurrence of venous thromboembolism in patients with familial thrombophilia. ARCH INTERN MED 1997;157 (19):2227-2232 [PubMed]
Biemond BJ, Friederich PW, Levi M, Vlasuk GP, Büller HR, ten Cate JW, Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis. CIRCULATION 1996;93 (1):153-160 [PubMed]
Büller HR, Koopman MM, Diagnostic and therapeutic management of patients with deep-vein thrombosis: coming to maturity?. NETH J MED 1996;48 (3):81-84 [PubMed]
Büller HR, Koopman MM, Brandjes DP, van der Meer J, Prins MH, ten Cate JW, Diepe veneuze trombose: leiden de recentelijk verbeterde inzichten tot echte vooruitgang in de directe patiëntenzorg?. NED TIJDSCHR GENEESKD 1996;140 (11):587-590 [PubMed]
Friederich PW, Sanson BJ, Simioni P, Zanardi S, Huisman MV, Kindt I, Prandoni P, Büller HR, Girolami A, Prins MH, Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. ANN INTERN MED 1996;125 (12):955-960 [PubMed]
Knipscheer HC, Boelen CC, Kastelein JJ, van Diermen DE, Groenemeijer BE, van den Ende A, Büller HR, Bakker HD, Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. PEDIATR RES 1996;39 (5):867-871 [PubMed]
Meenan J, Hommes DW, Mevissen M, Dijkhuizen S, Soule H, Moyle M, Büller HR, ten Kate FW, Tytgat GN, van Deventer SJ, Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist. SCAND J GASTROENTERO 1996;31 (8):786-791 [PubMed]
Michel BC, Seerden RJ, Rutten FF, van Beek EJ, Büller HR, The cost-effectiveness of diagnostic strategies in patients with suspected pulmonary embolism. HEALTH ECON 1996;5 (4):307-318 [PubMed]
Michel BC, Seerden RJ, van Beek EJ, Büller HR, Rutten FF, Kosten van diagnostiek en behandeling wegens longembolie lager door toepassing van de consensusstrategie. NED TIJDSCHR GENEESKD 1996;140 (37):1864-1868 [PubMed]
Nurmohamed MT, van Riel AM, Henkens CM, Koopman MM, Que GT, d'Azemar P, Büller HR, ten Cate JW, Hoek JA, van der Meer J, van der Heul C, Turpie AG, Haley S, Sicurella A, Gent M, Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. THROMB HAEMOSTASIS 1996;75 (2):233-238 [PubMed]
Prins JM, Büller HR, Meta-analysis: the final answer, or even more confusion?. LANCET 1996;348 (9021):199 [PubMed]
Roelse JC, Koopman MM, Büller HR, ten Cate JW, Montaruli B, van Mourik JA, Voorbert J, Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis. BRIT J HAEMATOL 1996;92 (3):740-743 [PubMed]
ten Cate H, Biemond BJ, Levi M, Wuillemin WA, Bauer KA, Barzegar S, Buller HR, Hack CE, ten Cate JW, Rosenberg RD, Factor XIa induced activation of the intrinsic cascade in vivo. THROMB HAEMOSTASIS 1996;75 (3):445-449 [PubMed]
Turkstra F, van Beek EJ, ten Cate JW, Büller HR, Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients. THROMB HAEMOSTASIS 1996;76 (1):9-11 [PubMed]
van Beek EJ, Reekers JA, Batchelor DA, Brandjes DP, Büller HR, Feasibility, safety and clinical utility of angiography in patients with suspected pulmonary embolism. EUR RADIOL 1996;6 (4):415-419 [PubMed]
van Beek EJ, Schenk BE, Michel BC, van den Ende B, Brandjes DP, van der Heide YT, Bossuyt PM, Büller H R, The role of plasma D-dimers concentration in the exclusion of pulmonary embolism. BRIT J HAEMATOL 1996;92 (3):725-732 [PubMed]
Biemond BJ, Levi M, ten Cate H, Soule HR, Morris LD, Foster DL, Bogowitz CA, van der Poll T, Büller HR, ten Cate JW, Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. THROMB HAEMOSTASIS 1995;73 (2):223-230 [PubMed]
Biemond BJ, Levi M, ten Cate H, van der Poll T, Büller HR, Hack CE, ten Cate JW, Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. CLIN SCI 1995;88 (5):587-594 [PubMed]
Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP, Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. LANCET 1995;346 (8990):1593-1596 [PubMed]
Büller HR, ten Cate T, Coagulation and platelet activation pathways. A review of the key components and the way in which these can be manipulated. EUR HEART J 1995;16 (Suppl. L):8-10 [PubMed]
Cogo A, Lensing AW, Wells P, Prandoni P, Büller HR, Noninvasive objective tests for the diagnosis of clinically suspected deep-vein thrombosis. HAEMOSTASIS 1995;25 (1-2):27-39 [PubMed]
Koopman MM, Büller HR, ten Cate JW, Diagnosis of recurrent deep vein thrombosis. HAEMOSTASIS 1995;25 (1-2):49-57 [PubMed]
Prins JM, Koopmans RP, Büller HR, Kuijper EJ, Speelman P, Easier monitoring of aminoglycoside therapy with once-daily dosing schedules. EUR J CLIN MICROBIOL 1995;14 (6):531-535 [PubMed]
Tange RA, Dreschler WA, Prins JM, Büller HR, Kuijper EJ, Speelman P, Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial. CLIN OTOLARYNGOL ALL 1995;20 (2):118-123 [PubMed]
ten Cate JW, Koopman MM, Prins MH, Büller HR, Treatment of venous thromboembolism. THROMB HAEMOSTASIS 1995;74 (1):197-203 [PubMed]
van Beek EJ, Kuyer PM, Schenk BE, Brandjes DP, ten Cate JW, Büller HR, A normal perfusion lung scan in patients with clinically suspected pulmonary embolism. Frequency and clinical validity. CHEST 1995;108 (1):170-173 [PubMed]
Biemond BJ, Levi M, Nurmohamed MT, Büller HR, ten Cate JW, Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model. THROMB HAEMOSTASIS 1994;72 (3):377-380 [PubMed]
Jongbloets LM, Lensing AW, Koopman MM, Büller HR, ten Cate JW, Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis. LANCET 1994;343 (8906):1142-1144 [PubMed]
Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Büller HR, van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD, Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J CLIN INVEST 1994;93 (1):114-120 [PubMed]
Nurmohamed MT, Büller HR, ten Cate JW, Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients. DRUG AGING 1994;5 (1):20-33 [PubMed]
Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P, Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial. J ANTIMICROB CHEMOTH 1994;33 (4):823-835 [PubMed]
ten Cate H, Levi M, van der Poll T, Biemond BJ, van Deventer SJ, Buller HR, ten Cate JW, Inhibition of extrinsic coagulation activation in endotoxemia; therapeutic implications. PROG CLIN BIOL RES 1994;388:215-219 [PubMed]
ten Cate H, Schenk BE, Biemond BJ, Levi M, van der Poll T, Buller HR, ten Cate JW, A review of studies of the activation of the blood coagulation mechanism in chimpanzees (Pan troglodytes). J MED PRIMATOL 1994;23 (5):280-284 [PubMed]
van Beek EJ, Büller HR, Bounameaux H, Latex D-dimer for diagnosing pulmonary embolism. J NUCL MED 1994;35 (1):189-190 [PubMed]
van Beek EJ, Büller HR, Brandjes DP, Rutten GC, ten Cate JW, Diagnosis of clinically suspected pulmonary embolism: a survey of current practice in a teaching hospital. NETH J MED 1994;44 (2):50-55 [PubMed]
van Beek EJ, Levi M, Reekers JA, Hack CE, Büller HR, ten Cate JW, Increased plasma levels of PAI-1 after administration of nonionic contrast medium in patients undergoing pulmonary angiography. RADIOLOGY 1994;193 (3):821-823 [PubMed]
van Beek EJ, von der Möhlen MA, ten Cate JW, Brandjes DP, Büller HR, Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study. NETH J MED 1994;45 (5):206-210 [PubMed]
van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Büller HR, Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J EXP MED 1994;179 (4):1253-1259 [PubMed]
van der Poll T, Levi M, van Deventer SJ, ten Cate H, Haagmans BL, Biemond BJ, Büller HR, Hack CE, ten Cate JW, Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. BLOOD 1994;83 (2):446-451 [PubMed]
Voorberg J, Roelse J, Koopman R, Büller H, Berends F, ten Cate JW, Mertens K, van Mourik JA, Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. LANCET 1994;343 (8912):1535-1536 [PubMed]
Büller HR, Hirudin in the treatment of arterial and venous thrombotic diseases: a new perspective. Z KARDIOL 1993;82 (Suppl. 2):81-82 [PubMed]
Cogo A, Lensing AW, Prandoni P, Büller HR, Girolami A, ten Cate JW, Comparison of real-time B-mode ultrasonography and Doppler ultrasound with contrast venography in the diagnosis of venous thrombosis in symptomatic outpatients. THROMB HAEMOSTASIS 1993;70 (3):404-407 [PubMed]
Gianese F, Nurmohamed MT, Imbimbo BP, Büller HR, Berckmans RJ, ten Cate JW, The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure. BRIT J CLIN PHARMACO 1993;35 (3):335-339 [PubMed]
Heijboer H, Büller HR, Lensing AW, Turpie AG, Colly LP, ten Cate JW, A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. NEW ENGL J MED 1993;329 (19):1365-1369 [PubMed]
Oudkerk M, van Beek EJ, van Putten WL, Büller HR, Cost-effectiveness analysis of various strategies in the diagnostic management of pulmonary embolism. ARCH INTERN MED 1993;153 (8):947-954 [PubMed]
Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P, Once versus thrice daily gentamicin in patients with serious infections. LANCET 1993;341 (8841):335-339 [PubMed]
van Beek EJ, Tiel-van Buul MM, Büller HR, van Royen EA, ten Cate JW, The value of lung scintigraphy in the diagnosis of pulmonary embolism. EUR J NUCL MED 1993;20 (2):173-181 [PubMed]
van den Bos AA, Deckers JW, Heyndrickx GR, Laarman GJ, Suryapranata H, Zijlstra F, Close P, Rijnierse JJ, Buller HR, Serruys PW, Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty. CIRCULATION 1993;88 (5 Part 1):2058-2066 [PubMed]
Verstraete M, Nurmohamed M, Kienast J, Siebeck M, Silling-Engelhardt G, Büller H, Hoet B, Bichler J, Close P, Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group. J AM COLL CARDIOL 1993;22 (4):1080-1088 [PubMed]
Wortel CH, van Deventer SJ, Aarden LA, Lygidakis NJ, Büller HR, Hoek FJ, Horikx J, ten Cate JW, Interleukin-6 mediates host defense responses induced by abdominal surgery. SURGERY 1993;114 (3):564-570 [PubMed]
Brandjes DP, Heijboer H, Büller HR, de Rijk M, Jagt H, ten Cate JW, Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. NEW ENGL J MED 1992;327 (21):1485-1489 [PubMed]
Büller HR, Dyserinck HC, Vreeken J, Bakker S, Handleiding of touroperator: wie gidst de clinicus bij het literatuuronderzoek?. NED TIJDSCHR GENEESKD 1992;136 (16):797-800 [PubMed]
de Boer K, Büller HR, ten Cate JW, Levi M, Deep vein thrombosis in obstetric patients: diagnosis and risk factors. THROMB HAEMOSTASIS 1992;67 (1):4-7 [PubMed]
Dekker E, Büller HR, Kastelein JJ, Postmenopauzale oestrogeensubstitutie en het risico van atherosclerotische hart- en vaatziekten. NED TIJDSCHR GENEESKD 1992;136 (25):1197-1200 [PubMed]
Ginsberg JS, Brill-Edwards P, Burrows RF, Bona R, Prandoni P, Büller HR, Lensing A, Venous thrombosis during pregnancy: leg and trimester of presentation. THROMB HAEMOSTASIS 1992;67 (5):519-520 [PubMed]
Heijboer H, Cogo A, Büller HR, Prandoni P, ten Cate JW, Detection of deep vein thrombosis with impedance plethysmography and real-time compression ultrasonography in hospitalized patients. ARCH INTERN MED 1992;152 (9):1901-1903 [PubMed]
Heijboer H, Ginsberg JS, Büller HR, Lensing AW, Colly LP, ten Cate JW, The use of the D-dimer test in combination with non-invasive testing versus serial non-invasive testing alone for the diagnosis of deep-vein thrombosis. THROMB HAEMOSTASIS 1992;67 (5):510-513 [PubMed]
Heijboer H, Jongbloets LM, Büller HR, Lensing AW, ten Cate JW, Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis. ACTA RADIOL 1992;33 (4):297-300 [PubMed]
Hoek JA, Nurmohamed MT, Hamelynck KJ, Marti RK, Knipscheer HC, ten Cate H, Büller HR, Magnani HN, ten Cate JW, Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. THROMB HAEMOSTASIS 1992;67 (1):28-32 [PubMed]
Hommes DW, Bura A, Mazzolai L, Büller HR, ten Cate JW, Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis. ANN INTERN MED 1992;116 (4):279-284 [PubMed]
Lensing AW, Büller HR, Prandoni P, Batchelor D, Molenaar AH, Cogo A, Vigo M, Huisman PM, ten Cate JW, Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis: improvement in observer agreement. THROMB HAEMOSTASIS 1992;67 (1):8-12 [PubMed]
Lensing AW, Prins M, Koopman MM, Buller H, Which heparin for proximal deep-vein thrombosis?. LANCET 1992;340 (8814):311-312 [PubMed]
Levi M, Hack CE, de Boer JP, Brandjes DP, Büller HR, ten Cate JW, Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients. AGENTS ACTIONS SUPPL 1992;38 (2):292-298 [PubMed]
Levi M, Wilmink J, Büller HR, Surachno J, ten Cate JW, Impaired fibrinolysis in cyclosporine-treated renal transplant patients. Analysis of the defect and beneficial effect of fish-oil. TRANSPLANTATION 1992;54 (6):978-983 [PubMed]
Nicolaides AN, Arcelus J, Belcaro G, Bergqvist D, Borris LC, Buller HR, Caprini JA, Christopoulos D, Clarke-Pearson D, Clement D, Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK. INT ANGIOL 1992;11 (3):151-159 [PubMed]
Nurmohamed MT, Rosendaal FR, Büller HR, Dekker E, Hommes DW, Vandenbroucke JP, Briët E, Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. LANCET 1992;340 (8812):152-156 [PubMed]
Prandoni P, Lensing AW, Büller HR, Carta M, Cogo A, Vigo M, Casara D, Ruol A, ten Cate JW, Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. LANCET 1992;339 (8791):441-445 [PubMed]
Prandoni P, Lensing AW, Büller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, ten Cate JW, Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. NEW ENGL J MED 1992;327 (16):1128-1133 [PubMed]
van Beek EJ, Büller HR, van Royen EA, van Everdingen JJ, ten Cate JW, Het diagnostisch beleid bij vermoeden van longembolie: resultaten van een enquête onder Nederlandse internisten en longartsen. NED TIJDSCHR GENEESKD 1992;136 (7):319-323 [PubMed]
van der Poll T, van Deventer SJ, Hack CE, Wolbink GJ, Aarden LA, Büller HR, ten Cate JW, Effects on leukocytes after injection of tumor necrosis factor into healthy humans. BLOOD 1992;79 (3):693-698 [PubMed]
van der Poll T, van Deventer SJ, Pasterkamp G, van Mourik JA, Büller HR, ten Cate JW, Tumor necrosis factor induces von Willebrand factor release in healthy humans. THROMB HAEMOSTASIS 1992;67 (6):623-626 [PubMed]
Brandjes DP, Schenk BE, Büller HR, ten Cate JW, Management of disseminated intravascular coagulation in obstetrics. EUR J OBSTET GYN R B 1991;42 (Suppl):S87-S89 [PubMed]
Büller HR, Lensing AW, Hirsh J, ten Cate JW, Deep vein thrombosis: new non-invasive diagnostic tests. THROMB HAEMOSTASIS 1991;66 (1):133-137 [PubMed]
de Boer K, Büller HR, ten Cate JW, Treffers PE, Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets. BR J OBSTET GYNAECOL 1991;98 (1):42-47 [PubMed]
Heijboer H, ten Cate JW, Büller HR, Diagnosis of venous thrombosis. SEMIN THROMB HEMOST 1991;17 (Suppl. 3):259-268 [PubMed]
Herderscheê D, Limburg M, van Royen EA, Hijdra A, Büller HR, Koster PA, Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF-SPECT. ACTA NEUROL SCAND 1991;83 (5):317-322 [PubMed]
Lensing AW, Büller HR, ten Cate JW, Prandoni P, Confirmation of the failure of computerized impedance plethysmography in the diagnostic management of patients with clinically suspected deep-vein thrombosis. THROMB HAEMOSTASIS 1991;66 (6):744 [PubMed]
Levi M, Hack CE, de Boer JP, Brandjes DP, Büller HR, ten Cate JW, Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo. J CLIN INVEST 1991;88 (4):1155-1160 [PubMed]
Levi M, Lensing AW, Büller HR, Prandoni P, Dooijewaard G, Cuppini S, ten Cate JW, Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release. THROMB HAEMOSTASIS 1991;66 (4):426-429 [PubMed]
Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Vandenbroek MD, Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ-BRIT MED J 1991;303 (6802):543-548 [PubMed]
Prandoni P, Lensing AW, Büller HR, Carta M, Vigo M, Cogo A, Cuppini S, ten Cate JW, Failure of computerized impedance plethysmography in the diagnostic management of patients with clinically suspected deep-vein thrombosis. THROMB HAEMOSTASIS 1991;65 (3):233-236 [PubMed]
Prandoni P, Lensing AW, Huisman MV, Jonker JJ, Vigo M, Borm JJ, Büller HR, Sing AK, Carta M, ten Cate JW, A new computerized impedance plethysmograph: accuracy in the detection of proximal deep-vein thrombosis in symptomatic outpatients. THROMB HAEMOSTASIS 1991;65 (3):229-232 [PubMed]
Rosendaal FR, Heijboer H, Briët E , Büller HR, Brandjes DP, de Bruin K, Hommes DW, Vandenbroucke JP, Mortality in hereditary antithrombin-III deficiency--1830 to 1989. LANCET 1991;337 (8736):260-262 [PubMed]
van der Poll T, Levi M, Büller HR, van Deventer SJ, de Boer JP, Hack CE, ten Cate JW, Fibrinolytic response to tumor necrosis factor in healthy subjects. J EXP MED 1991;174 (3):729-732 [PubMed]
van der Poll T, Romijn JA, Endert E, Borm JJ, Büller HR, Sauerwein HP, Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. AM J PHYSIOL 1991;261 (4 Part 1):E457-E465 [PubMed]
van der Poll T, van Deventer SJ, Büller HR, Sturk A, ten Cate JW, Comparison of the early dynamics of coagulation activation after injection of endotoxin and tumor necrosis factor in healthy humans. PROG CLIN BIOL RES 1991;367:55-60 [PubMed]
van der Poll T, van Deventer SJ, Büller HR, Sturk A, ten Cate JW, Comparison of the early dynamics of systemic prostacyclin release after administration of tumor necrosis factor and endotoxin to healthy humans. J INFECT DIS 1991;164 (3):599-601 [PubMed]
Wiersinga WM, Prummel MF, Mourits MP, Koornneef L, Buller HR, Classification of the eye changes of Graves' disease. THYROID 1991;1 (4):357-360 [PubMed]
Brandjes DP, ten Cate JW, Buller HR, Pre-surgical identification of the patient at risk for developing venous thromboembolism post-operatively. ACTA CHIR SCAND 1990;156 (Suppl 556):18-21 [PubMed]
de Boer K, Büller HR, ten Cate JW, Weenink GH, Treffers PE, Diep veneuze trombose in de zwangerschap: diagnostiek, behandeling en preventie. NED TIJDSCHR GENEESKD 1990;134 (28):1349-1352 [PubMed]
de Vries I, van Deventer SJ, Debets J, Buller HR, ten Cate JW, Pauw W, Statius van Eps LW, Sturk A, Endotoxin-induced cytokines in human septicemia. ADV EXP MED BIOL 1990;256:635-640 [PubMed]
Heijboer H, Brandjes DP, Büller HR, Sturk A, ten Cate JW, Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. NEW ENGL J MED 1990;323 (22):1512-1516 [PubMed]
Lensing AW, Levi MM, Büller HR, Prandoni P, Vigo M, Agnelli G, Lupatelli L, Huisman MV, ten Cate JW, Diagnosis of deep-vein thrombosis using an objective Doppler method. ANN INTERN MED 1990;113 (1):9-13 [PubMed]
Lensing AW, Prandoni P, Büller HR, Casara D, Cogo A, ten Cate JW, Lower extremity venography with iohexol: results and complications. RADIOLOGY 1990;177 (2):503-505 [PubMed]
Nanninga PB, van Teunenbroek A, Veenhof CH, Büller HR, ten Cate JW, Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer. THROMB HAEMOSTASIS 1990;64 (3):361-364 [PubMed]
Stam J, Hommes DW, van der Does MC, ten Cate TJ, Büller HR, Kunnen bijna afgestudeerde artsen hun vakliteratuur interpreteren?. NED TIJDSCHR GENEESKD 1990;134 (17):854-857 [PubMed]
Sturk A, van Deventer SJ, Wortel CH, Levels JH, ten Cate JW, Büller HR, Sanders GT, Detection and clinical relevance of human endotoxemia. Z MED LAB DIAGN 1990;31 (3):147-158 [PubMed]
van der Poll T, Büller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW, Activation of coagulation after administration of tumor necrosis factor to normal subjects. NEW ENGL J MED 1990;322 (23):1622-1627 [PubMed]
van Deventer SJ, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A, Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. BLOOD 1990;76 (12):2520-2526 [PubMed]
Avvisati G, ten Cate JW, Büller HR, Mandelli F, Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. LANCET 1989;2 (8655):122-124 [PubMed]
Büller HR, ten Cate JW, Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate. AM J MED 1989;87 (3B):44S-48S [PubMed]
Hoek JA, Nurmohamed MT, ten Cate JW, Büller HR, Knipscheer HC, Hamelynck KJ, Marti RK, Sturk A, Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement. THROMB HAEMOSTASIS 1989;62 (4):1050-1052 [PubMed]
Huisman MV, Büller HR, ten Cate JW, Heijermans HS, van der Laan J, van Maanen DJ, Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting. ARCH INTERN MED 1989;149 (3):511-513 [PubMed]
Huisman MV, Büller HR, ten Cate JW, van Royen EA, Vreeken J, Kersten MJ , Bakx B, Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. CHEST 1989;95 (3):498-502 [PubMed]
Lensing AW, Prandoni P, Brandjes D, Huisman PM, Vigo M, Tomasella G, Krekt J, ten Cate JW, Huisman MV, Büller HR, Detection of deep-vein thrombosis by real-time B-mode ultrasonography. NEW ENGL J MED 1989;320 (6):342-345 [PubMed]
van Deventer SJ, Debets JM, Büller HR, ten Cate JW, van der Linden CJ, Buurman WA, Nieuwe ontwikkelingen op het gebied van sepsis: tumornecrosisfactor (cachectine). NED TIJDSCHR GENEESKD 1989;133 (1):17-19 [PubMed]
Huisman MV, Büller HR, ten Cate JW, Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis. ARCH INTERN MED 1988;148 (3):681-683 [PubMed]
ten Cate H, Henny CP, ten Cate JW, Büller HR, Clinical studies with low-molecular-weight heparin(oid)s: an interim analysis. AM J HEMATOL 1988;27 (2):146-153 [PubMed]
van Deventer SJ, Buller HR, ten Cate JW, Sturk A, Pauw W, Endotoxaemia: an early predictor of septicaemia in febrile patients. LANCET 1988;1 (8586):605-609 [PubMed]
van Deventer SJ, de Vries I, Statius van Eps LW, Pauw W, Büller HR, Sturk A, ten Cate JW, Endotoxemia, bacteremia and urosepsis. PROG CLIN BIOL RES 1988;272:213-224 [PubMed]
van Deventer SJ, Knepper A, Landsman J, Lawson J, ten Cate JW, Buller HR, Sturk A, Pauw W, Endotoxins in portal blood. HEPATO-GASTROENTEROL 1988;35 (5):223-225 [PubMed]
Huisman MV, Büller HR, ten Cate JW, Kosten-effectiviteitsanalyse van de diagnostiek bij patiënten met diep veneuze trombose. NED TIJDSCHR GENEESKD 1987;131 (14):584-588 [PubMed]
Huisman MV, Heijermans HS, Büller HR, van der Laan J, ten Cate JW, van Maanen DJ, Effectiviteit en veiligheid van herhaalde impedantieplethysmografie alléén ter opsporing van diep veneuze trombose. NED TIJDSCHR GENEESKD 1987;131 (14):580-584 [PubMed]
Sturk A, Morrien-Salomons WM, Huisman MV, Borm JJ, Büller HR, ten Cate JW, Analytical and clinical evaluation of commercial protein C assays. CLIN CHIM ACTA 1987;165 (2-3):263-270 [PubMed]
ten Cate H, Henny CP, ten Cate JW, Büller HR, Dabhoiwala NF, Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate. THROMB HAEMOSTASIS 1987;57 (1):92-96 [PubMed]
van der Sande JJ, Buller HR, Intravascular coagulation in surgery for large acoustic neuromas. J NEUROL NEUROSUR PS 1987;50 (5):648-649 [PubMed]
van Deventer SJ, Pauw W, ten Cate JW, Janssen ME, Büller HR, Sturk A, Clinical evaluation in febrile patients of an optimized endotoxin assay in blood. PROG CLIN BIOL RES 1987;231:489-499 [PubMed]
Büller H, Peters M, Burger B, Nagelkerke N, ten Cate JW, Breederveld C, Heymans H, Vitamin-K status beyond the neonatal period. A prospective study in normal breast-fed and formula-fed infants. EUR J PEDIATR 1986;145 (6):496-499 [PubMed]
Henny CP, ten Cate H, ten Cate JW, Prummel MF, Peters M, Büller HR, Thrombosis prophylaxis in an AT III deficient pregnant woman: application of a low molecular weight heparinoid. THROMB HAEMOSTASIS 1986;55 (2):301 [PubMed]
Huisman MV, Büller HR, ten Cate JW, Vreeken J, Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study. NEW ENGL J MED 1986;314 (13):823-828 [PubMed]
Lensing AW, Levi MM, ten Cate JW, Huisman MW, Büller HR, Trombosediagnostiek in Noord-Holland anno 1985. NED TIJDSCHR GENEESKD 1986;130 (32):1434-1436 [PubMed]
Büller HR, ten Cate JW, Sturk A, Thomas LL, Validity of the endotoxin assay in post surgical patients. PROG CLIN BIOL RES 1985;189:405-417 [PubMed]
Henny CP, ten Cate H, Surachno S, Stevens P, Büller HR, den Hartog M, ten Cate JW, The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis. THROMB HAEMOSTASIS 1985;54 (2):460-462 [PubMed]
Henny CP, ten Cate H, ten Cate JW, Moulijn AC, Sie TH, Warren P, Büller HR, A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs. J LAB CLIN MED 1985;106 (2):187-196 [PubMed]
Huisman MV, Büller HR, Basart DC, ten Cate JW, A comparison of impedance plethysmography and strain gauge plethysmography in the diagnosis of deep venous thrombosis in symptomatic outpatients. THROMB RES 1985;40 (4):533-541 [PubMed]
Huisman MV, ten Cate JW, Büller HR, Oral anticoagulants after calf-vein thrombosis. LANCET 1985;2 (8462):1011 [PubMed]
Hull RD, Hirsh J, Carter CJ, Jay RM, Ockelford PA, Buller HR, Turpie AG, Powers P, Kinch D, Dodd PE, Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial. ANN INTERN MED 1985;102 (1):21-28 [PubMed]
ten Cate H, Henny CP, ten Cate JW, Büller HR, Mooy MC, Surachno S, Wilmink JM, Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients. THROMB RES 1985;39 (2):211-222 [PubMed]
Basart DC, Huisman MV, Büller HR, Ockelford PA, ten Cate JW, Grasboer A, Marsman JW, Vreeken J, Evaluation of impedance plethysmography as a single non-invasive test for the diagnosis of clinically suspected deep vein thrombosis. NETH J MED 1984;27 (6):197-201 [PubMed]
Büller HR, ten Cate JW, Vreeken J, Diagnostiek van diep veneuze trombose. II. Strategie van onderzoek. NED TIJDSCHR GENEESKD 1984;128 (49):2312-2314 [PubMed]
Büller HR, ten Cate JW, Vreeken J, Diagnostiek van diep veneuze trombose. I. Methoden van onderzoek. NED TIJDSCHR GENEESKD 1984;128 (49):2307-2312 [PubMed]
Henny CP, ten Cate H, Dabhoiwala NF, Büller HR, ten Cate JW, Effect of hormonal manipulation on antithrombin III activity in patients with prostatic carcinoma. EUR UROL 1984;10 (3):202-206 [PubMed]
ten Cate H, Henny CP, Büller HR, ten Cate JW, Magnani HN, Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease. ANN NEUROL 1984;15 (3):268-270 [PubMed]
Thomas LL, Sturk A, Büller HR, ten Cate JW, Spijker RE, ten Cate H, Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures. AM J CLIN PATHOL 1984;82 (2):203-206 [PubMed]
Büller HR, Hobbelen PM, Princen AW, Moelker HC, ten Cate JW, The effects of antithrombin III, heparin and a novel heparinoid infusions on the bleeding tendency using an experimental model in the rat. THROMB RES 1983;31 (6):787-797 [PubMed]
Büller HR, Ockelford PA, Hull RD, Strategies to diagnosis and screening of deep venous thrombosis and pulmonary embolism. NETH J SURG 1983;35 (4):121-128 [PubMed]
Büller HR, ten Cate JW, Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation. THROMB HAEMOSTASIS 1983;49 (2):128-131 [PubMed]
Henny CP, Lim AE, Brummelkamp WH, Buller HR, ten Cate JW, A review of the importance of acute multidisciplinary treatment following spontaneous rupture of the liver capsule during pregnancy. SURG GYNECOL OBSTET 1983;156 (5):593-598 [PubMed]
Hull RD, Hirsh J, Carter CJ, Jay RM, Dodd PE, Ockelford PA, Coates G, Gill GJ, Turpie AG, Doyle DJ, Buller HR, Raskob GE, Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. ANN INTERN MED 1983;98 (6):891-899 [PubMed]
Richard LC, Büller HR, Bovilland J, ten Cate JW, Influence of anaesthesia on coagulation and fibrinolytic proteins. BRIT J ANAESTH 1983;55 (9):869-872 [PubMed]
Bolwerk CJ, Henny CP, Büller HR, ten Cate JW, Hereditary AT III deficiency and heparin. THROMB RES 1982;28 (5):689-691 [PubMed]
Büller HR, Bolwerk C, ten Cate J, Roos J, Kahlé LH, ten Cate JW, Postoperative hemostatic profile in relation to gram-negative septicemia. CRIT CARE MED 1982;10 (5):311-315 [PubMed]
Büller HR, Boon TA, Henny CP, Dabhoiwala NF, ten Cate JW, Estrogen-induced deficiency and decrease in antithrombin III activity in patients with prostatic cancer. J UROLOGY 1982;128 (1):72-74 [PubMed]
Henny CP, Lim TE, Brummelkamp WH, Büller HR, ten Cate JW, Spontaneous rupture of Glisson's capsule during pregnancy. An acute surgical emergency. NETH J SURG 1982;34 (2):72-75 [PubMed]
Henny CP, ten Cate H, Büller HR, ten Cate JW, Ambulatory heparin treatment. LANCET 1982;1 (8272):615 [PubMed]
Thomas LL, Henny CP, Büller HR, Sturk A, Joop K, ten Cate JW, Chromogenic endotoxin determination in blood--clinical relevance. KLIN WOCHENSCHR 1982;60 (14):759-760 [PubMed]
Büller HR, ten Cate JW, Zwangerschap en ontstolling. NED TIJDSCHR GENEESKD 1981;125 (18):710-713 [PubMed]
Büller HR, Weenink AH, Treffers PE, Kahlé LH, Otten HA, ten Cate JW, Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion. SCAND J HAEMATOL 1980;25 (1):81-86 [PubMed]
Key publications

van Vlijmen EFW, Veeger NJGM, Middeldorp S, Hamulyák K, Prins MH, Büller HR, Meijer K, Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. BLOOD 2011;118 (8):2055-61; quiz 2375 [PubMed]
Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M, Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. CIRCULATION 2011;124 (14):1573-1579 [PubMed]
Buller HR, Lensing AWA, Prins MH, Oral Rivaroxaban for Symptomatic Venous Thromboembolism REPLY. NEW ENGL J MED 2011;364 (12):1178
Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M [Contributors: Connolly SC, Crowther M, Eikelboom J, Gibson M, Milling TJ, Albaladejo P, Cohen A, Lopez-Sendon J, Middeldorp S, Schmidt J, Verhamme P, Beyer-Westendorf J, Wyse DG, Garcia D, Prins M, Nakamya J, Büller HR, Mahaffey K, Alexander J, Demchuk A, Raskob G, Schulman S, Meeks B, Zotova E, Holadyk-Gris I, Pinto T, Behr M, Lim T, Anand R, Bastani A, Caterino J, Clark C, Concha M, Cornell J, Eriksson E, Fermann G, Fulmer J, Goldstein J, Kereiakes D, Lotfipour S, Milling T, Moll S, Pallin D, Patel N, Refaai M, Rehman M, Schmaier A, Schwarz E, Shillinglaw W, Sinert R, Singer A, Takata T, Venkat A, Weinstein D, Welker J, Welsby I, Wiener S, Wilson J, Blostein M, van Keer L, Verschuren F, Coppens M, van Wissen S, Alikhan R, Breen K, Hall R]] , Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. NEW ENGL J MED 2016;375 (12):1131-1141 [PubMed]
Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI, Thrombosis: a major contributor to global disease burden. ARTERIOSCL THROM VAS 2014;34 (11):2363-2371 [PubMed]


All Publications

Research programmes

Venous and arterial thromboembolic diseases

In the area of diagnosis and treatment of venous thrombosis and pulmonary embolism there are still some major challenges. The use of simple clinical prediction rules and bedside blood tests that can be safely used in the family care setting is an important research focus of dr. Büller at the present time. In collaboration with colleagues from the Universities of Utrecht and Maastricht two large clinical outcome studies are underway. He has played a crucial role in the design and execution of these projects.

Other diagnostic studies under his supervision focus on improving both the use of ultra sonography and spiral CT, with particular emphasis on further simplifying the algorithms and improving the quality of life of patients. With respect to treatment dr. Büller currently leads as chairman of the steering committee at least five international clinical studies with new simple oral or subcutaneous antithrombotic agents in patients with venous thromboembolism or arterial fibrillation.

Theme: Cardiovascular Diseases

Faculty
Prof. dr. H.R. Büller
Prof. dr. S. Middeldorp MD PhD

PhD Students
N. Kraaijpoel MD
F.I. Mulder

Other research related activities
  • None reported
Current research funding
  • AMC